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Abstract 
D-Hydrox isocaproate Dehydrogenase: A Broad Specificity 
D-2-H dy roxyacid Dehydro eease 
L. bulgaricus D-2-hydroxyisocaproate dehydrogenase (D-HicDH) catalyses 
the NAD+-dependent stereospecific and reversible reduction of a broad 
spectrum of aliphatic and aromatic 2-ketoacids. 
Numerous crystal forms of the wild type and H205Q mutant D-HicDH 
were found. However, attempts at phasing the subsequent diffraction data 
using several molecular replacement programs were unsuccessful. 
The multiple isomorphous replacement method was then used to try and 
phase the D-HicDH data sets. Unfortunately, suitable heavy atom derivatives 
were not found. 
The multiwavelength anomalous dispersion phasing method was then 
employed to try and solve the D-HicDH structure. In order to obtain a usable 
anomalous signal, methionine residues in the protein had to be substituted 
for selenomethionine. 100% Selenomethionyl incorporation into the protein 
was eventually achieved by transforming the plasmid harbouring the D- 
HicDH gene into a methionine auxotrophic cell strain. However, the 
subsequent Se-Met D-HicDH were not of sufficient quality for MAD phasing 
experiments. 
PtLDH Stability Studies 
The L-lactate dehydrogenase from Plasmodium falciparum is a target for 
antimalarial drug design. Previous kinetic experiments had shown the 
enzyme to be catalytically unstable against oxidation. This was thought to be 
the result of inappropriate inter-subunit disulphide bond formation. In order 
to stabilise the enzyme, one of the cysteine residues at the subunit interface 
was mutated to valine, alanine and serine. 
The mutant crystal structures reveal that the initial enzymatic rate is 
dependent on the degree to which the dimer subunit has been perturbed. 
All three mutant PJLDH structures clearly show electron density for a 
glycerol molecule at the dimer interface of the tetramer. This is interesting 
because 10% glycerol is known to stabilise the tetramer. Thus, it may be 
possible to further enhance the stabilisation of the oligomeric state of the 
enzyme by using other small solutes such as sucrose and glucose. 
Recombinant Triple Mutant Pig M4 LDH 
Pig M4 L-LDH is used as a model for human M4 L-LDH in antimalarial 
selectivity studies. In order to overproduce the enzyme, the gene encoding 
the pig muscle LDH had previously been ligated into a pKK plasmid, this 
was then transfomed into an E. coli strain. On sequencing of the gene 3 sets 
of non-silent mutations were discovered. This had the effect of mutating 3 
residues in the protein. Even though the mutations are at remote sites from 
the active site, the recombinant triple mutant pig M4 LDH has a kýat drop of 
40% compared to the wild type. The crystal structure of the mutant has been 
solved. The model shows that the loss in activity of the mutant could 
probably be attributed to a destabilising change due to the S202N mutation. 
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B. sterothermophilus (bs) 
E. coli 
H. methylovorum 
L. case i 
L. bulgaricus 
L. helveticus 





Lactobacillus delbrueckii subsp. bulgaricus 
Lactobacillus helveticus 
Plasmodium falciparum 
ADH alcohol dehydrogenase 
D-GDH glycerate dehydrogenase 
D-HicDH D-hydroxyisocaproate dehydrogenase 
or Broad specificity D-hydroxyacid dehydrogenase 
D-LDH D- isomer specific lactate dehydrogenase 
D-3PGDH D- 3-phosphoglycerate dehydrogenase 
HADH Short-chain L-3-hydroxacyl-CoA dehydrogenase 
L-HicDH L-hydroxyisocaproate dehydrogenase 
or Broad specificity L-hydroxyacid dehydrogenase 
L-LDH L- isomer specific lactate dehydrogenase 
LDH lactate dehydrogenase 
MDH malate dehydrogenase 
ADP Adenosine diphosphate 
AMP Adenosine monophosphate 
ATP Adenosine triphosphate 
cAMP cyclic adenosine 3', 5'-monophosphate 
CRP cAMP receptor protein 
DDT dichlorodiphenyl-trichloroethane 
DHAP Dihydroxyacetone phosphate 
DNA Deoxyribonucleic acid 
DTT Dithiothreitol 
EDTA Ethylene diamine tetraacetic acid 
GNDA Gossylic nitrile diacetate 
HEPES N- 2- hydroxyethylpiperazine- N'-2- ethane sulphonic acid 
IPTG Isopropyl (3-D-thiogalactoside 
L Broth Luria broth 
LB Agar Luria-Bertani agar 
MES 2- [N-Morpholino] ethane sulphonic acid 
NAD+ Nicotinamide adenine dinucleotide (oxidized form) 
NADH Nicotinamide adenine dinucleotide (reduced form) 
NADP+ Nicotinamide adenine dinucleotide phosphate (oxidized 
form) 
NADPH Nicotinamide adenine dinucleotide phosphate (reduced form) 
PAGE Polyacrylamide gel electrophoresis 
PEG Polyethylene glycol 
RNA Ribonucleic acid 
iv 
SDS Sodium dodecyl sulphate 
Se-Met Selenomethionine 
TEA Triethanolamine 
tNADH 1,4,5,6- tetrahydronicotinamide adenine dinucleotide 
UV Ultra-violet radiation 
YT Yeast tryptone 
A Absorbance 
°C Degrees Celsius 
D Daltons 
g Relative centrifugal force (in multiples of gravitational force) 
g Gram 







O. D. Optical density 
rpm Revolutions per minute 
U Unit of enzyme activity (µmol NADH oxidized / min) 
A Angstom units (1x101° metres) 
a, b, c, a, (3, y Real space unit cell dimensions 
B-factor Temperature factor 
dm;,, Minimum Bragg spacing 
h, k, 1 Reciprocal lattice points (and indices of a reflection) 
Fhkj Structure factor for the h, k, l reflection 
IFobsI Observed structure factor amplitude 
IFcaicl Calculated structure factor amplitude 
NCS Non-crystallographic symmetry 
MAD Multiple Anomalous Dispersion 
or Multiwavelength Anomalous Diffraction 
MIR Multiple Isomorphous Replacement 
MR Molecular Replacement 
PDB Protein Data Bank 
Rcryst Crystallographic R-factor 
Rfree Free R-factor 
r. m. s. d. Root-mean-square deviation 
SIR Single Isomorphous Replacement 
SRS Synchrotron radiation source 
x, y, z Real space cartesian coordinates 
MS Mass Spectrometry 
MALDI Matrix-Assisted Laser Desorption Ionization 
ESI Electrospray Ionization 
V 
Unit Prefix 
k Kilo (103) 
c Centi (10-2) 
m milli (10-3) 
µ Micro (10-6) 
n Nano (10-9) 
p Pico (10-12) 







One letter code Three letter code Full name 
A Ala Alanine 
C Cys Cysteine 
D Asp Aspartate 
E Glu Glutamate 
F Phe Phenylalanine 
G Gly Glycine 
H His Histidine 
I Ile Isoleucine 
K Lys Lysine 
L Leu Leucine 
M Met Methionine 
N Asn Asparagine 
P Pro Proline 
Q Gln Glutamine 
R Arg Arginine 
S Ser Serine 
T Thr Threonine 
V Val Valine 
W Trp Tryptophan 
Y Tyr Tyrosine 
Amino Acid Mutation Nomenclature 
e. g. H205Q: The 205th amino acid residue histidine has been replaced by a 
glutamine residue. 
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L and D -2-Hydroxyacid Dehydrogenases 
1.1 Enzymes 
The enormous variety of biochemical reactions that comprise life are nearly all 
mediated by a series of biological catalysts known as enzymes. 
Enzymes differ from chemical catalysts in several respects. Firstly, the rates of 
enzyme catalysed reactions are at least several orders of magnitude greater than 
those of the corresponding chemically catalysed reactions, and typically 106 to 
1012 orders of magnitude greater than the uncatalysed reactions. Secondly, the 
catalytic activities of many enzymes are regulated; this control can be mediated 
through the concentration of the enzyme's substrates, products or some other 
molecule. The regulatory process initiated could lead to a covalent or allosteric 
modification of the catalyst, or a change in the amounts of enzyme synthesised. 
Furthermore, in contrast to chemical catalysts, enzyme catalysed reactions occur 
in milder conditions. For instance, most biochemical reactions occur below 
100°C (most occuring between 25-40°C), at around neutral pH, and usually at 
atmospheric pressure. Another advantage of enzymes over conventional 
chemical catalysts is that the biochemical catalysts are highly specific: An 
enzyme usually catalyses a single chemical reaction or a set of closely related 
reactions. 
These properties make enzymes extremely useful as catalysts for a broad 
range of organic synthetic reactions used in the pharmaceutical industries, with 
their capacities for producing chirally pure compounds being the most exploited. 
1 
A class of enzymes widely applied in organic synthesis is the dehydrogenases. 
1.2 Dehydrogenases 
Physiologically, the role of the dehydrogenases is to catalyse important redox 
reactions involved in the metabolism and energy conversion of living cells. 
There are many dehydrogenase subfamilies; these include the short-chain, 
medium-chain and 2-hydroxyacid dehydrogenases. 
The short-chain dehydrogenase subfamily consists of enzymes such as short- 
chain L-3-hydroxyacyl-coA dehydrogenases (HADH) which catalyse the third 
step in the fatty acid (3-oxidation pathway in mitochondria, converting L-3- 
hydydroxyacyl-Coenzyme A to 3-ketoacyl-coenzyme with the concurrent 
reduction of NAD+ (Noyes and Bradshaw, 1973). 
The medium-chain dehydrogenase subfamily is comprised of enzymes such as 
the various classes of medium-chain alcohol dehydrogenases (ADH) that 
cataylse the oxidation of alcohols to aldehydes using NADH as a cofactor 
(Schwartz et al., 1979). 
From an industrial point of view, one of the most valuable groups of 
dehydrogenases are the NAD+- (and to a lesser extent NADP+-) -dependent-2- 
hydroxyacid dehydrogenases (Hummel and Kula, 1989). This is because chirally 
pure 2-hydroxyacids are valuable compounds for the production of various 
pharmaceuticals such as penicillins, cephalosporins, anti-hypertensives, anti- 
obesity compounds, sweetners, etc. Also, the 2-hydroxyacid dehydrogenases 
themselves are often the targets of inhibitory rational drug-design (e. g. Dunn et 
al., 1996). 
2 
1.3 NAD+-dependent 2-H dy roxyacid Dehydrogenases 
Despite the widespread use of 2-hydroxyacid dehydrogenases, much remains 
to be learned about the factors that determine the specificity and 
stereospecificity of these enzymes. However, because of the increasingly broad 
spectrum of new or unnatural substrates that the enzymes are called upon to 
catalyse, it is becoming essential that the structural basis of substrate specificity 
and stereospecificity is understood. As well as advancing knowledge of the 
physiological functions performed by the enzymes, this information would also 
aid in the rational modification of enzyme specificity through site-directed 
mutagenesis. 
1.3.1 The NAD+ and NADP+ Coenzymes 
The coenzyme nicotinamide adenine dinucleotide (NAD+) is a major electron 
acceptor in the oxidation of molecules. The reactive part of NAD+ is its 
nicotinamide ring. In the oxidation of a substrate the nicotinamide ring accepts a 
hydrogen ion and two electrons (equivalent to a hydride ion). The reduced form 
of the electron carrier is known as NADH (Figure 1.1). 
The electron donor in most reductive biosynthetic processes is NADPH, the 
reduced form of nicotinamide adenine dinucleotide phosphate (NADP+). 
NADPH differs from NADH in that the 2'-hydroxyl group of its adenosine 








reduction of nicotinamide 
ON+ 
11 


















Figure 1.1 The structures of NAD+ and NADP+. The cofactors bind to dehydrogenases in an 
energetically unfavourable form, shaped like a boomerang, that is stabilised by interactions with 
the protein (Holbrook et al., 1975). 
1.3.2 The NAD+-Dependent 2-Hydroxyacid Dehydrogenase 
RPnrtinn 
NAD+-dependent 2-hydroxyacid dehydrogenases catalyse the stereospecific 
and reversible reduction of aliphatic and aromatic 2-oxocarboxylic acids to the 
corresponding 2-hydroxycarboxylic acids (Figure 1.2). 
2-oxocarboxylate 













Figure 1.2 General reaction of NAD+-dependent 2-Hydroxyacid Dehydrogenases. (R: substrate 
side-chain). 
The enzymes distinguish between the stereospecific isomers of their substrates 
and bind only one of them. Therefore on this basis the NAD+-dependent 2- 
hydroxyacid dehydrogenases can be divided into two groups depending on 
4 
whether they bind the D or L enatiomer of the 2-hydroxyacid substrate (Clarke 
and Daffron, 1998). 
1.3.3 Stereo specificity of NAD+-dependent 2-Hydroxyacid 
Dehydrogenases 
1.3.3.1 The Hydride Transfer to NAD+ is Stereospecific 
Oxidation of the the hydroxyacid involves the removal of two hydrogen 
atoms. One is transferred as a hydride ion H- to the dihydronicotinamide moiety 
of the coenzyme, the other is releasesd as a proton (Fersht, 1985). 
In dehydrogenases the hydride transfer to NAD+ is stereospecific : Using a 
deuterated substrate, so that the enzyme tranferred a deuterium atom to NAD+ 
instead of a hydrogen atom , 
it was found that some dehydrogenases transferred 
the hydride to one side of the ring, and others to the opposite side (Weinhold et 
al., 1991) (Figure 1.3). 






Figure 1.3 Stereospecific hydride transfer to NAD+. (D: deutrium atom). 
Therefore, for many years the NAD+-dependent dehydrogenases have been 
further divided into two groups depending on the stereospecificity of hydrogen 
transfer to the C4 atom of the dihydronicotinamide moiety. The C4 position of 
NADH is a prochiral centre (an atom of a molecule which becomes a chirality 
centre by replacing one of the two stereoheterotopic ligands attached to it by a 
different ligand is said to be a prochirality centre e. g. C-1 of ethanol; C-3 of 
butan-2-ol). Class A NAD+-dependent dehydrogenases transfer a hydride ion to 
5 
the pro-R (A-side) face of NAD+, whereas the class B enzymes transfer to the 
pro-S (B-side) face. 
There is no metabolic or mechanistic reason for the existence of the two 
classes of dehydrogenase: The difference in classes A and B is due only to 
differences in the structures of the catalytic domains. The orientation of the 
bound nicotinamide group is determined by specific hydrogen bonds to the 
amide group in one orientation and steric clashes between amide and protein 
groups in the other. The coenzyme conformations in the two classes of enzymes 
are similar except that the orientations of the nicotinamide rings differ by -180° 
(Holbrook et al., 1975). For a specific enzyme in different species the 
stereochemistry is maintained because the conformation of the enzyme remains 
preserved. 
1.3.3.2 Substrate Stereospecificity 
Another aspect of stereospecificity in NAD+-dependent 2-hydroxyacid 
dehydrogenase reactions concerns the substrate: Only one of the two possible 
enatiomers of the 2-hydroxyacid is formed on reducing the 2-ketoacid substrate. 
The achiral ketoacid is bound and presented to the enzyme in such a way that 
only one side of the substrate is ready to accept transfer of the hydride ion from 
C4 of dihydronicotinamide. The same catalytic mechanism can be used to 
reduce a ketoacid to an L- or D-hydroxyacid (cf. hydride transfer in L- and D- 
LDHs, below). 
The NAD+-dependent 2-hydroxyacid dehydrogenases' chiral selectivity is 
extreme, for instance, for L-lactate dehydrogenase the chirality rule is only 
broken once in 108 turnovers (Anderson and La Reau, 1988). 
6 
This property of enatioselectivity makes the group of enzymes attractive as 
catalysts for the pharmaceutical industry. 
1.4 NAD+-dependent L-2-Hydroxyacid Dehydrogenases 
1.4.1 Amino Acid Sequence Comparison 
The NAD+-dependent L-2-hydroxyacid dehydrogenases comprise one of the 
largest and best-studied families of nucleotide-binding proteins. Most members 
of the family share a common structure-function relationship. The amino acid 
sequence comparison of three members of the enzyme family from various 
sources are shown in Figure 1.4. 
The sequence alignment shows that the members of the NAD+-dependent L-2- 
hydroxyacid dehydrogenase family are highly homologous, and that the pig L- 
LDH isoenzymes are virtually identical to the human L-LDH isoenzymes (see 
Chapter 8). The catalytic residues are also shown to be conserved in all proteins, 
these residues include; R109 (in the L-LDH numbering system, based upon the 
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1.4.2 The General Structure of NAD+-dependent L-2-Hydrox aid 
Dehydrogenases 
1.4.2.1 Dehydrogenases have Modular Polypeptide Chains 
Dehydrogenases are in general fairly large proteins consisting of either a 
tetramer or a dimer of mostly identical polypeptide chains. The lengths of the 
chains vary slightly, but they are typically around 330 residues. The polypeptide 
chains fold into two distinct functional domains, known as the NAD+- and 
substrate-binding domains. However, the functionally similar NAD+-binding 
domains occur in different regions of the polypeptide in the dehydrogenases. 
1.4.2.2 The NAD+-binding Domain 
Despite the lack of any amino acid sequence homology the NAD+-binding 







Figure 1.5 (a) An idealised representation of the NAD+-binding domain from various L-2- 
hydroxyacid dehydrogenases. The yellow and blue segments each represent a mononucleotide 
binding domain. (b) Side-on view of the fold. (From Voet and Voet, 1995). 
The dinucleotide-binding fold differs in detail from one dehydrogenase to 
another. However, in its idealised form the 80 - 100 amino acid fold consists of 
six strands of parallel 13 sheet with four parallel a helices running antiparallel to 
the sheet. 
The NAD+-binding domain consists of two approximately identical 
mononucleotide binding units related roughly by 2-fold symmetry (Rao and 
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Rossmann, 1973). `The half-structure' is formed by a pair of 13-a-(3-a-(3 motifs: 
Each half of the domain binding one of the nucleotides in the dinucleotide 
NAD+. The mononucleotide binding unit is also known to occur in other 
proteins, for example flavodoxin, which binds the mononucleotide FMN 
(Rossmann et al., 1974). 
The structurally conserved (3a(3cc(3 super-secondary motif of the dinucleotide- 
binding domain is commonly referred to as the Rossmann fold. 
In most L-2-hydroxyacid dehydrogenases the regions of similar structure in 
the coenzyme-binding domains form the structural framework of the main chain 
that binds NAD+. The actual interactions between the coenzyme and protein 
occur, however, through amino acid side chains, with the coenzyme binding in 
almost identical positions in the enzymes. But, NAD+ binding involves different 
combinations of side chains in different enzymes. Indeed, sequence comparisons 
of the same enzyme from different species has shown that side chains vary as 
much as nonfunctional surface residues (Rossmann et al., 1975). So, there are 
several ways of reaching a common structural goal, and this is reflected in the 
evolution of the enzymes. The absence of significant sequence homologies in 
the NAD+-binding domain of the different dehydrogenases suggest that it is 
difficult to say anything about the evolutionary histories of these enzymes apart 
from that they appear to be very ancient. 
Although most of the residues vary in the coenzyme-binding domain, there are 
still some conserved residues among dehydrogenases in this fold. This is due to 
the fact there are strong stereochemical constraints at specific positions in the 
fold that must be kept in order to maintain the structure and function of the 
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domain. These invariant chains make it possible to predict from amino acid 
sequence the regions in the polypeptide chain that are involved in coenzyme 
binding. 
The (3A-aB-ßB-c C-(3C motif (Figure 1.5) is a structurally conserved motif 
comprising of about 30 residues. It has been used to identify the NAD+-binding 
domains where the dehydrogenase structures are unknown. This region contains 
three conserved glycine residues with the sequences Gly/Ala-X-Gly/Ala-X-X- 
Gly/Ala where X is any residue. The glycine-rich region is involved in a turn 
next to the adenine-ribose moiety (Rossmann et al., 1975). Larger sidechains at 
these positions would disturb the structural framework of the fold and push 
NAD+ out. 
There are also six hydrophobic conserved residues which form a hydrophobic 
core between the a-helix and (3-sheets. 
1.4.2.3 NAD+ / NADP+ Discrimination 
The NAD+-binding domain also contains a conserved aspartate located some 
25 residues from the glycine-rich region further towards the C-terminus (residue 
53 in Figure 1.4). The residue's function is to discriminate between the 
coenzymes NAD+ and NADP+. NAD+ binds to most L-2-hydroxyacid 
dehydrogenases through hydrogen bonds between its 2'-OH of the adenosine 
ribose moiety and the conserved aspartate. However, NADP+ has a phosphate 
group attached to its 2'-OH and therefore it is prevented from binding to NAD+- 
linked dehydrogenases by steric clashes and repulsions between the two 
negative groups. Instead of the aspartate residue, dehydrogenases that are 
dependent on NADP+ have a small side chain, usually glycine, to make room for 
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the phosphate group and a positively charged side chain, such as arginine, 
nearby to bind the phosphate (Clarke and Daffron, 1998). 
1.4.2.4 The Substrate-binding Domain 
As well as recognising and binding a specific substrate enatiomer, the 
substrate-binding domain also provides the amino acid residues required for 
catalysis. 
The substrate-binding domains of the 2-hydroxyacid dehydrogenases have 
completely different sequences as well as structures. In fact, apart from L-LDHs' 
and MDHs', a unique topology has been observed in each dehydrogenase. 
1.4.2.5 The Active Site 
The active site of the NAD+-dependent dehydrogenases is located in a cleft 
between the NAD+- and substrate-binding domains. The respective domains of 
the two binding sites are orientated so that the reactive part of the coenzyme, C4 
of the nicotinamide ring, is in close proximity to the hydrogen atom to be 
transferred from the substrate. 
The most important residues within the active site are arginine-171, histidine- 
195, aspartate-168 and threonine-246 (again, the numbering system is based 
upon dogfish muscle L-LDH). The histidine and aspartate residues are involved 
in proton transfer during catalysis. Threonine-246 hydrogen bonds with the 
substrate's carboxyl group, and this is complemented by a hydrogen bond 
between the substrate carbonyl and histidine-195. Both Thr246, His 195 serve to 
orient the substrate through hydrogen bonding (Figure 1.11, page 21). 
Argininel7l also binds and orients the substrate in the active site by forming a 
bifurcated ion pair between its NH2 and NH1 groups and the carboxyl group of 
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the substrate. It is thought that this interaction may also play a small part in 
substrate specificity (Hart et al., 1987). 
1.4.2.6 The Active Site Loop and its Role in Substrate Specificity 
The major structural rearrangement that occurs during substrate binding is the 
movement of an external loop of polypeptide (residues 99-110) between a-helix 
D and (3-sheet D of the coenzyme-binding domain (Figure 1.5). This loop, 
known as the active site loop, extends out into the solution in the apo and binary 
complexes, leaving the active site exposed to the solvent. However, on forming 
a ternary complex the loop closes over the active site, excluding solvent from 
the site (Holbrook et al., 1975). The movement of the loop also has the effect of 
bringing a catalytically important arginine residue (carried on the active site 
loop) into proximity with the reactants. Arginine-109 serves to stabilise the 
transition state in the hydride transfer (discussed below). 
Loop closure is the rate limiting step in catalysis for L-LDH (Waldman et al., 
1987; Clarke et al., 1986) and the conformational change is thought to be 
mediated through the movement of two `hinges', connected by a rigid segment, 
producing one motion (Gernstein and Chothia, 1991). 
The second role of the loop is to determine substrate specificity through 
contacts around residues 101-103. This role has been investigated using site- 
directed mutagenesis. 
While residue 102 is a glutamine in most L-LDHs, there is a third conserved 
arginine at this locus in the majority of L-MDHs. It was thought that the arginine 
formed a bifurcated interaction with the carboxymethyl group of oxaloacetate 
(L-MDH's ketoacid substrate) in the closed ternary complex (Figure 1.6). 
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0 CH3 O0 
0000 
Pyruvate Oxaloacetate 
Figure 1.6 The chemical structures of pyruvate and oxaloacetate. 
This hypothesis was shown to be correct when the uncharged side-chain of 
glutamine-102 was substituted for the positively charged side chain of arginine 
in Bacillus stearothermophilus L-LDH (bsLDH) (Wilks et al., 1988): The 
resulting mutant switched its specificity from pyruvate (L-LDH's ketoacid 
substrate) to oxaloacetate. The catalytic efficiency for pyruvate reduced by 104 
and increased by 103 for oxaloacetate. 
Further proof of the active site loop's role in substrate discrimination has come 
from further site-directed mutagenic studies. For example, rat testicular L-LDH 
reduces a wide variety of large ketoacids, such as pyruvate ketobutyrate, 
ketovalerate and phenylpyruvate. The enzyme's broad specificity is thought to 
arise from its unusually hydrophobic loop residues (methionine-102, valine-103, 
serine-105) (Clarke and Dafforn, 1998). Inserting this sequence into the loop of 
bs L-LDH caused the mutant enzyme to have a similar ketoacid specificity as the 
rat enzyme (Wilks et al., 1990). 
It should be noted that substrate discrimination is not solely due to the residues 
on the active site loop and arginine-171. Specificity of an enzyme is determined 
in conjuction with several other factors, such as charge differentiation, steric 
clashes, hydrophilic / hydrophobic interactions, etc. and is thus a complex 
process. 
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1.4.3 General Reaction Mechanism of NAD+-dependent L-2-hydroxyacid 
Deh dro eý nases 
The chemical reaction mechanisms of the NAD+-dependent L-2-hydroxyacid 
dehydrogenases are in principle very similar. 







Figure 1.7 Typical mechanism for hydride transfer in NAD(P)+-dependent L-2-hydroxyacid 
dehydrogenases. 
2-Hydroxyacid dehydrogenases have an ordered bi-bi mechanism with the 
coenzyme binding first followed by the substrate (reviewed in Dalziel, 1975). 
Typically, at pH 7, the equilbrium constants for the reactions are -- 104 in favour 
of the 2-hydroxyacid and NAD+. However, the binding affinities for both 
NADH and ketoacid are usually 50-100 -fold stronger than those for NAD+ and 
2-hydroxyacid, respectively. 
Hydroxyacid dehydrogenases often exhibit inhibition by excess substrate 
(Dalziel, 1975). This is due to the formation of an `abortive' complex of NAD+ 
and ketoacid (Figure 1.8). At high concentrations of substrate the ketoacid has a 
greater chance of forming an adduct with the enzyme-coenzyme binary complex 
before the NAD+/H can leave the active site, leading to substrate inhibition. 
E 





Figure 1.8 The general catalytic cycle of 2-hydroxyacid dehydrogenases. (E= Enzyme). 
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The Oil-Water-Histidine mechanism proposed by Parker and Holbrook (1977) 
suggests how the transfer of the hydride ion from the 2-hydroxyacid to NAD+, 
may be catalysed. On formation of a ternary complex, the flexible active site 
loop lowers, closing the active site to bulk solvent (White et al., 1976). This 
conformational change also pushes the coenzyme further into the enzyme and up 
against a hydrophobic pocket. This in turn causes the rearrangement of positive 
charge on the nicotinamide ring from the Nl to the C4 position where the 
environment is more hydrophilic. The coenzyme's unstable C4+ carbocation is 
now susceptible to nucleophilic attack by a hydride ion donated by the nearby 
a-carbon of the 2-hydroxyacid substrate. The hydride exchange is balanced by 
proton transfer from the C2 hydroxyl group of the substrate to a conserved 
unprotonated histidine residue (acting as a general acid-base), producing a 2- 
keto acid. In effect there is a net flux of two electrons from the imidazole ring of 
histidine to the Ni position of NAD+. 
It was later found that the catalytic histidine in most NAD(P)+-dependent 
dehydrogenaes is hydrogen bonded to an aspartate (Birktoft et al., 1982). This 
His-Asp pairing is commonly located in the active sites of many proteins, such 
as serine proteases (Kraut, 1977). It was suggested that the His-Asp pair acts as 
a charge-relay system (Blow et al., 1970): The hydrophilically buried aspartate 
residue's carboxylate group is thought to raise the pKa of the histidine through 
the negative charge and also to confine its location (Fersht, 1985). Thus, on 
binding 2-hydroxyacid substrate to the active site an interface is formed between 
the hydrophobic environment of the NAD+ and the hydrophilic environment of 
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the His-Asp pair. Along with the active-loop closure, this interface is thought to 
facilitate electron transfer. 
The Oil-Water-Histidine model was found to be incomplete; the model did not 
adequately explain how the unfavourable reverse reaction was catalysed, nor did 
it consider the role of another conserved arginine (numbered 109 in L-LDH) 
within the active site: This arginine is distinct from the one which forms a salt 
bridge with the carboxyl group of the substrate. A revised mechanism was later 
proposed by Grau et al. (1981) (Figure 1.9). 
Upon loop closure, the positively charged guanidinium group of the arginine- 
109, situated on the active site loop, moves to a position between the histidine 
and 2-oxoacid, thus charge-balancing the active site vacuole. The carbonyl 
group of the substrate is polarised; electrons being pulled from the a-carbon to 
the carbonyl oxygen. The histidine residue then donates a proton to the carbonyl 
oxygen of the 2-keto acid, leaving the a-carbon with a partial positive charge. 
This carbocation is now susceptible to to hydride attack from NADH. Moreover, 
the developing charge on the histidine residue would push the arginine away 
from the substrate, pushing the flexible loop open with the concomitant release 
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Figure 1.9 The modified OiI-Water-Histidine mechanism proposed by Grau et al., (1981). 
The back reaction is essentially the reverse of the mechanism forward 
reaction: Electronic rearrangements in NAD+ cause the formation of a positive 
charge at the C4 position of the nicotinamide ring. NADH is then formed via 
nucleophilic attack from the C2 hydrogen of the hydroxyl substrate. The 
histidine regains its positive charge by removing the substrate's 03 hydrogen. 
This modified Oil-Water- Histidine mechanism thus introduces a balancing of 
charge repulsion at the nicotinamide ring, and hence, allows for reversibility. 
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Site-directed mutagenic studies have shown a 400-fold reduction in kcat by the 
reverse reaction if the catalytic arginine is substituted for the neutral glutamine 
(Clarke et al., 1986). 
1.4.4 Examples of L-2-Hydroxyacid Dehydrogenases 
1.4.4.1 L-Lactate Dehydro eý nase (discussed in Chapters 6 and 8) 
L-Lactate Dehydrogenases catalyse the stereospecific interconversion of 
pyruate and L-lactate using the NADH/NAD+ redox cofactor. The enzymes are 
commonly found in the archaea, prokaryia and eukaryia. In eukaroytes the L- 
LDH family of enzymes usually exist as tetramers, formed by a tetrahedral 
arrangement of catalytically independent monomers. All have a very similar 
overall topology, as originally described for dogfish M4 L-LDH (Rossmann et 
al., 1971). In lower organism they are commonly found as dimers (Holbrook et 
al., 1975). 
'reverse' reaction --- -- 
pyruvate L-lactate 
L-Lactate Dehydrogenase HH 
CH3 + NADH + H+ 
COO_ 
CH3 




2.8 x 10-12 (Holbrook et at, 1975) 
Figure 1.10 The reaction catalysed by L-Lactate dehydrogenase. 
+ NAD+ 
The major metabolic role of L-LDH is to allow the continous conversion of 
glucose to two molecules of lactic acid (which are excreted) and ATP in 
anaerobic tissues and cells. The enzyme achieves this by reducing pyruvate to 
lactate, thereby recycling the limited quantities of NAD+ (NAD+ is reduced to 
NADH by glyceraldehyde-3-phosphate dehydrogenase (GAPDH) during the 
prior metabolic reaction). This anaerobic role is found in micro-organisms and 
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higher organisms. In the aerobic environments of certain organs of higher 
animals the reverse reaction is catalysed by L-LDH in order to produce lactate to 
fuel the heart. 
In the reversible reaction the pro-R (A-side) hydrogen at C4 of NADH is 
stereospecifically transferred to the re face of pyruvate at C2 to form L- (or S-) 
lactate. The active site residues involved in pyruvate binding and catalysis are 
shown below (Figure 1.11): - 



















Figure 1.11 The interactions involved in the binding of pyruvate binding and catalysis in the 
active site of L-LDH. 
L-LDH preferably catalyses the reduction of pyruvate, but it can also reduce 
other small 2-ketoacids with a single negative charge such as 2-oxobutyrate, 2- 
oxovalerate and 2-oxocaproate (Figure 3.1) to a far less, but still significant 
degree. In contrast, the enzymatic reaction towards branched substrates like 2- 
oxoisovalerate and 2-oxoisocaproate is only very marginal (Wilks et al., 1990). 
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1.4.4.2 L-Malate Dehydrogenase 
L-Malate Dehydrogenases (MDH) catalyse the reversible oxidation of L-malate, 
a four carbon a-hydroxy dicarboxylate, to the ketone oxaloacetate, by 
transferring a hydrogen from the A-face of NAD+ (reviewed in Banaszak and 
Bradshaw, 1975). 
oxaloacetate L-malate 
L-Malate Dehydrogenase 0 




Figure 1.12 The reaction catalysed by L-malate dehydrogenase. 
Prokaryotes have only one form of the enzyme and it is located in several 
cellular compartments. However, in eukaryotes there are two distinct forms 
(isoenzymes) of dimeric the protein, a cytoplasmic form (cMDH) and a 
mitochondrial form (mMDH). The physiological role of mMDH is to catalyse 
the penulimate step of Krebs cycle, whereas the cMDH isoenzyme is involved in 
the malate-aspartate shuttle (Voet and Voet, 1995). 
Even though the two isoenzymes are less than 20% idential in terms of amino 
acid sequence, they share a common polypeptide chain fold. Furthermore, the 
structure of MDH has been shown to be remarkably similar to that of L-LDH, 
with very similar active sites: The mutation of a single active site loop residue in 
MDH caused a marked shift in specificity and selectivity towards that of L-LDH 
(Wilks et al., 1988). However, unlike L-LDH, malate dehydrogenase has a very 
narrow substrate specificity (Boernke et al., 1995). As mentioned earlier, this 
difference in substrate accommodation is thought to be due the presence of a 
second conserved arginine residue in MDHs' on the mobile active site loop, also 
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providing further evidence for a charge-balancing mechanism in 2-hydroxyacid 
dehydrogenases (Chapman et al., 1999). 
1.4.4.3 L-2-Hydroxyisocaproate Dehydrogenase 
L-2-hydroxyisocaproate dehydrogenase (L-HicDH) (or broad specificity L- 
hydroxyacid dehydrogenase) from L. confusus was discovered by Schütte et al. 
(1984) during a screen of microbial dehydrogenases. L-HicDH has a broad 
substrate spectrum, catalysing the reduction of a wide range of L-2- 
hydroxyacids with branched and unbranched aliphatic side chains of medium 
size (such as pyruvate, 2-oxoisocaproate and 2-oxocaproate) as well as aromatic 
residues, such as phenylpyruvate (with R containing four to seven carbon atoms) 
as substrates (Schütte et al. 1984; Feil et al. 1994) (See Figure 3.1). 
2-oxocarboxylate L-2-hydroxycarboxylate 
L-HiCDH 9H 
R+ NADH + H+ R+ NAD+ 
COO 00 
Figure 1.13 The broad specificity reaction catalysed by L-2-hydroxyisocaproate dehydrogenase. 
Amino acid alignment studies showed that L-HicDH contains two inserts of 
two amino acids (residues 102-103 and 106-107) when compared with the L- 
LDH enzymes (excluding P. falciparum L-LDH), in the region corresponding to 
the active site loop (Feil et al. 1994; Niefind et al. 1995). As mentioned earlier, 
this loop is involved in catalysis and in assuring the substrate specificity of the 
enzymes, and so it was proposed that the inserted residues increase the size and 
thus the specificity of the substrate-binding region. The location and functional 
role of these inserted residues were investigated using site-directed mutagenesis 
(Feil et al. 1994). It was demonstrated that even if the four `inserted' residues 
were deleted L-HicDH was still active against phenylpyruvate albeit with a 
23 
markedly reduced activity. Thus, the four residue insert is not necessary, and 
therefore, not solely responsible for reactivity towards larger substrates. 
It was observed that the deletion of residues Asn 106 and Pro 107 (Figure 1.4 
numbering system) had a marked effect on substrate specificity; the deletions 
resulted in reduced kcat values for the reactions with pyruvate and 2- 
oxocaproate. However, a more than 10- fold k, at value increase was observed 
when 2-phenylpyruvate was used as the substrate. But a more than 100-fold 
increased kcat value was observed for 2-oxoisocaproate; the catalytic efficiency 
(kat/KM) is 5-fold higher with 2-oxoisocaproate compared to the wild type 
enzyme. It appears that the deletion of the proline and glutamine residues 
favours the binding of 2-ketoacid substrate branched at C4. 
Further experiments showed that the conserved Gln 105 (Figure 1.4) between 
the two inserts had a comparable substrate-binding role with Gln 102 in other L- 
hydroxyacid dehydrogenases (see 1.4.2.6). Later the crystal structure of 
L. confusus L-HicDH (Niefind et al. 1995) revealed that the other conserved 
glutamine residue between the two amino acid inserts, namely G1n104, also has 
a crucial function: In most L-LDH structures this residue is directed towards the 
substrate. This narrows the space that is available for a potential substrate 
residue, and increases the non-polar character of the region. Steric hindrance 
from the residue would be a serious problem if attempting to bind branched or 
aromatic substrates. However, in L-HicDH Gin 104 is turned back on itself and 
fixed by a strong hydrogen bond to G1n115, so that it presents its hydrophobic 
methylene groups to the substrate binding site and thus cannot disturb the 
binding of branched or aromatic substrates. 
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1.5 NAD+-dependent D-2-Hydroxyacid Dehydro enases 
1.5.1 A Distinct Family of 2-Hydroxyacid Deh dro enases 
D-2-hydroxyacid dehydrogenases catalyse the NADH reduction of 2-ketoacids 
to give NAD+ and D-2-hydroxyacid. This family of enzymes includes D-lactate 
dehydrogenase (D-LDH) (e. g. Kochhar et al., 1992), D-2-hydroxyisocaproate 
dehydrogenase (D-HicDH) (or broad specificity D-hydroxyacid dehydrogenase) 
(Bernard et al., 1994), glycerate dehydrogenase (GDH) (Greenler et al., 1989), 
D-3-phosphoglycerate dehydrogenase (D-3PGDH) (Tobey and Grant, 1986) and 
erythronate-4-phosphate dehydrogenase (Schoenlein et al., 1989). 
This enzyme family only emerged recently. Before that the idea that enzymes 
such as D-LDH was the chiral alternative to the L- enantiomer specific LDH was 
dismissed. However, Grant (1989) demonstrated that glycerate dehydrogenase 
and erythronate-4-phosphate dehydrogenase displayed significant sequence 
homology to D-3-phosphoglycerate dehydrogenase. In contrast, these proteins 
do not display much similarity with other oxidoreductases or with other 2- 
hydroxyacid dehydrogenases. The `creation' of a new family of 2-hydroxyacid 
dehydrogenases was later reinforced by the discovery of other D- enantiomer 
specific dehydrogenases. 
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1.5.2 Amino Acid Sequence Comparison 
The amino acid sequence comparison of members of the D-2-hydroxyacid 
dehydrogenase family are shown in Figure 1.14. 
The consensus NAD+-binding domain GxGxxGx(17)D is found in the middle of 
the sequence alignment (starting at residue 211 in Figure 1.14). The alignment 
also shows that the D-HicDH and D-LDH enzymes are related most closely 
within the family and the erythronate-4-phosphate dehydrogenase is the most 
distantly related. 
The residues implicated in substrate binding catalysis (Arg300) and catalysis 
(His361; apart from erythronate-4-phosphate dehydrogenase) are highly 
conserved (Dengler et al., 1997; Kochhar et al., 2000) (see 1.5.3.2). A histidine 
residue at position 266 (or H205 in the D-HicDH numbering system) is also 
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1.5.3 Members of the D-Hydroxyacid Dehydrogenase Family 
1.5.3.1 VanH gene product 
With one exception all the D-2-hydroxyacid dehydrogenase family members 
use NAD+ and not NADP+ as the coenzyme: The NADPH-dependent D-2- 
hydroxyacid dehydrogenase is thought to be involved in resistance to the 
antibiotic vancomycin. In vancomycin susceptible bacterial strains the antibiotic 
forms a complex with D-alanine - D-alanine dipeptides essential for 
peptidoglycan crosslinking, thereby disrupting the cell wall of the 
microorganism. The antibiotic complex is formed through vancomycin 
hydrogen bonding to the -NH peptide groups of peptidoglycans (Barna and 
Williams, 1984). However, in the strain Enterococcus faecium BM4147, 
vancomycin resistance is conferred by five gene products (Wu et al., 1995). One 
of these genes, vanH, encodes a NADPH-dependent D-2-hydroxyacid 
dehydrogenase. It has been suggested that the molecular basis of vanomycin 
resistance is the formation of D-lactate - D-alanine depsipeptides which the 
antibiotic is incapable of recognising (Arthur et al., 1992). 
1.5.3.2 D-Lactate Dehydrogenase 
Most of the biochemical and kinetic information regarding the D-2- 
hydroxyacid dehydrogenase family has come from the study of D-LDH. 
Unlike the ubiquitous L-LDH enzyme, D-lactate dehydrogenase (D-LDH) is 
only expressed in lower organisms (anthropods, mulluscs, etc. ) and bacteria: 
Some micro-organisms, such as Lactobacillus plantarum, possess both the D- 
and L-LDH enzymes (Vinals et al., 1993. ). Like most D-hydroxyacid 
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dehydrogenases, D-LDH is a dimeric protein with each subunit consisting of a 
substrate-binding domain and a cofactor-binding Rossmann fold. 
A number of crystallographic, site-directed mutagenic, chemical modification, 
kinetic and physiochemical property studies have been carried out on D-LDH's 
from various sources (Dym et al., 2000; Vinals et al., 1995; Kochhar et al., 
1992; Kochhar et al., 2000). These investigations show that the active sites of 
the D- and L-LDH enzymes are remarkably similar: In both enzymes, a 
histidine-aspartate (or glutamate) couple appears to act as a H+ donor / acceptor 
and a conserved arginine residue binds the a-carboxylate group of the substrate. 
As mentioned earlier, primary and tertiary structural analysis of the D-LDH 
enzymes have also revealed the presence of a conserved aspartate some 17 
residues up stream of the glycine -rich (G/AXG/AXXG/A) putative NAD+- 
binding motif.. As with all NAD+-dependent L-2-hydroxyacid dehydrogenases, 
site-directed mutagenic studies on Lactobacillus delbruekii subsp. bulgaricus D- 
LDH have shown that the conserved aspartate residue is essential for 
NAD+/NADP+ discrimination: Substituting D175 for an alanine causes a 40-fold 
shift in coenzyme preference from NADH to NADPH (Bernard et al., 1995). 
The presence of analogous amino acids involved in substrate binding and 
catalysis (in virtually identical positions in the two groups of proteins) but 
lacking any significant sequence identity seems to suggest an apparent 
evolutionary convergence of the active sites (and cofactor-binding sites) of L- 
LDH and D-LDH, and all D-2-hydroxyacid deydrogenases. This in turn seems to 
suggest that the two families of enzymes share a similar reaction mechanism. 
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The structural basis for the opposing enantiospecificities of D-LDH and L- 
LDH has been the subject of a number of biochemical studies (e. g. Siebanaller 
et al., 1983). Following the crystallographic elucidation of the structures of both 
enzymes (Dym et al., 2000; Dunn and Holbrook, 1996; Grau et al., 1981), the 
ability of LDH to bind only one stereoisomer of lactate could be easily 
explained in terms of steric restrictions at the active sites of the enzymes. The 
same catalytic mechanism can be used to reduce a ketoacid to an L- or D- 
hydroxyacid if the spatial relation of the catalytic histidine ring and 
nicotinamide ring are kept constant and the 2-ketoacid is rotated through 180° so 
that the hydride approaches from re- or the si-face of the ketone . The reduction 
to either L- or D-hydroxyacid is achieved by arginine which binds the a- 
carboxyl group of the substrate being rotated by 180° (cf. Figures 1.11 and 
1.15). 
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Figure 1.15 The interactions involved in the binding of pyruvate binding and catalysis in the 
active site of D-LDH. 
In L-LDH (and all L-2-hydroxyacid dehydrogenases) transfer of the C-4 
hydrogen of the dihydronicotinamide ring is from the re face of the substrate, 
forming the L-isomer of the hydroxyacid. Whilst in D-LDH (and presumably in 
all D-2-hydroxyacid dehydrogenases) the hydrogen is added to the si 
face to 
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form the D-isomer. In both LDH enzymes the A-side hydrogen of NAD is 
transferred. 
The basic understanding of the molecular principles behind the 
enantioselectivity in D- and L-2-hydroxyacid dehydrogenases led to attempts at 
engineering D-LDH activity into L-LDH. The strategy employed by Sakowicz et 
al. (1995) was to induce the pyruvate molecule in Bacillus stearothermophilus 
L-lactate dehydrogenase (bsLDH) to bind in an alternative, 180°-rotated, 
orientation that would lead to D-lactate production. In order to achieve this Arg- 
171, the carboxylate binding residue of the L-enzymes, was mutated to a 
tyrosine and Gln-102, on the active site loop, was mutated to an arginine in 


















NH Tyr 171 
Arg 171 
Wild Type Double Mutant 
Figure 1.16 Site-directed mutagenic attempt at switching to D-specificity in bsLDH. 
Switching substrate stereospecificity using this strategy met with a measure of 
success; upon pyruvate reduction, up to 2.3% of the lactate produced by the 
double mutant was of the D-isomer form. This represents an estimated -105-fold 
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relaxation of the natural L-stereoselectivity of bsLDH (Anderson and La Reau, 
1988). 
The precise physiological role of D-LDH is as yet uncertain, however, like one 
L-LDH, D-LDH might simply catalyse the final reaction in anaerobic glycolysis. 
This is strongly supported by the fact that arachnids possess only the D-isomer 
specific LDH (Long and Kaplan, 1968). 
Another possible metabolic function for D-LDH is the detoxification of 
methylglyoxal (Figure 1.17). Methylglyoxal is formed as a by-product in 
NADPH-dependent acetone and acetol monooxygenase reactions, and it is 




Figure 1.17 The chemical structure of methylglyoxal. 
It has been known for sometime that glyoxalase I and II tandemly converts 
methylglyoxal to D-lactate (Douglas and Shinkai, 1985). So, it has been 
suggested that D-LDH converts the D-lactate into the metabolically versatile 
pyruvate substrate. 
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1.5.3.3 D-Glycerate Dehydrogenase (or Hydroxypyruvate Reductase) 
D-glycerate dehydrogenase catalyses (GDH) the NADH-linked reduction of 
hydroxypyruvate to D-glycerate (Figure 1.18) in a diverse range of organisms; 
the enzyme has been purified from bacterial, plant and mammalian sources 
(Goldberg et al., 1994; Greenler et al., 1989; Rosenblum et al., 1971). In all 
cases the GDH 
hydroxypyruvate 
CH2OH 







Figure 1.18 The reaction catalysed by D-glycerate dehydrogenase. 
enzymes are dimeric in nature with a monomer molecular mass between 33,000 
and 42,000 Daltons. The GDHs' belong to the A class of NADH-linked 
dehydrogenases with the hydrogen being transferred to the si face of 
hydroxypyruvate (Goldberg et al., 1994). 
GDH is one of the enzymes involved in the serine cycle. This cycle is one of 
the ways in which type II methyltrophs incorporate inorganic carbon (Brock and 
Madigan, 1988). 
1.5.3.4 D-3-Phosphoglycerate Dehydrogenase 
D-3-phosphoglycerate dehydrogenase (D-3PGDH) is involved in the 
`committing step' in serine biosynthesis (Tobey and Grant, 1986). Serine 
biosynthesis is important in that it not only controls the concentrations of serine 
in an organism, serine is also a intermediate in the synthesis of cysteine and 
glycine (Figure 1.19). 
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Figure 1.19 Catalytic steps in the pathway of serine biosynthesis. 
D-3PGDH is unusual among the class of D-2-hyroxyacid dehydrogenases in 
that it shows a marked allosteric regulatory response: Serine binds cooperatively 
to the enzyme and inhibits its catalytic activity. The inhibition is brought about 
by a reduction in the maximal catalytic rate of the enzyme rather than through a 
weakening of substrate interaction (Clarke and Daffron, 1998). Also, unlike the 
other members of the enzyme family, D-3PGDH has three domains, and it is a 
tetramer, rather than the conventional D-family dimer. It is thought that the extra 
domain has a serine binding site which mediates the regulatory response 
(Schuller et al., 1995). 
1.5.3.5 Erythronate-4-Phosphate Dehydrogenase 
The DNA sequence of a gene essential for pyridoxine (Vitamin B6) 
biosynthesis, pdxB, appears to be rather similar in sequence to D-3- 
phosphoglycerate dehydrogenase (Schoenlein et al., 1989). Schoenlein et al., 
(1989) have also suggested that 4-hydroxy threonine is a major intermediate in 
pyridoxine biosynthesis. Therefore, it is thought that the pdxB gene product 
encodes for a dehydrogenase that reduces the hydroxyacid erythronate-4- 
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phosphate to form 3-hydroxy-4-phospho-hydroxy 2-ketobutyrate, an 
intermediate thought to be required for 4-hydroxy threonine biosynthesis 
(Figure 1.20). 
OP OP 
Erythronate 4-phosphate OH Dehydrogenase ? OH 
HO -H O 4-phospo- 4-hydroxy threonine 
(pdxB gene product) hydroxy threonine 
HOOC HOOC 
erythronate 4-phosphate 3-hydroxy 4-phospo- 
hydroxy 2-ketobutyrate 
Figure 1.20 Putative steps in the production of 4-hydroxy threonine. 
1.5.3.6 D-2-Hydroxyisocaproate Dehydrogenase (discussed in Chapter 3) 
D-2-hydroxyisocaproate dehydrogenase (D-HicDH) (or broad specificity D- 
hydroxyacid dehydrogenase) has a broad substrate spectrum (similar to that of 
L-HicDH) (Bernard et al., 1994). D-HicDH catalyses the reduction of a wide 
range of D-2-hydroxyacids with branched and unbranched aliphatic side chains 
of medium size. The physiological functions of the enzyme are as yet unknown. 
Jensen (1976) has suggested that macromolecular evolution is a result of 
substrate ambiguity in enzymes: The primitive enzymes were likely to have 
broad substrate specificities. It is possible to imagine the evolution of a protein 
from a broadly specific protein (such as D-HicDH or L-HicDH) to a narrowly 
specific protein that is committed to a particular pathway. Events such as gene 




2.1 Protein Crystallisation 
2.1.1 Introduction 
One of the main obstacles in obtaining a crystallographic macromolecular 
structure is the ability to grow single crystals that are suitable for high resolution 
X-ray diffraction analysis. 
Growing good quality macromolecular crystals is still essentially a trial-and- 
error process where the factors that effect crystal growth are systematically 
sought: These variables are then optimised to produce the best crystals possible. 
Crystallisation screens are commercially available (e. g. Hampton Research, 
Laguna Niguel, CA92677-3913, USA) and were employed to search for initial 
crystallisation conditions. The Hampton Research protein screens are a sparse 
matrix (Jancarik and Kim, 1991) of 98 conditions (50 solutions in screen 1 and 
48 in screen 2) that have proven to be successful for crystallisation in the past. 
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2.1.2 Principles of Protein Crystallisation 
Protein crystallisation can be described as a process whereby the protein is 
slowly precipitated from its solution. It is a complex process that is as yet poorly 
understood for several reasons: Firstly, proteins are structurally dynamic 
molecules whose physiochemical properties (such as solubility) vary as a 
function of innumerable factors such as pH, ionic strength, solvent content, 
contaminants, temperature, etc. Added to this is the inadequate understanding of 
the forces which drive macromolecular crystallisation from a solution. 
For crystallisation to occur the protein solution, typically greater than 95% 
pure, must be brought to supersaturation. Protein molecules aggregate to form 
small nuclei at a high level of supersaturation (any higher, and the protein would 
aggregate as an amorphous precipitate). Nuclei formation should then occur 
slowly to maximise the degree of order in the structure. 
Ideally, the protein solution, by depletion, would return to the lower end of 
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Parameter e. g. precipitate concentration 
Figure 2.1 Solubility curve for a typical protein. 
Maintaining a high level of supersaturation would result in the formation of many nuclei and thus 
many small crystals. 
2.1.3 Crystallisation Techniques 
There are four main crystallisation techniques that can be used; dialysis, liquid- 
liquid diffusion, batch crystallisation and vapour diffusion. 
All of the crystallisation trials carried out used either the hanging or sitting 
drop variant of the vapour diffusion method (McPherson, 1990). In the hanging 
drop method up to 5p. l of protein solution is placed on a plastic coverslip and is 
usually mixed with the same volume of precipitant solution to make up the 
mother liquor. The coverslip is then placed upside down over a well containing 
about 1 ml of precipitant solution. The well is sealed by applying oil or vacuum 
grease around the edge of the depression before the coverslip is put into place. 
Disposable plastic tissue culture plates were used to supply the wells. The sitting 
drop method is similar, however, up to 100p. 1 of the protein solution mixture is 
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pipetted into the depression of a micro-bridge (Hampton Research) that has been 
placed in the well itself. 
In the vapour diffusion methods of crystallisation, equilibration proceeds by 
diffusion of water between the two solutions. This leads to the concentration of 
the solutes in the drop due to the vast differences in the volumes of the protein 
and well solutions. This in turn leads to supersaturation of the protein solution. 
2.1.4 Cryo-cooling Crystals 
All macromolecular crystals suffer from dose-dependent radiation induced 
loss of diffraction intensity. The X-ray induced damage is due to presence of 
large amounts of water in the protein crystal and the potential diffusion of free- 
radicals within it (Henderson, 1990). This problem can be dramatically reduced 
by flash-cooling the crystal in the presence of a cyro-protectant to very low 
temperature (Garman and Schneider, 1997). 
Lowering the temperature of the crystal gradually would result in the 
formation of ice. Ice effects the protein diffraction pattern by contributing to the 
diffraction pattern and by shearing the protein crystal lattice. Cryoprotectants 
are chemicals, such as alcohols or sugars, which reduce the formation of ice. 
Flash-cooling a crystal (taking it from non-cryo conditions to cryo conditions 
rapidly) with a cryo-protectant causes the aqueous solution, in and around the 
crystal, to freeze amorphously, like glass. This process, known as vitrification, 
can sometimes lead to an increase in mosaicity (the degree of order in the crystal 
lattice). However, there are several advantages of cryo-cooling crystals such as 
the potential of collecting a data set from a single crystal due to reduced 
radiation damage; whereas, data collection at room temperature would normally 
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require multiple crystals, which may lead to problems when scaling the multiple 
data sets together. Also, a higher resolution data set might be obtained from a 
crystal that had been flash-cooled as compared to one mounted at room 
temperature, since protein damage due to radiation is reduced and thermal 
vibrations within the crystals are reduced at low temperature. 
The methods employed in the mounting and cooling of crystals prior to 
cryogenic data collection involved soaking the protein crystals in mother liquor 
containing increasing concentrations of the cyro-protectant additive (often with 
a slight increased precipitant concentration). The crystals were then suspended 
in a small nylon loop (surrounded by a thin layer of cryo-protectant solution) 
and rapidly plunged into a stream of gaseous nitrogen set at a constant 10OK: 
The temperature of which was controlled by a Cryostream (Oxford 
Cryosystems). 
2.2 X-ray Sources and Detectors 
2.2.1 Introduction 
Crystallographic protein structure determination requires an X-ray source and 
an X-ray detector to determine the intensity and position of the diffracted beam. 
During this work either an in-house rotating anode generator with a MacScience 
double image plate or synchrotron radiation with a Mar Research single image 
plate was used for data collection purposes. 
2.2.2 X-ray Sources 
X-rays are electromagnetic radiation with wavelengths of 1000 - 0.1A. There 
are two main types of X-ray source commonly used; the home laboratory 
rotating anode generator and the more powerful synchrotron radiation source. 
40 
2.2.2.1 Rotating anode generators 
In the rotating anode generator electrons from a heated tugsten filament are 
accelerated through a potential difference towards a rotating cylindrical metal 
anode under a vacuum. The anode target can be made from molybdenum, cobalt, 
iron or some other metal: For protein crystallography the anode is usually 
copper. 
Most of the electron energy is lost as heat when the particles strike the anode. 
However, some of the energy is converted into X-ray radiation, this can be 
emitted in two distinct ways. One way is as a smooth continuous intensity 
distribution as a function of wavelength (Figure 2.2). This is because charged 
particles (such as electrons) emit electromagnetic radiation, known as 
`Bremsstrahlung', when they are either accelerated or decelerated. The cut-off at 
the shorter wavelength, indicating the most energetic X-rays, is where a photon 
will have energy corresponding to all the energy of one electron. 
If the potential difference is great enough then a point will be reached when 
the impacting electrons will cause electronic transitions between the inner 
orbitals in the atoms of the anode material: Electrons in the anode atoms shoot 
out of lower lying orbitals, this is then accompanied by electrons from higher 
orbitals occupying the empty orbitals and releasing energy in the form of X-rays 
at a specific wavelength. This gives rise to what is known as characteristic 
radiation, as the wavelength of the emitted X-ray is dependent on the anode 
metal type. It is manifest as sharp intense peaks in the spectrum. 
If copper is used as the anode characteristic X-ray radiation will be emitted at 
1.54178A and 1.39217A. The former X-ray wavelength, called CuKa radiation, 
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comes from aL to K-shell electronic transition. This is the most intense 
radiation peak emitted and was the X-ray wavelength used during in-house data 
collection. 












Figure 2.2 X-ray spectrum from a rotating anode / sealed tube with copper as the anode. 
The X-ray intensity of the emitted radiation is on an arbitrary scale. (From Blundell and 
Johnson, 1976). 
Earlier generators had a fixed piece of metal as the anode (sealed tubes), but, 
due to heating of the anode caused by the electron beam at the focal spot there 
had to be a limit on the maximum power of the sealed tube. However, as the 
electron beam is not continually focused on the same spot in the rotating anode 
tube the heat can be more efficiently removed by water cooling: This ensures 
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that the rotating anode can run at a higher power than the sealed tube and thus 
produce more intense X-rays. 
In most diffraction experiments monochromatic X-rays are required. If a 
rotating anode tube is used with a copper anode the high intensity CuKa 
radiation can be selected for by using either a nickel filter or a piece of graphite. 
The nickel filter would remove most of the CuKß radiation and some of the 
continuous spectrum. But the intensity of the Ka radiation would also be slightly 
reduced. Graphite, however, reflects CuKa X-rays at a scanning angle of 13.1 
(Drenth, 1995) and produces `cleaner' X-rays with a narrower wavelength 
bandwidth. 
2.2.2.2 Synchrotron radiation 
It is preferential to use a synchrotron radiation source as they give many 
orders of magnitude more intense X-rays than conventional in-house generators. 
The first synchrotrons were built to accelerate electrons and positrons to high 
energies (nearly to the speed of light) for experiments in particle physics. 
`Bending magnets' are used to ensure that the particles travel in an 
approximately circular motion. As the charged particles pass through the 
bending magnets they are accelerated towards the centre of the ring. Therefore 
the particles lose energy by emitting electromagnetic radiation. During the 
1970s crystallographers started to utilise the intense X-ray radiation `by- 
product' and by the 1980s radiation-dedicated synchrotrons had been built. 
In addition to bending magnets the radiation-dedicated synchrotrons also have 
wigglers, wavelength shifters and undulators in the straight sections (Helliwell, 
1992). These are magnetic devices which cause the charged particles to 
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accelerate (or decelerate) causing X-ray emission but give no net displacement 
in particle trajectory. 
Monochromators for synchrotron radiation are usually made from a pair of 
germanium or silicon crystals and have a narrower wavelength bandwidth than 
graphite. 
There are several advantages of using synchrotron radiation over a home 
laboratory source. For example, the high intensity X-rays usually enable 
diffraction data to be collected to a higher resolution. Also, a brighter source 
ensures that better data can be collected from weakly diffracting crystals (such 
as small crystals or crystals with very large unit cells). The X-ray beam at a 
synchrotron has a low divergence resulting in sharper reflections (diffracted 
spots) and thus a better signal-to-noise ratio. 
Another advantage of synchrotron radiation is its wavelength tunability. Any 
wavelength within the spectral range can be selected for by adjusting the 
scanning angle of the monochromator; this property is of particular use in the 
multiwavelength anomalous dispersion phasing method. 
2.2.3 X-ray Detectors 
2.2.3.1 Introduction 
Photographic film used to be relied upon to record diffraction data. Collecting 
and analysing such data was a time consuming process as hundreds of rolls of 
film had to be developed and then the density of the spots individually measured 
with a densitometer. However, in recent years faster, more accurate X-ray 
detectors that allow data collection to be automated have been developed: These 
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include electronic & charge coupled device (CCD) area detectors (Pflugrath, 
1992) and image plates. 
2.2.3.2 Image plates 
Image plates are composed of a flat base coated with a 150µm thick layer of 
BaFBr phosphor (a very efficient absorber of X-rays) doped with europium 
(Eu2+) (Amemiya and Miyhara, 1988). Irradiation of the image plate by X-rays 
cause the Eu2+ ions to be excited into quasi-stable Eu 3+ ions. This stored energy 
can be released by scanning the image plate with a He-Ne red laser; the laser 
stimulates the Eu 3+ ions into emitting violet light. The intensity of the emitted 
light is proportional to the number of X-ray photons absorbed by that region of 
the plate. Thus, by filtering away the incident red light and measuring the violet 
light with a photomultiplier, it is possible to determine the X-ray intensities of 
the spots on the plate. Any residual `image' can then be erased by exposing the 
image plate to bright yellow light. 
Fading of the stored image is not a problem in X-ray diffraction experiments 
as it takes about two months for a 50% reduction in image intensity (Amemiya 
and Miyhara, 1988). 
Apart from being faster and easier to use, image plates have a dynamic range 
(1: 105) several orders of magnitude larger than photographic film. 
A double image plate (DIP) was employed for in-house data collection. This 
allows data to be collected rapidly; whilst one image plate is irradiated by X- 
rays the other is being scanned and then erased ready for the next round of 
irradiation. 
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2.3 X-ray Diffraction Theory 
2.3.1 The Crystal 
The basic repeating unit of a crystal is known as the unit cell: When the unit 
cell is repeated through translations parallel to the three edges (x, y, z) defined 
by the crystal axes, without rotation, it gives the crystal lattice. Therefore, a 
crystal can be regarded as a semi-infinite three-dimensional array of unit cells. 
The unit cell is defined by three vectors a, b and c (in the x, y and z directions, 
respectively) with the angles a, ß and y between them. 
In most crystals, the parallelepiped-shaped unit cell has internal symmetry in 
that two or more molecules are related by axes or planes of symmetry. The 
largest aggregate of molecules that when repeated an integral number of times 
through symmetry operations yield the entire unit cell is known as the 
asymmetric unit (Figure 2.3). For protein molecules, there are only 65 possible 
types of crystal lattice (ie. space groups) in which asymmetric units may 
crystallise. 
j07 ,e \ 
14011 
Figure 2.3 An example of a unit cell and its asymmetric unit. A single unit cell is outlined 
heavily and the asymmetric unit is shaded. 
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2.3.2 X-ray Diffraction 
Diffracted beams are commonly referred to as 'reflections'. This is because in 
the Bragg model of X-ray diffraction each spot in the diffraction pattern is seen 
as a reflection from a set of imaginary equidistant parallel planes which pass 
through atoms within the crystal. 
The planes cut an axis, for example the x-axis, into equal parts that have a 
length of all, a/2, a/3, etc. The integers 1,2,3 etc. are known as indices. If a set 
of planes cut the x-axis into a/h, y into b/k and z into c/1 pieces, they are known 
as the (h k 1) planes. If a set of planes are parallel to an axis that particular index 
is 0. 
A set of planes (h k 1) only produce a diffracted beam when the incident X-ray 
waves, of wavelength X, make an angle 0 with the planes, such that 0 meets the 
conditions of Bragg's law: 
2dsinO = nA 
where d is the interplanar spacing and n is an integer. 
Consider diffraction from a two-dimensional array of scatterers (Figure 2.4). A 
number of equidistant parallel lines can be drawn through all scatterers. 
According to the Bragg model of diffraction, each `plane' acts as a reflecting 
surface for X-rays. If the interplanar distance is an integral number of 
wavelengths, ie. 2dsinO = nA, then all emerging X-rays will be in phase and thus 
interfere constructively to produce a strong diffraction beam. However, incident 
X-rays at any other angle would cause the reflected beams from successive 
planes to be out of phase; these would destructively interfere with one another 
and produce no diffracted beam. 
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Figure 2.4 Parallel rays reflected from two successive planes. 
In this case n=1, however, this can apply any number of planes. The angle of diffraction is 
inversely porportional to the interplanar distance. d=interplanar distance, 00=diffraction angle. 
The three-dimensional crystal lattice hence determines a three-dimensional 
lattice of scattered X-rays; this can be represented as the `reciprocal lattice'. As 
the crystal rotates so does the reciprocal lattice. 
The reciprocal lattice is a convenient abstract concept useful for constructing 
the directions of diffraction by a crystal. The reciprocal lattice spacings are 
related to the spacings of the reflections on the detector. However, the reciprocal 
lattice spacings are inversely related to the crystal lattice spacings : It is therefore 
possible to obtain unit cell dimensions from reflection spacings. The space group 
of the unit cell can be determined by looking for symmetry within the diffraction 
pattern and the absence of certain Bragg reflections. 
Diffraction conditions are determined not only by the reciprocal lattice, but 
also by the radius of the `Ewald sphere', which has a radius reciprocal to the X- 
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ray wavelength X, ie. it is equal to 1/X (Figure 2.5): Bragg's law is satisfied when 
a lattice point comes into contact with the sphere. Therefore, diffracted beams 
are only observed when a reciprocal lattice point is on, or passes through, the 
surface of the Ewald sphere. 
Other reciprocal lattice points can be brought to diffraction by rotating the 
crystal, and thus the reciprocal lattice, causing the intersection of new lattice 
points on the Ewald sphere. 
Crystal 










X-ray data collection results in a list of reflections: Each reflection is assigned 
an X-ray intensity and also indices hkl, that relate to its position in the 
diffraction pattern (hkl corresponding to the reciprocal lattice planes that 
produced the reflection). 
The directions of the scattered waves are dependent upon the crystal lattice and 
the X-ray wavelength, and not upon the unit cell contents. The structural 




2.4 Molecular Structure from Diffraction Data 
2.4.1 Calculating Electron Density 
In order to ascertain a molecular structure from diffraction data the `Fourier 
series' model of diffraction is applied. In this model, each atom or each 
infinitesimal volume of electron density is seen as the X-ray diffractor. 
A diffracted beam, seen as a complicated wave, is the sum of diffractive 
contributions from all atoms (or infinitesimal electron density elements) within 
the unit cell. Therefore, each diffracted X-ray wave can be mathematically 
described as a Fourier series, known as a structure-factor, containing one term 
for each atom (or electron density element) in the unit cell: 
n 
Fhkl =f [cos 2TL(hxj + ky1 + lzj) +i sin 2n(hxj + ky1 + lz1)] 
j=1 
where n is the total number of atoms contained within the unit cell. 
The electron cloud of an atom scatters X-rays. Term f is the atomic scattering 
factor of an atom j. The atom, seen as a sphere of electron density, has a 
scattering power proportional to the number of electrons in the atom; scattering 
is also dependent on atomic vibrations. The terms in parentheses describe a 
three-dimensional wave function: x1, yj and zj represent fractional coordinates of 
atom j in the unit cell, ie. real space. The indices h, k and 1, as well as 
corresponding to a specific reflection, are also the frequencies of the X-rays 
along the x-, y- and z-axes, respectively. The phase of a wave is only dependent 
on the position of the scattering atom in the unit cell: For instance, one atom j at 
the fractional coordinates (x3, yj, z1) contributes to the hkl reflection with a 
diffracted wave of phase 27t(hxj + kyj + lz3) (with respect to a reference wave). 
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During Fourier synthesis of the structure-factor equation the basic waveform 
used is the complex number [cos 2n(hxj + kyj + lz1) +i sin 27t(hxj + kyj + lz3)], 
where i is the imaginary number . Having a complex number as the basic 
waveform enables the phase of a reflection to be determined (discussed later). 
Using the number theory equality cos 0+i sin 0= e`0, the three-dimensional 
wave function can be expressed as an exponential. Therefore the structure-factor 
for a specific reflection, Fhkl, can be re-written as: 
n 2mi(hx + ky + lz ) Fhkl =feiii 
J=1 
The ultimate goal of X-ray crystallography is to calculate the average electron 
density p at every position x, y, z, ie. p(x, y, z), in the unit cell into which the 
protein structure can be built. Firstly, in order to achieve this goal, the structure- 
factor is treated as the sum of contributions from infinitesimally small volume 
elements of electron density: 
Fhkl =fff p(x, y, z)e2m(hx 




y, z)e p 
2ht(hx + ky + ") dV 
v 
where V is the unit cell volume. 
A function f(x) that is related to F(h) in the method shown below is defined as 
the Fourier transform of F(h) and similarly F(h) is the Fourier transform of f(x): 
F(h) _r f(x)e2"`(h") dx 
and 
f(x) _ .E F(h)e-2ngh") dh 
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The units of the variable h are reciprocal to those of x. The Fourier transform 
is thus a relationship between a structure and its diffraction pattern. Therefore, 
the Fourier transform of all the structure factors (which are in reciprocal space, 
with reciprocal length spacings in A-1), gives an image of the unit cell and its 
contents in real space, with spacings in A): 
ý` -2Itt(hx + ky + lz) P(X'Ylz) =VEL. EFhkie 
hkI 
or 
-2nt(hx + ky + lz) Fhkle p(x, y, Z) =V 
hld 
ie. electron density is the Fourier transform of all the structure-factors in the 
diffraction pattern. (The electron density map is a contour map of p(x, y, z) ). 
The electron density equation above suggests that the quality of the crystal 
structure depends upon the number of reflections included in the summation of 
the Fourier synthesis. The Fourier synthesis consists of adding waves of varying 
frequency; the smaller the values of h, k and 1, the greater the frequency. The 
high-frequency terms are reflections nearer the centre of the diffraction pattern 
(produced by crystal lattice planes with large interplanar spacings): These confer 
gross features to the three-dimensional electron density map. The detailed 
features of the map are conferred by the high-frequency terms near the edge of 
the diffraction pattern. The maximum resolution of a structure is taken to be the 
minimum interatomic spacing, d,,,;,,, included in the Fourier synthesis. 
2.4.2 The Phase Problem 
A structure-factor can be represented as a complex vector in two dimensions 
using a phase-vector (or Argand) diagram (Figure 2.6). In the Argand diagram, 
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the structure-factor is divided into a real and imaginary part where the amplitude 
is proportional to the length of the vector, IAI, and the phase (with respect to a 
reference wave) is represented by the angle a made with the real axis. 
imaginary axis 




Figure 2.6 Argand diagram for a structure-factor. 
real axis 
Using simple vector arithmetic, the vector A may be expressed as: 
A= lAlcosa+i(JAisina) 
or 
A= JA (cos a+ isin a) 
where i is the imaginary number . 
Therefore, using the complex number equality cos 0+i sin 0= e`° : 
A= lAlela 
Thus, expressing the phase (in radians) of a reflection Fhkl as ahkl = 27ca'hkl , the 
electron density equation may be re-written as: 
I 
-2ni(hx + ky + lz - 2na'hk, 
) 
P(7C, y, Z) =VI hkl 
Ie 
The amplitude 
I Fhkl I can be directly obtained from the intensity of the 
reflection (Ihkl) as 
I Fhkl I- (Ihkl)12, subject to various polarisation and absorption 
correction factors. The frequencies of the the 
diffracted X-rays are given by the 
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indices of the reflection hkl. But, as the objective is to determine the atom 
positions within the unit cell, the phase information cannot be calculated; in 
effect the relative phases of the refections are lost in X-ray data collection. 
In small molecule crystallography direct phasing methods can be used (e. g. 
Woolfson, 1997): The phase information can be revealed from statistical 
relationships in the intensity data of a crystal. Recently, direct phasing methods 
have been used utilised for a few small protein structures determined at atomic 
resolution. However, the overwhelming majority of crystallographic protein 
structures are not at atomic resolution and are too large for direct phasing 
methods; in these cases `indirect' methods are used to obtain initial phases for 
each reflection. 
2.4.3 The Molecular Replacement Method 
2.4.3.1 Introduction 
In protein crystallography initial phases for a first molecular model can be 
obtained if the structure of a similar or homologous protein is already known. 
For example, a previously determined crystal structure may be used as a `search 
model' to obtain an initial electron density map for a mutant or inhibitor 
complex of the structure. Also, homologous proteins can be used to `solve' (ie. 
obtain initial phases) new structures of interest: This is based on the observation 
that proteins which are homologous in amino acid sequence commonly have 
similar polypeptide chain folds. 
Frequently, the known protein structure has a different crystalline arrangement 
to that of the unknown (usually new) structure. Therefore the search model has 
to be be transferred into the new target unit cell, this is achieved using the 
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molecular replacement method (Rossmann and Blow, 1962). If there is one 
molecule in the asymmetric unit, the transformation matrix relating the two 
structures requires six parameters: Three angles define the rotation required to 
bring the structures into the same orientation and three translation parameters 
superimpose the two structures. 
A brute-force six-dimensional search for the required transformation matrix 
(with respect to an origin) is not viable as it is beyond the capacity of even the 
fastest modern computers. However, the search can be greatly simplified by 
splitting the operation into two three-dimensional searches ( e. g. Driessen and 
Tickle, 1996): The rotational search is used to find the correct orientation of the 
search model and then the translational search is used to place the orientated 
model into the correct position within the target unit cell. 
2.4.3.2 The Rotation Function 
The rotational search is carried out by looking for agreement between the 
Patterson functions of the known and unknown models. The Patterson function 
is a Fourier transform of the set of squared structure-factor intensities without 
phases (h, k, 1,1 Fhkl 12) 
P(u, v, w) _ V, V 
I r' hkl 
12e-21rt(hu + kv + 1w) 
Patterson-space unit cells are of the same dimensions as real-space cells and the 
x, y and z dimensions of Patterson vector-space are called (u, v, w). The 
function 
does not produce an electron density map of the unit cell contents but rather a 
density map of the vectors between atoms of the unit cell (including vectors 
between the same pair of atoms but in opposite directions), superimposed and 
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emanating from the origin of the map. Self-vectors (vectors between equilvalent 
atoms) result in a peak at the origin. In a Patterson map there are n(n - 1) vectors 
from a crystal containing n atoms in the unit cell. 
The intramolecular Patterson function is independent of the position of the 
molecule within the unit cell, however, rotating the molecule alters the Patterson 
map (ie. changing the orientation of the structure changes the Patterson 
function). 
For identical or closely related molecules in two different lattices, the 
orientation of the unknown structure is determined by superimposing the 
different Patterson maps by applying a `cross-rotation function' that maximises 
the overlap between the maps. A search for molecular symmetry axes within a 
crystal involves comparing a Patterson map with itself in different orientations, 
and is known as the self-rotation function. Determination of any local symmetry 
axes by the self-rotation function will reduce the number of possible solutions to 
the cross-rotation function. 
Most molecular replacement programs output a large number of possible 
rotation solutions. Each solution usually has a correlation coefficient, between 
the observed and calculated Patterson vectors, associated with it: The coefficient 
commonly reflects the product of the agreement at each position of the two 
Patterson maps. The product will only be large if both maps have high density 
coinciding at one position. The `correct' rotation solution(s) will normally have 
a correlation coefficient well above the others. 
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2.4.3.3 The Translation Function 
Translation searches are employed to determine the location of molecules 
(with known orientation) in a unit cell: The search is usually carried out by a 
trial and error process whereby the orientated model is placed at various 
positions; each time structure factor amplitudes are calculated (I Fc,, Ic I) and 
compared with the observed structure factor amplitudes (I Fobs 1) by calculating 
an R-factor (described later) and a correlation factor. The correlation coefficient 
has the advantage over the R-factor in that the coefficient is insensitive to the 
intensity scale. 
As with the rotation function, if more than one molecule occupies the 
asymmetric unit, the translation function of each molecule must be determined 
independently. In such cases, the subsequent translation solutions have even 
lower R-factors and greater correlation coefficients than the first solution. 
2.4.3.4 Rigid body refinement 
Some computer programs improve the molecular replacement solution by 
applying rigid body refinement; in this procedure a rigid geometry is assigned to 
the whole (or parts) of the model and attempts made to minimise the fit of 
I Fcaic I to I Fobs I. 
2.4.4 The Multiple Isomorphous Replacement Method 
2.4.4.1 Introduction 
Molecular replacement requires the availability of a known homologous 
protein structure. If this does not exist, isomorphous replacement can be applied; 
this is a commonly used method for determining phase angles where nothing is 
known about the three-dimensional structure of the protein. This technique 
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requires the attachment of heavy atoms (atoms with high atomic number) to the 
protein molecules in a crystal (Kendrew et al., 1958) Phases calculated from the 
positioned heavy atoms can then be used to obtain an initial electron density 
map. 
Every atom in the unit cell contributes to all measured reflections, however, 
any atom's contribution is greatest to the reflection whose indices correspond to 
lattice planes that intersect the atom. So, if a few atoms were introduced into 
identical positions within all unit cells of a crystal, without any alteration in 
crystalline packing (isomorphism), the changes observed in the intensities of the 
diffraction pattern would be greater in some reflections than in others. Adding 
heavier atoms (larger scattering factors) to a crystal would increase the 
differences in the diffraction pattern which would then be large enough to 
measure. 
2.4.4.2 Obtaining Phases from Derivative Data 
If heavy atoms can be bound at a small number of well defined sites, with high 
occupancy, to the native protein to form a heavy atom derivative crystal, it may 
be possible to derive some phase information for the native dataset. 
Assuming that Fp is the structure-factor of a reflection for the native protein, 
FPH is the structure-factor for the corresponding reflection in the derivative 
crstal and that FH is the structure-factor for the heavy atom, simple vector 
arithmetic shows that, for acentric reflections (ie. non-centric reflections): 
FPH = FP + FH 
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and that FH is the structure-factor for the heavy atom, simple vector arithmetic 
shows that, for acentric reflections (ie. non-centric reflections): 
FPH=FP+FH 
This is because all scattering atoms contribute to a reflection (Figure 2.7a). For 
centric reflections (where the phase angle up is 0 or it, if the origin of the system 
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Figure 2.7 Structure factors in the isomorphous replacement phasing method for (a) acentric 
reflections (b) centric reflections. 
FH can be determined once the heavy atom(s) can be located. From the data 
collection experiments the magnitudes I Fp I and I FPH I can be computed. 
However, in order to calculate an electron density map, the phase angle ap of the 
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vector Fp has to be determined for each reflection. It follows from the previous 
equation that for acentric reflections: 
FP = FPH - 
FH 
To calculate ap, the above vector equation is represented in a complex plane: 
The vector -FH is placed at the origin and a circle of radius I FPH I centered at 








Figure 2.8 Determining phase angles for acentric reflections using vectors in the isomorphous 
replacement method. (Adapted from Rhodes, 1993). 
The equation for Fp is only satisfied where the two circles intersect. Therefore 
the phase angles made with vectors Fap and Fbp are the possible phases of the 
reflection. At this point it is clear that the best phase that can be obtained from 
the solutions is the mean in between the two possibilities. So, the phase error 
using the single isomorphous replacement (SIR) method can be quite large. In 
order to eliminate phase ambiguity a second heavy atom derivative (F'H) can be 
prepared and, provided that heavy atom is not at the same position, a unique 




Figure 2.9 (a) A second derivative is prepared and again there are two possible phase angles for 
F. (b) F`p corresponds with Far, so c is the the correct phase for F. 
In theory, the phase angle calculated for the reflection should be exact. But, 
this is based on several assumptions, including ideal isomorphism, precise 
measurement of X-ray intensities and knowledge of the exact heavy atom 
positions, none of which are perfectly met in practice. These imperfections may 
lead to the `phasing circles' grazing one another, causing uncertainity in the 
phase angle (or the circles may not intersect at all). These uncertainies are 
measured in terms of `phase probabilities' :A probability density function will 
have a maximum at the most probable phase. Other derivatives may be 
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necessary to improve the quality of the phases. The method is therefore called 
multiple isomorphous replacement (MIR). 
Data sets from heavy atom derivatives are often at a lower resolution when 
compared with the corresponding native data sets. Therefore, initially phase 
estimates are not available for native reflections at a higher resolution than that 
of the best heavy atom derivative. Generally, for useful phase information to be 
extracted a derivative crystal has to diffract to at least 4.5A. 
For perfect isomorphism the crystalline packing must be identical. The 
intensity differences between the native and derivative data sets are then 
exclusively due to the attached heavy atoms. Perfect isomorphism hardly ever 
occurs. Errors due to nonisomorphism are commonly one of the main obstacles 
in MIR (as it causes difficulties during heavy atom position refinement). 
Nonisomorphism can manifest itself as a slight change in protein conformation 
as a consequence of heavy atom binding, but it usually presents itself as a 
change in the unit cell dimensions. Normally, in practice changes in cell lengths 
relative to the native crystal of up to - 0.5% can be tolerated. 
There are several parameters for assessing the overall quality of phase 
information obtained from a derivative dataset (Wolf et al., 1991). These 
include the occupancy of the heavy atoms, Rclli,, phasing power and R; SO. 
Rcuii for centric reflections is expressed as: 
1: 11FPH± FPI-FH(calc)I 
RCullis 
- hkc j: IFPH±FPI 
hkl 
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In practice the obsevered amplitude I FPH I will be too short or too long to 
exactly reach the endpoint of FH (Figure 2.7). The difference is called the `lack 
of closure error', so in essence the Rcll; s is: 
<lack of closure> / <isomorphous difference> 
An Rcll; s for centric reflections (expressed as a function of resolution) less than 
0.6 is considered to be excellent and anything less than 0.9 is usable. 
The phasing power is the measure of the quality of a derivative and it is 
expressed as: 
<I FH I> / <lack of closure> 
Phasing power values greater than 1.5 are considered excellent and anything 
more than 0.5 is usable. 
.., 
I FPH ±FpI; for a good derivative it R;, 0 is the isomorphous difference (I 
hkl 
should normally be between - 0.15 and 0.25 (ideally, if no heavy atoms were 
bound then the R;, 0 would be zero). If the nonisomorphism 
between the native 
and derivative crystals is appreciable, the R10 will appear larger than it really is. 
2.4.4.3 Locating heavy atom positions 
The phase and magnitude of FH can be calculated easily if the positions of the 
heavy atoms within the unit cell are known. 
Patterson functions are formulated as squares of the number of electrons of the 
scattering atoms, therefore Patterson maps of heavy atom derivative crystals are 
dominated by vectors between heavy atoms. However, these protein derivative 
Patterson maps are usually not interpretable because the number of peaks in a 
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Patterson map is also related to the square of the number of atoms. To overcome 
this problem, a difference Patterson function is used to locate the heavy atoms. 
A difference Patterson map (I FPH I- IFpI )2 is calculated with the amplitudes 
of a derivative crystal and the amplitudes of an isomorphous native crystal: 
AP(u, v, w) =1 OF2hkle_2ht(hu + 
kv + 1w) 
where LF2hkl=(IFPH I- IFPI)2" 
Therefore, the scatter of the light protein atoms is removed and the difference 
map shows just the vectors between heavy atoms (and noise). 
Symmetry within the unit cell can be used to locate heavy atom positions in 
the difference Patterson map. For example, if a protein crystallises in the P21 
space group (a two-fold screw axis along c) an atom at (x, y, z) will have an 
identical symmetry-related atom at (-x, -y, 1/2+ z). Therefore the vectors between 
such atoms in a difference Patterson map will all lie at (2x, 2y, -1/2). As these are 
in fractional unit cell coordinates, (u, v, w) = (2x, 2y, 1/2). All heavy atom vectors 
lie in the Patterson unit cell plane w= 1/2. These planes, that contain difference 
Patterson vectors between symmetry-related atoms, are known as Harker 
sections. If heavy atoms are bound such that they are attached at equivalent 
positions throughout the crystal, the heavy atoms peaks can be found on the 
Harker sections. Once a heavy atom is found its position can be refined using 
least-squares or maximum-likelihood methods (described later) and then 
subsequent heavy atoms sought. 
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2.4.4.4 Preparing heavy atom derivative crystals 
The search for heavy atom derivatives is still essentially a trial-and-error 
process. The preferred derivative preparation method involves soaking the 
protein crystal in a solution of the heavy atom reagent, this is the technique 
presented in the thesis. Other derivative procedures such as chemical or genetic 
modification of the protein and xenon atom attachment (Drenth, 1995) exist; 
however, these methods are as yet not as successful as soaking heavy atoms into 
a crystal. 
(Cocrystallisation is not often employed because the crystals tend not to grow or 
grow nonisomorphously). 
A considerable volume of the protein crystal is occupied by water (Matthews, 
1968), providing solvent channels and pores where extra molecules may enter 
and bind to the protein without disturbing the crystal lattice. However, some 
sites will be more or less accessible than others. Therefore, multiple sites at less 
than full occupancy are common. 
The heavy atom soaking solution is identical in composition to the mother 
liquor, apart from the added reagent and often a slight increase in precipitant 
concentration. After soaking, if the heavy atom occupancy is not very high the 
reagent concentration can sometimes be increased, but the chances of 
nonisomorphism or even crystal degradation are greater. The soaking time 
varies between minutes and months; it depends on the time required for the 
reaction to reach equilibrium, this is determined by a number of factors. For 
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example, the diffusion rate is dependent on the crystal's solvent content and on 
the size of the heavy atom compound. 
Although the search for suitable heavy atom reagents is an empirical process, 
the biochemical properties of the protein, and the chemical properties of the 
buffers & precipitants, can be employed in the search (Blundell and Johnson, 
1976). For instance, histidine residues often act as ligands to heavy atoms such 
as uranium or samarium. The pH should not be too low as it is the neutral 
histidine side chain that acts as the ligand: However, if the pH is too alkali some 
heavy atom salts, such as those containing Sm3+, are easily hydrolysed. Platinum 
and mercury compounds tend to be more reactive at lower pH values; platinum 
compounds commonly binding to the the sulphur atom in methionine, whereas 
mercury compounds tend to associate with free sulphide groups. Still, it is often 
the case that many reagents are tried before a potential derivative is found. 
2.4.5 The Multiwavelength Anomalous Dispersion Method 
2.4.5.1 Introduction 
Like MIR, the method of multiwavelength anomalous dispersion (MAD) is a 
de novo phasing approach. But, unlike MIR, the MAD technique takes 
advantage of anomalous diffraction in determining the phase angles 
(Hendrickson, 1991). 
Anomalous scattering is a phenomenon which influences the intensities of X- 
ray reflections and causes a breakdown of Friedel's Law so that Ihkl # 1_h-k_1. The 
difference in intensities of Friedel pairs in an anomalous scattering data set can 
establish their phases in the nonanomalous scattering data set. 
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2.4.5.2 Anomalous Scattering 
All elements absorb as well as emit radiation. There is a sudden drop in 
absorption just below the characteristic emission wavelengths (Figure 2.2). This 
is known as the `absorption edge' of the element. An element exhibits 
anomalous scattering when the incident X-ray wavelength is close to the 
absorption edge of the element. 
Thus far, X-ray diffraction has been treated as scattering from a free electron 
of an isolated atom. However, a basic model of anomalous diffraction can be 
described if the isolated scattering atom's electron is related to bound electronic 
states of the atom (James, 1948). 
If an incident photon has relatively low energy it is either scattered or not, but 
it cannot be absorbed as it has insufficient energy to cause electronic transitions. 
Therefore, as the photon scatters with no phase delay, only the normal atomic 
scattering coefficient f° can be used to describe the scattering. 
On the other hand, if the incident photon has a high enough energy, some 
photons will be scattered normally, some absorbed and re-emitted at lower 
energy (fluorescence), and some photons will be absorbed and immediately re- 
emitted at the same energy: In the latter case, the photon is retarded compared to 
a normally scattered photon, thus the scattered photon can be seen as gaining an 
imaginary component f' to its phase. 
This effect can be measured as a function of X-ray energy by observing the 
sharp increase in absorption or fluorescence: The imaginary anomalous 
scattering component f is proportional to these measurable quantities. An 
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Figure 2.10 Profile of the imaginary anomalous scattering component f' ' of isolated elemental 
as a function of X-ray energy. 
The real component of the anomalous scattering f is related to f' by the 
Kramers-Kronig transformation (Kronig and Kramers, 1928). The total 
scattering factor is then 
f=f°+f+ýf' 
2.4.5.3 Effects of anomalous scattering 
Using the structure-factor equation it is possible to show that a specific 
reflection Fhkl and its `opposite' F_h_k_1 will have the same magnitude and 
opposite phases (ie. Ihkl = I-h-k-l and ahkl = -a-h-k-l), this is known as Friedel's Law. 
In the presence of anomalous contributions, the magnitudes of Friedel pairs are 
no longer identical and the phases are no longer centrosymmetric around the 
complex plane origin. Differences observed between Friedel pairs at the same 
wavelength are know as `Bijvoet differences', whereas differences observed in 
the same Fhkl at different wavelengths are called `dispersive differences'. Both 
the dispersive and Bijvoet differences are used for phasing in a multiwavelength 
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experiment. The changes observed in intensity are very small, usually only a 
few percent between reflection pairs. 
Centric reflection pairs Fhkl and F_h_k_1 are related through the space group's 
point symmetry (Laue symmetry) and are not Friedel pairs. Centric reflections 
can be used to determine data quality statistics (e. g. Rmerge) in the absence of 
anomalous contributions. A comparison of centric reflection statistics to the 
merged Friedel pairs (which should merge significantly higher) indicates 
whether a useable anomalous signal is present. 
A structure-factor FHP X1+ (the H indicating an anomalous scatter) measured at 
a wavelength X1, where anomalous diffraction does not occur can be represented 
in a complex plane as shown in Figure 2.11. If the same structure factor is 
measured at a wavelength A2 where anomalous diffraction occurs, the structure- 
factor F1 A2+ will now have contributions from the normal scattering 
component Flip X I+ and an anomalous scattering component, the latter consisting 
of two perpendicular vectors one of which is real (AFr+) and the other imaginary 
(AF; ). 
At the wavelength X1 where there is no anomalous scattering, there will be a 
Friedel mate FHP XI- which is a reflection in the real axis of FHP X1+. However, at 
wavelength X2 anomalous diffraction occurs and thus Friedel's Law is broken: 
AFr is the real axis relection of AFr+, but it can be proved that the imaginary 
anomalous contribution OF; - is the inverted reflection of OF; '. Therefore FHP A2+ 
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Figure 2.11 Structure-factors under anomalous scattering. (Adapted from Rhodes, 1993). 
2.4.5.4 Obtaining Phases from anomalous scattering data 
The phase angle for each structure-factor has to be determined. Considering 
the structure-factor FHP ý'1+ it is known from Figure 2.11 that: - 
FHP Xi+ = FHP a. 2+ - AFr+ - OFj+ 
The phases of the anomalous components (real and imaginary) depend only 
upon the location of the anomalous scatters within the unit cell, these positions 
can be found using Patterson methods (described later). Also, the magnitudes of 
AFr and OF; are fairly constant for a given element and are independent of the 
reflection angle, the magnitudes of FHP 
X1+ and FHP ? 2+ can be directly 
determined. As with the MIR method, the above equation can be solved for 
Flip X1+ geometrically using a Harker diagram (Figure 2.12). 
70 
Figure 2.12 Harker diagram determining the phase of a structure-factor. 
There is some phase ambiguity, the phases of both Fa and Fb both solve the 
equation. However, the structure-factors Friedel mate helps in the correct phase 
determination. A second equation can be derived for FHP ý1+ by reflecting FHP X2- 
and its components across the real axis (Figure 2.13a). The magnitude of FHP X2- 
is still the same, OF; ' = AF; - and AFr+ = AFr , so: 
FHP a, i+ =I FHP X2- I- AFr+ + OFj+ 
Again, the above equation can be solved geometrically (Figure 2.13b). The 
phase ambiguity has been removed as one of the solutions to the equation 






Figure 2.13 (a) Reflection of a structure-factor and its components across the real axis (b) 
Removal of phase ambiguity. (Adapted from Rhodes, 1993). 
(As with MIR programs, MAD computer programs calculate phase numerically 
rather than geometrically by obtaining solutions to a series of simultaneous 
equations). 
One of the advantages of using MAD over MIR is that there are no 
nonisomorphism problems associated with anomalous scattering, this is because 
all the diffraction data required for MAD phasing can be collected from a single 
crystal. However, an isomorphous replacement signal is generally a lot stronger 
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than an anomalous signal. The phasing methods may also be combined, for 
example if the multiple isomorphous method includes anomalous scattering 
information, it is called the MIRAS method (or SIRAS if a single derivative is 
used). MIRAS is particularly useful in improving the protein phase angles of 
MIR or MAD data. 
Generally, for useful phase information to be extracted from anomalous data 
sets the crystal has to diffract to at least 3.5A (Hendrickson, 1991). The success 
of MAD phasing also depends on data quality and completeness, and special 
techniques for collecting Friedel opposites, such as the inverse beam geometry 
method; this method reduces the effects of radiation damage, etc. by measuring 
Bijvoet pairs close together in time by exploiting centrosymmetry in the 
diffraction pattern. 
2.4.5.5 Locating anomalous scatters 
If the anomalous scattering atoms within the unit cell can be located then the 
corresponding phase contributions (real and imaginary) can be calculated. 
However, if the anomalous scatters are not heavy atoms which have been soaked 
into a crystal, a difference Patterson map cannot be used to locate them. In such 
cases, one of the functions that could be calculated is a `Bijvoet difference 
Patterson' map with coefficients (ý FhkJ 
I-I F_h-k-l 
OP uvw=1E AF2e-2"«hu 
+ kv + 1w) (V 
nkr 
where AF2 =(I Fhkl 
I 
-I 
F_h-k-l I )2" 
To increase the signal-to-noise ratio the I Fhkl I and 
I F_h-k-1 I values chosen 
would be from the wavelength that had the 
largest value of f '. 
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2.4.5.6 Choosing wavelengths for MAD data collection 
The Cromer-Liberman theoretical values for scattering factors are not very 
accurate near an absorption edge. This is because the anomalous scattering atom 
is not isolated and is affected by the chemical environment (Smith, 1991). 
Therefore for each MAD experiment, X-ray absorption spectra are measured by 
fluorescence detection and used to directly determine the profile of the 
imaginary anomalous scattering component f' as a function of wavelength 
(Hendrickson et al., 1988). The f values can then be derived from the 
corresponding f' spectra using the Kramers-Kronig relationship. 
Once the actual scattering factors f' and f have been determined in the 
energy range of the sample crystal, the exact X-ray wavelengths have to be 
chosen for the MAD data collection. For a MAD experiment at a single 
aborption edge, at least 2 wavelengths are required; however, it is best to use 
three or four so that the phase can be over-determined. The first wavelength to 
choose is the one with the largest signal, ie. maximal f '; this is indicated as X1 
in Figure 2.14. The second wavelength often chosen is X2, the point of inflexion 
in f, with the maximal if I. The third and fourth wavelengths are at points 
remote from the absorption edge. 
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Figure 2.14 Schematic plot of experimental values for j" and f as a function of X-ray energy. 
(NB. 1 KeV = 12.398 / ? A. in A). 
MAD experiments are possible using `in-house' X-ray sources, but there are 
severe limitations due to the sporadic availability of characteristic emissions and 
the weakness of the Bremsstrahlung. So, almost all MAD phasing experiments 
are performed at radiation-dedicated synchrotrons. This is because synchrotrons 
are not only expectionally brighter X-ray sources but also any suitable 
wavelength in the spectral range can be selected with a monochromator. In 
addition, the selected radiation has a very narrow wavelength bandwidth; this is 
highly desirable for MAD phasing as the f and f' contributions to the atomic 
scattering factor change considerably with wavelengths near the X-ray 
absorption edge(s) of the element. 
2.4.5.7 Incorporation of anomalous scatters 
The protein should contain an element that gives a sufficiently strong 
anomalous signal. However, the elemental absorption edge(s) must be within the 
accessible X-ray spectrum to be useful. Using synchrotron radiation, the 
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accessible window is from -0.3 to -3. OA. This range includes the K edges 
(electronic transitions in the K-shell) from Ca (Z = 20) to Ce (Z = 58); and the 
L111 edges (electronic transitions associated with the six 2p electrons) from Sb (Z 
= 51) to U (Z = 92) (Hendrickson, 1991). Several of the heavy atom elements 
used in MIR and a few lighter elements can in theory be used in MAD 
experiments. 
Frequently, new protein structures have been determined from the anomalous 
scattering of Se (Z = 34) in selenomethionine. Selenomethionine (Se-Met) is an 
analogue of the amino acid methionine, where the sulphur atom has been 
replaced with a selenium atom. The X-ray absorption edge of selenium (X = 
0.98A) is easily accessible with synchrotron radiation. Often, selenomethionine 
can replace methionine residues fully without perturbing the protein's structure 
or function (Hendrickson et al., 1990). Incorporation of Se-Met into a protein 
does not perturb the macromolecular structure or function. It has been suggested 
that approximately one Se atom per 150 amino acids in a protein is sufficient for 
a successful application of MAD (Hendrickson et al., 1990), however this is 
only a rule of thumb and it depends strongly on the quality of the diffraction 
data. 
There are several ways in which selenium can be introduced into the protein. 
There were two methods employed in this thesis (described in detail in chapter 
5): The first method involved growing the bacterial host strain on a 
selenomethionine substrate instead of a methionine-containing substrate, and 
blocking the host's methionine biosynthetic pathway using an excess of six 
amino acids. The second procedure used recombinant techniques in which the 
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protein was expressed in a methionine auxotroph and grown with 
selenomethionine as a nutrient. In both cases, the degree to which 
selenomethionine substituted methionine in the target protein was assessed 
using mass spectrometry. 
2.5 Protein Structure Refinement 
2.5.1 The Initial Model 
After obtaining the initial experimental phases from molecular replacement, 
MIR, or MAD an initial model of the protein structure can be built into the first 
electron density maps. As the initial phases obtained are only estimates of the 
true phases, the model will contain errors and is likely to have poorly defined 
regions. However, the overall fold/conformation of the protein is likely to be 
correct. 
2.5.2 Structure Refinement 
2.5.2.1 Introduction 
Crystallographic refinement aims to improve the fit of the model to the 
observed diffraction data. This is achieved by fitting jFcaicj to be as near as 
possible to IFobsl . Three methods of refinement were used, maximum likelihood, 
least squares, and molecular dynamics. Refinement has a limited radius of 
convergence, so parts of the model which are in error will not refine to their 
correct positions. 
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2.5.2.1 Refinement of protein structures 
In order to define the atomic positions the coordinates x, y, and z are required. 
However, it is common to use the temperature (or B-) factor as a parameter. 
Therefore, for each atomic position four parameters have to be refined. This 
presents a problem in protein refinement, that of poor parameter: observation 
ratio. Therefore protein structures are almost always refined with known 
chemical information as a restraints. Not only do covalent (bond lengths and 
angles, Engh and Huber, 1991) and non covalent (hydrogen bonds and Van der 
Waals interactions) restraints prevent chemically incorrect structures, they also 
allow the parameters to be fitted, and therefore increase the 
observation: parameter ratio. 
2.5.2.2 Maximum likelihood refinement 
Maximum likelihood refinement is based on probability statistics. Using the 
constraints imposed by the experimental data, maximum likelihood refinement 
considers the likelihood of a particular reflection being observed and produces 
the model most likely to have given rise to that data. It also takes into account 
the completeness of the data and errors in the coordinates, and thus tends to 
produce more complete density than least squares refinement. 
2.5.2.3 Least squares refinement 
Least squares refinement attempts to refine structures usually in reciprocal 
space, minimising the difference between the observed and calculated electron 
densities. It involves adjusting the positions of the atoms in the asymmetric unit 
until the sum of the squared differences between lFcalcl and IFobslis minimised. 
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2.5.2.4 Refinement by simulated annealing 
Simulated annealing (or molecular dynamics) refinement (Brünger et al., 
1987) is the most popular method of protein structure refinement, by subjecting 
the model to a large increase in temperature (usually around 3000K). The major 
advantage of using these high and obviously biologically unrealistic 
temperatures is that the model can transverse local minima and the radius of 
convergence is significantly increased when compared to techniques such as the 
classical gradient descent (conjugate-gradient and other least-squares methods). 
Simulated annealing was the refinement method used most extensively in the 
work presented in this thesis. 
Simulated annealing searches for the conformation of the structure with the 
lowest energy, with the agreement with the diffraction data as part of the 
function. This minimisation function can be represented as : 
E= Echem + WxrayExray 
where Echem gives information about chemical interactions, E, ray describes the 
difference between the observed and calculated structure factor amplitudes in a 
form that is similar to that for least squares equation : 
Exray = 
Ehkl Fobs (hkl)j-KI F, (hkl)]2 
where K is a scale factor. Wxray is a weighting factor which that balances the 
terms Echem and Exray" If W, ýay is too large the refinement 
is weighted towards the 
diffraction data and the structure will show unrealistic deviations from ideal 
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geometry. If Wxray is too small the refined structure will not satisfy the 
diffraction data. 
2.5.2.5 Rebuilding the model 
The model was rebuilt in 0 (Jones et al., 1991), using difference maps. 
Rebuilding was based on the 13Fobs - 2Fcalcl and 12Fobs - Fcalcl maps, taking into 
consideration the IFobs - Fcalcl and I-Fobs - Fcalci maps. Side chain positions, and 
short areas of backbone were rebuilt accounting for the positions of surrounding 
residues, symmetry equilvalents, etc. 
2.5.2.6 Monitoring the progress of refinement 
The goal of refinement is to produce a chemically realistic model that satisfies 
the diffraction data. The overall progress of crystallographic refinement is 
traditionally monitored by the R-factor Ruyst : 
Ihkl 
W hkl (I Fobs (hkl)I -kI Fcacc (hkl)I) RuySt = Ehr! I Fobs (hkl)I 
where whu are weights and k is a scale factor. 
The R, ryst should be viewed with some caution 
because an acceptable value 
may be obtained through over-fitting the data, giving an incorrect structure with 
realistic stereochemistry. To combat this a cross-validation factor Rfree (Brünger, 
1992b)is also used. The Rfree is calculated from a random subset of data (the 
test-set) comprising 5-10% of the total data. This test-set is then omitted from 
, ajc 
from Fobs can then be measured without refinement. Thus the deviation of F. 
bias from the model. Stereochemical and conformational parameters of the 
model during and after structure refinement can also be used to assess the 
quality of the model. 
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Chapter 3 
Lactobacillus delbrueckii subsp. bulgaricus D-2- 
Hydroxyisocaproate Dehydrogenase: A Broad 
Specificity D-2-Hydroxyacid Dehydrogenase 
3.1 D-2-Hydroxyisocaproate Dehydrogenase 
Lactobacillus delbrueckii subsp. bulgaricus D-2-hydroxyisocaproate (or D-2- 
hydroxy-4-methylpentanoate) dehydrogenase was discovered when a genomic 
library from L. bulgaricus was used to complement an E. coli mutant strain, 
grown in anaerobic conditions, deficient for both lactate dehydrogenase and 
pyruvate formate lyase (Bernard et al., 1994). 
D-2-hydroxyisocaproate dehydrogenase (D-HicDH) has been identified in 
several species such as L. casei (Hummel et al., 1985), L. curvatus (Hummel et 
al., 1988) and the yeast Rhodotorula graminis (Baker et al., 1992). The enzyme 
has a broad substrate specificity. It catalyses a wide spectrum of D-2- 
hydroxyacids with branched and unbranched aliphatic side chains of medium 
size. 
The kinetic mechanism, coenzyme binding and substrate inhibition of 
L. bulgaricus D-HicDH had previously been studied by Alvarez et al. (1997). 
They showed that the enzyme has a bi-bi ordered mechanism with NADH 
binding first, and that the enzyme could be inhibited by excess concentrations of 
pyruvate. This substrate inhibition was shown to be be directly attributed to the 
formation of a NAD+-pyruvate adduct. The substrate specificity range of the 
enzyme has also been examined (Johnsen, 1995; Bernard et al., 1994) (Table 



















benzylpyruvate cyclopentyl pyruvate 
Figure 3.1 The chemical structure of the 2-ketoacids used in D-HicDH specificity studies. 
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SUBSTRATE kcat (s) KM M Ki (mM) kcat/ KM (s" M" ) 
phenylpyruvate 22.2 ± 0.7 31.5 ± 4.0 4.7+1.8 7.05 x 105 
2-ketooctanoate 91.4 ± 1.4 298.6 ± 14.4 - 3.06 x 105 
2-ketocaproate 14.7 ± 0.1 19.7 ± 0.6 18.2 ± 1.4 7.46 x 105 
2-ketoisocaproate 21.5 ± 0.7 21.8 ± 2.9 62.4 ± 47.8 9.86 x 105 
2-ketovalerate 21.1 ± 0.4 57.1 ± 4.1 33.5 ± 5.4 3.70 x 105 
2-ketoisovalerate 16.0 ± 0.6 20500 ± 1600 - 7.80 x 102 
2-ketobutyrate 51.6 ± 1.1 1750 ± 80 53.3 ± 5.3 2.95 x 104 
pyruvate 47.5 ± 3.0 15000 ± 1900 - 3.17 x 103 
benzylpyruvate 56.7 ± 1.4 36.1 ± 2.7 11.2 ± 2.8 1.57 x 106 
cyclopentyl pyruvate 11.9 ± 0.2 14.1 ± 0.8 5.5 ± 1.0 8.44 x 105 
Table 3.1 Steady state kinetic constants for the various substrates reduced by D-HicDH. The 
assay solutions contained 0.2mM NADH and were at pH 7.5. Measurements were taken at 25°C. 
(Data taken from Johnsen, 1995). 
Most of the substrates tested weakly inhibited the enzyme, apart from pyruvate, 
2-ketoisovalverate and 2-ketooctanoate. Inhibition by phenylpyruvate was 
stronger. The preferred substrates of L. bulgaricus D-HicDH are those which 
consist of a three-carbon 2-oxocarboxylic moiety whose C3 is substituted with a 
hydrophobic `tail'. Thus, apart from C3-branched 5 carbon 2-ketoisovalerate, 
the substrates with strongly hydrophobic tails (namely, benzylpyruvate, 
cyclopentyl pyruvate, 2-ketoisocaproate, 2-ketocaproate, phenylpyruvate and 2- 
ketovalerate) are recognised better than the one carbon substituted 2- 
ketooctanoate. The unsubstitued pyruvate, along with 2-ketoisovalerate are 
poorly recognised substrates. 
The high KM for 2-ketoisovalerate, is revealing about the structure of the 
substrate binding pocket of the enzyme. It has been suggested that the pocket 
consists of two compartments (Johnsen, 1995). The first would be the active site 
of the protein where the 2-oxocarboxylic moiety would sit. The second site 
could be a region where hydrophobic interactions take place. The compartments 
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may be linked by a narrow cleft, and this could explain the poor binding of the 
n-branched 2-ketoisovalerate. 
A sequence comparison of several D-HicDH and D-LDH enzymes (Figure 3.2) 
shows that accommodation of larger substrates in the broad specificity enzymes 
is not due to insertions in the active site loops of D-HicDH (cf. L-HicDH and L- 
LDH section 1.4.4.3). 
The given name of the enzyme, 2-hydroxyisocaproate dehydrogenase, is a 
misnomer, as the enzyme is no more specific for 2-ketoisocaproate than for 
phenylpyruvate or 2-ketocaproate. 
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3.2 The H2050 Mutation 
In order to assign functions to specific amino acids in L. bulgaricus D-HicDH 
mutants of conserved and semi-conserved residues (Figure 1.14) were 
constructed and characterised (Bernard et al., 1996). Enzyme inactivation with 
diethylpyrocarbonate indicated that a single histidine residue was involved in 
catalysis and it was demostrated that H296 is responsible for proton exchange in 
the reaction. The acid residues D259 or E264 were thought to be involved in the 
stabilisation of His296 in the protonated state. However mutation of both 
residues caused a similar and large reduction in kcat/KM. This indicated that 
D259 and/or E264 could partner H296. Mutation of the R235 residue lead to an 
increase in KM and a reduction in kcat for 2-ketoisocaproate. This residue is 
probably involved binding of the carboxylate group of the substrate. 
A partially conserved histidine residue at 205 (conserved in 10/13 members of 
the D-2-hydroxyacid dehydrogenase family) was then mutated to a glutamine. 
The H205Q mutant showed, a 7-fold increase for KM for NADH; a 2-10 fold pH 
dependent increase in kcat for 2-ketoisocaproate; a 2-30 fold increase in KM for 
2-ketoisocaproate; and a 7-20 fold reduction in substrate inhibition. In order to 
confirm the observations that the kinetic constants for the H205Q mutant had 
improved Johnsen (1995) performed further steady state kinetics experiments 
using 3 substrates (Table 3.2 and Figure 3.3). 
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2-ketoisocaproate cyclopentyl pyruvate benzylpyruvate 
WT H205Q WT H205Q H205Q 
kcat (S-') 41.1 ± 0.7 138.3 ± 3.0 29.7 ± 1.04 129.0 ± 2.1 284.0 ± 6.5 
KM (µM) 19.2 ± 1.0 723.7 ± 41.8 9.7 ± 1.3 332.0 ± 14.0 603.8 ± 40.2 
K; (mM) 3.55 ± 0.29 135.8 ± 32.7 3.5 ± 0.7 54.7 ± 9.3 - 
kcat/ KM (S-1M-1 ) 2.4 x 106 1.92 x 105 3.06 x 106 3.89 x 105 4.70 x 105 
Table 3.2 Steady state kinetic constants for the various substrates reduced by WT and H205Q D- 
HicDH. The assay solutions contained 0.2mM NADH and were at pH 6.5. Measurements were 
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Figure 3.3 Observed and calculated kcat for WT and H205Q mutant D-HicDH. 
Filled circles are the data points for wild type D-HicDH. 
Open circles are data points for H205Q 
mutant D-HicDH. (Similar graphs were obtained 
for other 2-ketoacid substrates Johnsen 1995). 
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The graphs show that the H205Q mutant enzyme has a vastly superior catalytic 
rate at high substrate concentrations. The table shows that the mutant enzyme 
also has higher KM values and lower K; values compared with wild type D- 
HicDH. These modifications in the kinetic properties make the H205Q mutant 
enzyme very attractive for use in the industrial production of chirally pure 
compounds. For example, the enhanced mutant enzyme may be used in the 
production of chirally pure L-phenylalanine, a synthon in the production of the 
dipeptide sweetner Aspartame (Figure 3.4). 
L-HicDH 
D-HicDH 




NAD NADH CH2 
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Figure 3.4 The preparartion of phenylalanine. Oxidation of D, L-phenyllactate with D- and L- 
HicDH and simultaneous reductive amination of the formed phenylpyruvate with phenylalanine 
dehydrogenase (PheDH). 
Comparsion of the L. bulgaricus D-HicDH sequence with the crystal structures 
of L. casei D-HicDH (Dengler et al., 1997) and L. helveticus D-LDH (Dunn and 
Holbrook, 1991) suggest that the H205 residue is on the (3D strand of the 
Rossmann fold motif in the coenzyme binding site. The structures show that 
H205 is within 5A of the pyrophosphate backbone of NADH. Therefore it is 
presumed that the reduced binding of NAD+ and NADH to the H205Q mutant 
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(Bernard et al., 1996) may be the result of weakened binding between the 
uncharged glutamine and pyrophosphate. This increased NAD+-off rate would 
therefore decrease the probability of the formation of an abortive adduct and so 
improve the catalytic efficiency of the mutant enzyme. 
Interestingly however, the His 205 residue has recently not been implicated in 
coenzyme binding in L. bulgaricus D-LDH (Kochhar, 2000). The KM for NADH 
remained essentially unchanged when His 205 was replaced with lysine. 
3.3 Aims 
Molecular models of the wild type and H205Q mutant L. bugaricus D-HicDH 
enzymes were required in order to determine the structural basis for substrate 
specificity and stereospecificity, and also to understand the role played by the 
H205Q mutation in enhancing the catalytic efficiency of the enzyme. 
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Chapter 4 
Purification, Crystallisation and Diffraction Data 
Collection of the Wild Type & H205Q mutant D-2- 
Hydroxyisocaproate Dehydrogenases 
L. bulgaricus D-HicDH has a low pI of 4.8 and is stable overnight at pH 4.5 
(Johnsen, 1995). Using these physiochemical properties a single purification 
protocol had previously been devised for the wild type and mutant enzymes 
(Bernard et al., 1994). 
4.1 Purification of D-HicDH 
As the pGIN113/6 plasmid carries an ampicillin resistance gene, the Luria- 
Bertani (LB) agar and Luria (L) Broth (Sambrook et al., 1989) used to grow the 
E. coli cells all contained 1 µg/ml of ampicillin to select for the cell strain 
expressing the D-HicDH (wild type or H205Q) enzyme. 
Using aseptic techniques, a glycerol stock of the wild type clone 
AR58p[GIN113/6] (or the clone harbouring the H205Q mutant) was streaked 
out onto a 1.6% LB agar plate and grown overnight at 370C. A single bacterial 
colony was toothpicked from the plate and used to inoculate 5ml L Broth, this 
was again grown at 37°C in a shaking incubator (220 revolutions/min) for 8 
hours. 500g1 of the culture was transferred to a sterile 250m1 flask containing 
5 0m1 L Broth, which was then grown for a further 4 hours at 37 0 C. 
The 50m1 L Broth was used to inoculate a sterile 2 litre flask containing 500ml 
L Broth, this was then grown at 370C. When the culture had reached mid-log 
phase of growth (usually A600nm 0.4-0.6) protein expression was induced by 
derepressing the lambda repressor (Turner et al., 1997); this was achieved by 
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derepressing the lambda repressor (Turner et al., 1997); this was achieved by 
heat shocking the culture at 420C for 3 hours. After induction, the bacterial 
culture was grown at 37 0C overnight. 
The cells were then harvested by centrifugation at 4,000rpm for 20 minutes at 
4°C. Following this, the cells were resuspended in a minimal volume of 50mM 
TEA pH 6.5. The bacterial suspension was then sonicated on ice, using 5 repeats 
of 10 seconds medium-power sonication bursts. The subsequent cell debris was 
pelleted by centrifugation at 4°C for 25 minutes at 20,000rpm. The supernatant 
was then dialysed against 50mM sodium citrate pH 4.5 overnight. 
The dialysate was spun at 20,000rpm for 20 minutes at 40C in order to remove 
any insoluble material. The supernatant was loaded onto a column packed with 
250m1 S- Sepharose resin (Sigma) which had been pre-equilibrated with 2 
column volumes of 50mM sodium citrate pH 4.5. The unbound protein fraction 
was eluted by washing the cationic exchange column with a further 2 column 
volumes of 50mM sodium citrate pH 4.5 (Figure 4.1). 
A (276nm) 
Fraction 
Figure 4.1 Plot of unbound fraction eluting from the S- Sepharose column. 
The column was run `under gravity' and the elution profile was 
followed by measuring A276ro 
using a Pharmacia UVICORD (8300 
Uvicord II) and a chart recorder. 
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The unbound fraction was then dialysed against 50mM triethanolamine (TEA) 
pH 6.5 overnight. 
The protein sample was again spun at 20,000rpm for 20 minutes at 40C to get 
rid of any sediment and the supernatant loaded onto a column packed with 150m1 
Q- Sepharose resin (Sigma) which had been equilibrated with 2 column volumes 
of 50mM TEA pH 6.5. The bound protein fraction was then eluted with a 600m1 
0-0.5M NaCl gradient (Figure 4.2). 
A (276nm) 
Fraction 
Figure 4.2 Plot of bound fraction eluting from the Q- Sepharose column. 
The column was run at a flow rate of 0.6m1 ml/min overnight. The elution profile was followed by 
measuring A276nm . The D-HicDH protein eluted at 
0.25-0.3M NaCl. 
SDS-PAGE analysis showed that the protein had been purified to homogeneity 
(Figure 4.3). 
The purified protein was then sterilised using a 0.221am syringe driven filter. 
Finally, the protein was stored at 40C in 40% (w/v) ammonium sulphate. 
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Figure 4.3 SDS- PAGE analysis of D-HicDH purification. 
12.5% acrylamide (Sambrook et al., 1989). Bands visualised using Comassie blue stain. 
(Lanes: M= Molecular weight standards, R= Rich crude cell extract sample taken from 50m1 L 
broth, C= Crude cell extract, A= After acid dialysis, S= After S-column, Q= After Q-column). 
The purity of protein samples taken at different stages of purification was 
analysed (Table 4.1). 
There are several assay systems for the dehydrogenase enzymes (Holbrook et 
al., 1975). The assay used involved spectrophotometrically following the change 
in absorbance at 340nm (Kornberg, 1955): NADH absorbs light at 340nm, 
however. this is removed by hydride transfer during the catalytic forward 
reaction (ie. the oxidised form, NAD+, does not absorb at 340nm). Therefore it is 








NADH + H' NAD` 
Figure 4.4 The broad specificity reaction catalysed by D-HicDH. 
The reaction equilibrium is in favour of the reduction of 2-keto acid to D-2-hydroxyacid. 
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The assay reaction mixture consisted of 0.2mM NADH, 1 mM a-ketoisocaproate 
buffered with 50mM TEA pH 8.0 to which specific volumes of the enzyme 
solution would be added (the total reaction volume being lml). Steady state rate 
measurements were taken from the initial linear portion of the reduction graph. 
Stage Volume Total Total Specific Yield Purification 
(ml) protein activity activity (%) factor 
(mg) a (U) b (U/mg) -fold 
Crude cell extract 84 614 3506 5.7 100 1.0 
After acid dialysis 79 297 3484 11.7 99.4 2.1 
After cationic 111 182 2981 16.4 85.0 2.9 
exchange 
(S - column) 
After anionic 153 114 2589 22.7 73.8 4.0 
exchange 
(Q - column) 
Table 4.1 Typical D-HicDH purification statistics from a2 litre L Broth preparation. 
a Protein concentration determined using the Bradford method (Bradford, 1976). This method 
was used instead of measuring A280rn, , as nucleic acids also absorb strongly at 
280nm. 
bA unit (U) is the amount of enzyme required to catalyse the oxidation of 1 µmol of NADH / 
min at 25 0 C. 
4.2 Protein Concentration 
Firstly, any salts (e. g. ammonium sulphate, NaCl, etc. ) and bound nucleotides 
(e. g. NAD+) present in the sample were removed as they would effect the 
crystallisation of the enzyme: This was achieved by dialysing the protein against 
large volumes of 5mM sodium acetate pH 5.0 containing 1 g/l activated 
charcoal, which would bind nucleotide contaminants. 
Before conducting any crystallisation trials the purified protein 
had to be 
concentrated: An Amicon Centricon centrifugal 
filter, with a molecular weight 
cutoff (MWCO) of lOkD, was used 
for this purpose. If further concentration was 
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necessary, an Amicon Microcon (for sample volumes less than 0.5m1) with a 
MWCO lOkD filter was utilised. 
Protein concentration and the presence of NAD+ were measured by recording 
the absorbance spectrum of the sample. 
The extinction coefficient at 280nm in a 1cm pathlength cuvette for a 1mg/ml 
solution of D-HicDH was 0.96 (Johnsen, 1995). Protein molecules absorb almost 
twice as strongly at 280nm than at 260nm (Roth, 1968). However, NAD+ has a 
very strong ultraviolet absorption peak at 260nm (although its reduced form, 
NADH, absorbs weakly at 260nm) (Holbrook et al., 1975). Therefore a 
A280nm/A260. ratio greater than 1.9 for the sample was taken to imply the 
absence of NAD+ in the protein solution. 
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4.3 Crystallisation and Diffraction Data Collection of the 
Wild Type & H205Q mutant D-2-Hydroxyisocaproate 
Dehydrogenases 
4.3.1 Crystallisation Method 
Unless otherwise stated, all crystallisation trials were performed using the 
hanging drop variant of the vapour diffusion method, with a drop consisting of 
341 protein solution + 341 well solution over a lml well, and the crystal trays 
were stored at 17°C. 
4.3.2 Data Processing and Reduction 
The X-ray data collected were processed and reduced using the HKL suite of 
programs (Otwinowski and Minor, 1996): The diffraction images were indexed 
using the DENZO program. The aim of `auto-indexing' is to determine the space 
group, calculate the approximate unit cell dimensions and find the orientation 
matrix of the unit cell. This operation requires only about 100 reflections from a 
single diffraction image and the X-ray beam position and crystal-to-detector 
position must be known; these spot positions and parameters are then refined 
(along with other parameters, such as background corrections). The intensities 
of the spots can then be integrated. 
The indexed data were then scaled and merged using SCALEPACK. The 
scaling operation put the intensities from different images on a common scale to 
account for variations in incident beam intensity, wavelength, etc. (see 5.2.4.1). 
The average mosaicity of the crystal is also calculated The scaled data are then 
merged, i. e. multiple observations are reduced to a mean intensity and standard 
deviation. 
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The scalepack2mtz program was then used to convert the reduced data to mtz 
format; the format used by the CCP4 suite of progams (Collaborative 
Computational Project Number 4,1994). The structure factor amplitudes were 
then calculated as the positive square root of the intensities using theCCP4 
program TRUNCATE. 
4.3.3 Crystallising the wild type & H2050 apoenzyme 
Three crystallisation conditions were found for the H205Q mutant apoenzyme 
using Hampton Screen (I). These were then further optimised. 
Apoenzyme crystallisation condition (1): 50mg/ml protein; 28% polyethylene 













(After 5 days) 
50 24 - 30 7.3-7.7 0.2 Small rod-shaped crystals (- 50µm 
in length) 
grew around precipitated protein 
22 2-30 7.3-7.7 0.2 Light precipitate 
60 24 - 30 7.3-7.7 0.2 Heavy precipi ate 
22 16 - 20 7.3-7.7 0.2 Clear drop 
11 24-30 7.3-7.7 0.2 Precipitate 
6 24 - 30 7.3-7.7 0.2 Micro-clusters of crystals' 
45 24 - 30 7.5-7.7 0.2 Very small rod-shaped crystals 
grew around precipitate 
6 10 - 16 7.3-7.7 0.2 Micro-clusters of crystals' 
17 4-10 7.3-7.7 0.2 Micro-clusters of crystals' 
- 4-10 - 0.05-0.5 Micro-clusters of crystals« 
Table 4.2 A selection of trials used to optimise apoenzyme crystallisation condition (1). 
+ The Hampton Screen protein dye `Izit' indicated that the micro-clusters were not protein. 
# Micro-clusters still formed in the complete absence of protein, and became more abundant at 
higher salt concentrations: This suggested that the clusters were CaC12 crystals. 
It was found that protein crystals only formed in a very narrow range when 
using these conditions. 
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Figure 4.5 Protein crystals grown using apoenzyme crystallisation condition (1). 
Apoenzyme Crystal form (1) 
One crystal initially diffracted to -'3A. However, the crystal started to rapidly 
deteriorate and so only a few images were collected. 
Apoenzyme crystallisation condition (2): 50mg/ml protein; 20% PEG 4000, 
10% propan-2-ol, 0.1 M Na Hepes pH 7.5. 
[Protein [PEG 4000] [Propan-2-ol] pH Results 
solution] Range Range Range 
(mg/ml) (%) (%) 
49 18 - 22 10 7.3-7.7 Crystals grew in drops at 
higher pH with lower [PEG] 
after 2 weeks 
47 14 -26 10 7.7-8.6 Crystals were found at mid 
[PEG] at pH 8.1 - 8.4 
25 14 -26 10 7.7-8.6 All drops remained clear 
47 17 2.5 - 15 7.7-8.6 Tiny crystals grew in 
precipitate at high [propan-2- 
ol]. However, the drops 
remained clear at lower 
concentrations 
40 - 50 15 - 20 10 8.3 Crystals formed in the higher 
[protein] drops 
Table 4.3 A selection of trials used to optimise apoenzyme crystallisation condition (2). 
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J 
Figure 4.6 Protein crystals grown using apoenzyme crystallisation condition (2). 
Apoenzvme Crystal form (2) 
Data collected using the in-house rotating-anode X-ray source (X = 1.5418A). 
Cryoprotectant solution No cryoprotectant needed 
Unit cell a=102.15 A, b= l 13.01A, c=102.43 A 
a=y90°, ß=90.03° 
Space group P21 
Total number of unique reflections 15,909 
Mean Redundancy 1.6 
Resolution 3.3k 
Mosaicity 1.570 
Completeness - Overall (20.0-3.3k) 
Outer shell (3.65-3.3k) 
82.6% 
79.3% 








Table 4.4 Diffraction data collection statistics of a apoenzyme crystainsation conuition kz) 
crystal. 
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Apoenzyme crystallisation condition (3): 50mg/ml protein; 2. OM ammonium 
dihydrogen phosphate, 0.1 M Tris HCl pH 8.5. 
[Protein [NH4H2PO4 pH Results 
solution] ] Range 
(mg/ml) Range 
(M) 
50 0.25-1.5 8.3-8.7 Very small bipyramidal tetragonal 
crystals at higher [NH4H2PO4] 
appeared after 4 days 
26 0.25-1.5 8.3-8.7 Drops remained clear 
30 - 50 1.5 -2.5 8.5 Small crystals grew in drops at mid 
[ rotein with -2M NH4H2PO4 
45 1.0-2.0 8.5 Small bipyramidal tetragonal 
crystals 1.8-2M NH4H2PO4 grew 
after 1 week 
Table 4.5 A selection of trials used to optimise apoenzyme crystallisation condition (3). 
Many attempts were made at increasing the size of the crystals, including 
increasing the hanging drop size and growing the crystals at 40C, all proved to 
be unsuccessful. 
In most cases, ammonium sulphate could replace ammonium dihydrogen 
phosphate as the precipitant and this still gave similar small tetragonal 
bipyramidal crystals. 
Figure 4.7 Protein crystals grown using apoenzyme crystallisation condition 
(3). 
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Virtually identical crystallisation conditions were found for the wild type 
apoenzyme. 
Apoenzyme Crystal form (3) 
The diffraction from this crystal form was poor (-4.8A), so data were not 
collected. 
4.3.4 Crystallising the wild type & H2050 binary complexes 
The conditions used to grow binary complex (enzyme + cofactor) crystals 
were found to be different from apoenzyme crystallisation conditions, apart 
from the latter condition, using ammonium dihydrogen phosphate & O. 1M Tris 
HCl pH 8.5 , which only gave small irregularly shaped crystals. 
Again Hampton Screen (I) was used; this gave 2 preliminary crystallisation 
conditions for the H205Q putative binary complex. 
Binary complex crystallisation condition (1): 30mg/ml protein, 2mM NADH; 
20% PEG 3350,0.1M TEA pH 7.5. 
[Protein [PEG 3350] pH Results 
solution] Range Range 
(m /ml) (%) 
20 - 50 15 - 30 7.5 Tiny crystals, slightly irregular in 
shape, formed in the higher 
[protein] drops 
20 - 50 25 - 40 7.5 Most drops were either clear or 
contained light precipitate 
50 - 70 15 - 30 7.5 Some well developed crystals were 
found in the high [protein] drops at 
26 - 28% PEG 3350 
70 - 90 15 - 30 7.5 Heavy precipitate 
67 24 - 30 6.8-7.1 Several well formed crystals in tray 
amongst larger irregularly shaped 
crystals 
Table 4.6 A selection of trials used to optimise binary complex crystallisation condition (1). 
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The crystals were found to be unstable; after a week they would become cracked 
and/or lose their birefrigency. Therefore the crystals had to be frozen in liquid 
nitrogen in matter of days. However, whilst trying to mount the crystals, they 
were found to be very fragile and would sometimes crack during manipulation. 
Figure 4.8 Protein crystals grown using binary complex crystallisation condition (1). 
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Binary complex Crystal form (1) 
Data collected using the Daresbury SRS laboratory (PX7.2, A=1.488 1). 
Cryoprotectant solution 22% PEG 3350,0.1M TEA pH 7.1, 
2mM NADH, 10% glycerol 
Unit cell a=63.32A, b=76.31A, c=80.64A, 
a=104.23°, 9=111.61 0, y=102.720 
Space group PI 
Total number of unique reflections 15,711 
Mean Redundancy 2.2 
Resolution 3.1A 
Mosaicity 2.420 
Completeness - Overall (20.0-3.1A) 
Outer shell (3.21-3.1A) 
79.3% 
84.1% 








Table 4.7 Diffraction data collection statistics of a binary complex crystallisation condition (1) 
crystal. 
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Binary complex crystallisation condition (2): 15mg/ml protein, 1mM NADH; 
0.4M ammonium dihydrogen phosphate. 
[Protein [NH4H2PO4 pH Drop size Results 
solution] ] Range (111 + -pl) (After 5 days) 
(mg/ml) Range 
5 -20 0.2-2.0 - 3+3 Larger crystals grew at 
[protein] above 
l 0mg/ml 
12.5 0.2-2.0 - 3+3 Concentrations above 
1.2M gave very large 
cubic-like crystals 
(- 400pm in length) 
25 0.2-2.0 - 3+3 Small crystals formed 
10 1.2-2.0 4.0-7.5 3+3 Addition of a buffer 
caused the formation 
of smaller crystals. 
5- 15 1.2-2.0 - 6+6 Very small crystals 
grew 
Table 4.8 A selection of trials used to optimise binary complex crystallisation condition (2). 
Small crystals were obtained when ammonium sulphate was used as the 
precipitant. 
Aop", 
Figure 4.9 Protein crystals grown using binary complex crystallisation condition (2). 
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Data collected using the in-house rotating anode X-ray source. 
Cryoprotectant solution 1.6M ammonium dihydrogen 
phosphate, 1 mM NADH, 25% 
glycerol 
Unit cell a=b=80.06A, c=266.95A, 
a=ß=y=90° 
Space group P422 
Total number of unique reflections 7,785 
Mean Redundancy 1.7 
Resolution 3.6A 
Mosaicity 1.3(1 
Completeness - Overall (25.0-3.6A) 
Outer shell (3.76-3.6A) 
84.7% 
80.2% 








Table 4.9 Diffraction data collection statistics of a binary complex crystallisation condition (2) 
crystal. 
One crystallisation condition was also found for the H205Q binary complex 
using Hampton Screen (II). Binary complex crystallisation condition 
(3): 
30mg/ml protein, 1 mM NADH; 30% PEG monomethylether (MME) 
5000, 
0.2M ammonium sulphate, 0.1 M MES pH 6.5. 
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[Protein [PEG MME pH [(NH4)2SO4] Results 
solution] 5000] Range Range (After -2 weeks) 
(mg/ml) Range (M) 
(%) 
30 20 - 28 6.3-6.7 0.2 Rhombohedral shaped 
crystals grew, they 
decreased in size as the 
[PEG] increased 
25 18 - 22 6.3-6.7 0.2 Huge crystals in drops 
containing 20 - 22% PEG 
MME 5K (Fig. 4.9a) 
15 - 25 20 -22 6.3-6.7 0.2 Crystals decreased 
dramatically in size as the 
[protein] decreased 
40 20 -22 6.3-6.7 0.2 Large rhombohedral shaped 
crystals formed in most of 
the drops (Fig. 
4.10). However, some drops 
also contained oblong 
sha ed crystals (Fig. 4.11) 
50 -60 20 - 22 6.5 0.2 Large irregularly shaped 
crystals developed 
5-15 24 -36 6.5 0.2 Most drops remained clear, 
but tiny crystals were seen 
others 
40 20 - 22 6.5 0.05-0.5 Drops containing 
less than 
0.2 M (NH4)2S04 remained 
clear. Drops which had 
greater than 0.2M 
[(NH4)2SO4] formed small 
crystals 
40 20 - 22 4.5-5.5 0.2 The 
drops at pH 4.5 - 5.0 
using 0.1 M contained precipitate. The 
Na acetate drops at pH 5.5 contained 
small irregularly shaped 
crystals and precipitate. 
Table 4.10 A selection of trials used to optimise binary complex crystaiIIsauuiIcuIIuI«uII kj). 
Varying the size of the hanging drop had negligible effect. Also, crystals did not grow when the 
NADH concentration was increased. 
During diffraction data collection it was found that the rhombohedral and 
oblong shaped crystals were two distinct crystal forms (cf. Fig. 
4.10 and Fig. 
4.11). 
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Figure 4.10 Protein crystals grown using binary complex crystallisation condition (3a). 
Binary complex Crystal form (3a) P21 
Data collected at the Daresbury SRS laboratory (PX9.6, X=0.87A) 
Cryoprotectant solution e. g. 22% PEG MME 5K, 0.2M 
(NH4)2SO4,0.1M MES pH 6.5, 
1 mM NADH, 10% glycerol. 
Unit cell a=77.41 A, b=112.21 A, c=81.14A, 
a=y=90°, ß=96.806 
Space group P21 
Total number of unique reflections 21,216 
Mean Redundancy 2.09 
Resolution 3. OA 
Mosaicity 0.62° 
Completeness - Overall (15.00-3.00A) 
Outer shell (3.24-3.00A) 
94.6% 
97.1% 








Table 4.11 Diffraction data collection statistics of a binary complex crystallisation condition (3a) 
crystal. 
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Figure 4.11 Protein crystals grown using binary complex crystallisation condition (3b). 
Binary complex Crystal form (3b) C2 
Data collected at the Daresbury SRS laboratory (PX7.2) 
Cryoprotectant solution e. g. 24% PEG MME 5K, 0.2M 
(NH4)2S04,0.1M MES pH 6.5, 
1 mM NADH, 10% glycerol. 
Unit cell a=161.28A, b=80.99A, c=125.84A, 
a=y--90°, ß=118.30 
Space group C2 
Total number of unique reflections 13,840 
Mean Redundancy 2.4 
Resolution 2.8A 
Mosaicity 0.83° 
Completeness - Overall (15.0-2.8A) 
Outer shell (2.94-2.8A) 
91.6% 
94.3% 








Table 4.12 Diffraction data collection statistics of a binary complex crystallisation conainon tit 
crystal. 
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Crystallisation trays which had been stored at 40C contained crystals that had a 






Figure 4.12 Protein crystals grown using binary complex crystallisation condition (3c). 
Binary complex Crystal form (3c) 
The binary crystals grown at 40C diffracted poorly (-6A), and so data were not 
collected. 
The wild type putative binary complex crystallised in the same manner as the 
H205Q mutant using the conditions above. 
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4.3.5 Crystallising the wild type & H2050 ternary complexes 
4.3.5.1 1 , 4,5 , 6-Tetrahydronicotinamide Adenine Dinucleotide 
In order to crystallise a ternary complex (enzyme + cofactor + substrate), the 
catalytic `turnover' of substrate & cofactor had to be prevented. For this 
purpose, 1,4,5,6- tetrahydronicotinamide adenine dinucleotide (tNADH) (Dave 
et al., 1968) was used: tNADH, a gift from T. Dafforn (Department of 
Biochemistry, Bristol University), is a synthesised highly reduced inactive 

















Previous studies on other dehydrogenases have shown that the analogue has 
similar binding affinities to the enzymes as NAD+ (Thevenot et al., 1975) and 
that tNADH binds to deydrogenases in a very similar conformation to NADH 
(Cedergren-Zappezauer et al., 1982). 
4.3.5.2 Crystallising the abortive ternary complex 
Only one of the previous crystallisation conditions (binary condition(2)) 
yielded suitable H205Q D-HicDH putative ternary complex crystals: - 
Ternary complex crystallisation condition (1): 8- 12mg/ml protein, 1 mM 
tNADH, 2.5mM a-ketoisocaproate in the drop solution; 1.2 - 1.4M ammonium 
dihydrogen phosphate, 0.1M Na acetate pH 5.0 in the well solution. 
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Figure 4.14 Protein crystals grown using ternary complex crystallisation condition (1). 
Ternary complex Crystal form (1) 
These crystals diffracted poorly (-5.5A), therefore data were not collected. 
One further condition for crystallising the ternary complex was found using 
Hampton Screen (I). 
Ternary complex crystallisation condition (2): 28mg/ml protein, 4mM tNADH, 
25mM a-ketoisocaproate in the 1.5pzl + 1.5pl drop solution; 8% PEG 4000, 
0.1M Na acetate pH 4.6 in the well solution (Table 4.13). 
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[Protein] [tNADH] [a-ketoisocaproatel [PEG pH Results 
(mg/ml) (mM) (MM) 4000] Range (after -2 weeks) 
Range 
28 4 25 7-12 4.4-5.0 Small cubic shaped 
(1.5µ1+1.5µ1 crystals found 
drop) in drops initially 
containing 9-10% 
PEG. * 
28 4 25 7-12 4.4-5.0 Cubic crystals found in 
several drops 
(-400µm). Other drops 
contain precipitate. 
10 4 25 7-12 4.4-5.0 Drops contain light 
precipitate. 
10 4 5 4-16 4.0-5.0 Drops contain light 
precipitate. 
15 1 5 4-16 4.0-5.0 Most drops contain 
some light precipitate. 
10 1 5 18 - 24 5.5-7.0 All drops contain heavy 
precipitate. 
15 1 5 18 - 24 5.5-7.0 All drops contain heavy 
precipitate. 
15 2 20 3-7 4.0-5.0 Drops remain clear. 
Table 4.13 A selection of trials used to optimise ternary complex crystallisation condition (2). 
The crystals found in the first two trays in table 4.8 diffracted well; very many 
attempts were made to repeat these crystallisation conditions: Unfortunately, 
heavy precipitate developed in most of the drops. It is still unclear as to why 
these crystallisation conditions (in which by far the best H205Q D-HicDH 
crystals grew) could not be reproduced. 
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Ternary complex Crystal form (2) 
Data collected at the Daresbury SRS laboratory (PX7.2) 
Cryoprotectant solution 15 % PEG 4000,0.1 M Na acetate 
pH 4.5,4mM tNADH, 25mM a- 
ketoisoca roate, 30% glycerol 
Unit cell a=80.1 1A, b=80.12A, c=277.24A, 
a=ß=y=90 ° 
Space group P41, P43, P4122 or P4322 
Total number of unique reflections 13,336 
Mean Redundancy 2.9 
Resolution 2.6A (81.1 % complete) 
2.9A (96.6% complete) 
Mosaicity 0.570 
Completeness - Overall (19.96-2.9A) 96.6% 
Outer shell (3.05-2.9A) 91.9% 
I/6 (I) - Overall 20.3 
Outer shell 4.4 
Rmerge - Overall 8.7% 
Outer shell 15.2% 
Table 4.114 Diffraction data collection statistics of a ternary complex crystallisation condition 
(2) crystal. 
The crystal diffracted beyond 2.4A, but there were many reflections overlaps 
due to the very long unit cell c axis. Therefore the detector had had to be pushed 
back to a distance where the resolution at the edge of the image plate was 2.6Ä, 
and the oscillation range reduced from 1.5° to 0.8°. However, still there were too 
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many reflection overlaps and so diffraction data was collected to a resolution of 
2.9A using a 1° oscillation range. 
The data were processed with primitive tetragonal symmetry in Denzo. The 
data were scaled in Scalepack using the space groups P41 and P43, this showed 
that there were systematic absences at the refection conditions 1= 4n. However, 
there were no systematic absences at 1= 2n; therefore the space groups could not 
P429 P4222 or P4 , assuming that the crystal 
did not exhibit pseudosymmetry in 
space group P4, as these space group show reflection absences at 1= 2n, 6n, 10n, 
etc. (Hahn, 1995). Also, there were no absences at k= 2n, so the space groups 
could not be P43212 and P41212, as these space groups with a two fold axes have 
reflections absent at k= 2n. Thus the space groups could be P41 or P43, or their 
higher space groups P4322 or P4122 which do not have two fold screw axes. The 
two sets of space group had approximately the same Rmerge values, so this did 
not help in determining the space group of the crystal. 
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Chapter 5 
Attempts at Phasing the D-2-Hydroxyisocaproate 
Dehydrogenase Diffraction Data Sets 
5.1 Molecular Replacement 
5.1.1 Choosing the Search Models 
The Protein Data Bank (PDB) (Berman et al., 2000) is the single 
worldwide archive structural database of biological macromolecules and is 
thus the most suitable place to search for proteins with known structure 
which have sequence (and therefore presumably structural) similarity with 
the target protein. For the molecular replacement phasing method, search 
models usually have to show at least 20% sequence similarity (Tickle, 1998). 
The European Bioinformatics Institute's Macromolecular Structure 
Database (EBI-MSD) program (Keller et al., 1998) was used to search the 
PDB with the protein sequence of lactobacillus delbrueckii subsp. 
bulgaricus D-hydroxyisocaproate dehydrogenase (accession I. D.: Q48534) 
(SWISS-PROT protein sequence database; Bairoch A. and Apweiler R. 
2000) (Table 5.1). 
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PDB Source and Name of Protein Sequence identity 
I. D. (%) a 
- Lactobacillus bulgaricus D-2- 100 
H drox isoca roate Deh dro enase 
2DLD Lactobacillus helveticus D-Lactate 38 
Deh dro enase 
1DLD Lactobacillus bulgaricus D-Lactate 36 
Deh dro enase 
1DXY Lactobacillus casei D-2- 34 
H drox isoca roate Deh dro enase 
1PSD Esherichia coli D-3-Phosphoglycerate 30 
Deh dro enase 
1GDH Hyphomicrobium methylovorum D- 28 
Gl cerate Deh dro enase 
2NAD Pseudomonas Sp. 101 Formate 28 
Deh dro enase 
1QP8 Pyrobaculum Aerophilum Formate 25 
Deh dro enase 
1PGJ Trypanosoma brucei 6-Phosphogluconate 21 
Deh dro enase 
" Sequence identity over the entire 333 amino acid residues of Lactobacillus bulgaricus 
D-2-Hydroxyisocaproate Dehydrogenase. 
Table 5.1 The protein structures found in the PDB which can be used as search models in 
the molecular replacement phasing of D-HicDH. 
5.1.2 Estimating the Number of Molecules in the Asymmetric 
Unit 
In order to determine the number of rotation and translation solutions 
expected during the molecular replacement procedure, the number of 
molecules per asymmetric unit must be known : This was estimated using the 
method proposed by Matthews (1968). 
VM cellvolume 
v 
Mnymu nmolsasu MZ 
where: - 
M is the molecular weight of the protein in Daltons (computed from the 
primary sequence using the ExPASy-tools programs, 2001) 
VM is the Matthews coefficient 
V is the cell volume (A3) 
nasymu is the number of asymmetric units, a. s. u., (determined by the space 
group of the protein crystal) 
nmolsasu is the number of molecules in the asymmetric unit 
Z is the number of molecules in the unit cell. 
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For many protein crystals, VM is usually between 1.66 and 4.0 A3/Da, 
corresponding to protein contents of 30 - 75%. Most values of VM are around 
2.5 A3 /Da (-50% solvent in the crystal). This helps to narrow down the 
possibilities for nmolsasu. 
VM values were determined using the Matthews_coef CCP4 program. 
5.1.3 Attempts at Solving the D-HicDH Structure using AMoRe 
5.1.3.1 The AMoRe Program 
The AMoRe (Automated Molecular Replacement) program package 
(Navaza, 1994) (CCP4) was initially used in attempting to solve the structure 
of D-HicDH. 
There are several operations required for structure solution using the 
AMoRe program. 
5.1.3.2 Sorting and Tabling 
The sorting operation converted the truncated data reflection file into a 
format used by the AMoRe program. 
After removing the PDB header information, solvent molecules and any 
ligands from the search model's structural file, the tabling operation was 
applied. This rotated the model so that its centre of mass was parallel to the 
coordinate axes, and the centroid of the coordinates was shifted to the origin, 
this helps to minimise the cell size required in the rotation operation (Wolf et 
al., 1991). Tabling also computed a molecular Fourier transform for use in 
structure factor calculations later. 
The search model was then viewed in the Quanta graphics program, and an 
integration radius of 75% of the minimum molecular radius was chosen to 
ensure that no cross molecular vectors were included 
in the Patterson search, 
as recommended by Blow (1995). 
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Sorting and Tabling provided a maximal distance from the centre of mass 
which was needed to calculate the size of the P1 unit cell used in the rotation 
function. The cell had to be at least the box bounding the model plus the 
chosen radius in each direction, this ensured that all the calculated inter- 
molecular Patterson vectors were excluded. But, the cell could not be too 
large otherwise too many structure factors would have been calculated 
(Navaza, 1994). Dodson (1995) has suggested that the cell dimensions 
should be twice the maximal distance from the centre of mass plus plus the 
chosen radius plus a small safety term (5A was used). The unit cell had 
angles all at 90°. 
5.1.3.3 The Rotation Function 
During the rotation function, structure factor amplitudes were calculated 
for the search model in the P1 cell. Spherical harmonic coefficients were 
then calculated for the target and search model Patterson maps. A cross- 
rotation function was then calculated. This finds possible solutions by 
Patterson overlap. There should be as many peaks standing out above the 
noise as there are molecules in the asymmetric unit. 
The radius of integration, unit cell dimensions and resolution cutoffs were 
then altered to obtain the best solution. 
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5.1.3.4 The Translation Function and Fitting 
The best 10-30 cross-rotation solutions were then put into the translation 
function in order to compute the translation solutions. In order to improve 
the subsequent solution(s) the resolution cutoffs were changed. 
If there is more than one molecule in the asymmetric unit, then the first 
solution was fixed and a translation solution computed for the second 
molecule, this procedure was then repeated for the other remaining 
molecules. 
Rigid body refinement (i. e. the fitting function) was then carried out on the 
best translation solution(s). 
5.1.3.5 Attempts at Phasing the D-HicDH Datasets 
(i) Using the H2050 D-HicDH ternary complex diffraction data obtained 
from crystals grown using condition 2 (in Chapter 4) 
The data was 96.6% complete at 2.9A and 81.1 % complete at 2.6 AS. When 
processed in P41 or P43: VM = 12.4 A3/Da =4 molecules/a. s. u. 
When processed in P4122 or P4322: VM = 6.2 A3/Da =2 molecules/a. s. u. 
Many attempts were made at finding rotation solutions using the data 
processed in the various space groups and using all the different search 
models, with numerous different AMoRe parameters. This included 
employing `modified' search models such as: - 
(1) Ca traces of the search models. 
(2) Monomers of the models with flexible loops and termini removed. 
(3) Just the structurally conserved NAD+-binding regions. 
(4) Poly-alanine, poly-glycine and poly-serine traces, produced using 
Moleman2 (part of the Uppsala suite of programs; Kleywegt, 2000). 
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(5) Superimposition of some of the search models, using the CCP4 program 
LSQKAB (which minimises the root mean square deviations between 
specified regions of the models). This was done to enhance regions of 
structural similarity (Tickle, 1998). 
(6) Combinations of the above models. 
In nearly all cases there were no clear rotation solutions. However, small 
rotation peaks above the noise were observed when using the data processed 
in P4122 and P4322 and a monomer of L. casei D-HicDH (Dengler et al., 
1997) as the search model. The space groups P4122 and P4322 should, and 
indeed did, possess the same rotation functions but different translation 
functions. The best of these rotation solutions are shown in Table 5.1. Only 
one very small rotation peak above the noise was observed in this (and all 
subsequent) cases. 
Search model: monomer of L. casei D-HicDH at 1.9 A. 
Radius of integration: 25A. Cell model: 105A x 105A x 105A. Resolution 
cutoff. - 10.0-3.5A. 
Solution Rotation of Eulerian angles (°) Correlation 
Number coefficient 
(%) 
Solution 1 74.44 60.47 84.87 10.8 
Solution 2 81.24 61.56 44.45 8.4 
Solution 3 63.41 56.73 207.34 8.0 
Solution 4 39.81 86.94 277.43 7.9 
Solution 5 23.70 41.32 224.54 7.8 
Solution 6 87.68 83.09 172.55 7.4 
Solution 7 51.92 65.24 176.05 7.4 
Solution 8 84.55 81.80 56.97 7.4 
Solution 9 11.18 55.89 204.78 7.2 
Solution 10 30.95 61.41 72.12 7.2 
Table 5.2 The rotation solutions from AMoRe for the ternary H205Q D-HicDH complex 
processed in the P4122 and P4322 space groups using the monomer of 
L. casei D-HicDH as 
the search model. 
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The top 30 rotation solutions were then put into the translation function. 
However, even after altering the various AMoRe parameters no peak above 
the noise in the translation function was observed in either the P4122 (Table 
5.3) or P4322 (Table 5.4) forms. Furthermore, the rotation solutions appeared 
to be consistent with a random array of atoms. Therefore attempts to improve 




Rotation of Eulerian angles 
(0) 
cc 0 Y. 
Translation 








Solution 1 74.44 60.47 84.87 0.9289 0.1938 0.1060 8.3 57.3 
Solution 2 81.24 61.56 44.45 0.1465 0.1632 0.3854 9.1 57.3 
Solution 3 63.41 56.73 207.34 0.0994 0.2556 0.3937 9.8 56.9 
Solution 4 39.81 86.94 277.43 0.7224 0.5916 0.3535 8.8 57.6 
Solution 5 23.70 41.32 224.54 0.3158 0.4544 0.4846 8.9 57.3 
Solution 6 87.68 83.09 172.55 0.9453 0.6131 0.0592 9.9 57.6 
Solution 7 51.92 65.24 176.05 0.3539 0.4831 0.0937 9.3 57.4 
Solution 8 84.55 81.80 56.97 0.9452 0.6222 0.2587 9.8 57.3 
Solution 9 11.18 55.89 204.78 0.9419 0.8875 0.3705 9.4 57.5 
Solution 10 30.95 61.41 72.12 0.0787 0.0747 0.3885 8.3 57.6 
Table 5.3 The translation solutions from AMoRe for the ternary H205Q D-HicDH complex 
processed in the P4122 space group using the monomer of L. casei D-HicDH as the search 
model. 
Solution Rotation of Eulerian angles Translation Correlation R- 
Number (°) (fractions of the unit cell) coefficient factor 
pc x y z (%) (%) 
Solution 1 74.44 60.47 84.87 0.1367 0.5498 0.4567 9.3 57.6 
Solution 2 81.24 61.56 44.45 0.7856 0.0987 0.6767 9.6 57.7 
Solution 3 63.41 56.73 207.34 0.6745 0.3351 0.2156 9.7 57.7 
Solution 4 39.81 86.94 277.43 0.2365 0.8734 0.1568 9.4 58.2 
Solution 5 23.70 41.32 224.54 0.5765 0.4509 0.2678 9.6 57.9 
Solution 6 87.68 83.09 172.55 0.0957 0.7567 0.4537 9.3 58.3 
Solution 7 51.92 65.24 176.05 0.591 0.6433 0.6876 8.5 58.3 
Solution 8 84.55 81.80 56.97 0.0837 0.2547 0.6232 9.1 58.4 
Solution 9 11.18 55.89 204.78 0.9945 0.4556 0.7845 8.7 58.5 
Solution 10 30.95 61.41 72.12 0.0653 0.3587 0.1432 8.9 58.5 
Table 5.4 The translation solutions from AMoRe for the ternary H205Q D-HicDH complex 
processed in the P4322 space group using the monomer of 
L. casei D-HicDH as the search 
model. 
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(ii) Using the wild type D-HicDH binary complex diffraction data obtained 
from c srýgrown using condition 1 
The data was 84.1% complete at 3.1 A. VM = 8.9 k3/Da =4 
molecules/a. s. u. 
Numerous attempts were made at finding a rotation solution; the best 
rotation functions were found when using the NAD+-binding domain 
monomer of L. casei D-HicDH ( the -150 amino acid residue model prepared 
after an examination of the structure in Quanta) (Table 5.5). 
Search model: NAD+-binding domain monomer of L. casei D-HicDH at 1.9A. 
Radius of integration: 19A. Cell model: 92A x 92A x 92A. Resolution cutoff. - 
9.0-4.1A. 
Solution Rotation of Eulerian angles (°) Correlation 
Number coefficient 
Solution 1 227.94 91.48 90.15 11.3 
Solution 2 18.91 113.74 358.11 10.6 
Solution 3 70.18 65.23 37.95 10.5 
Solution 4 198.70 88.13 12.00 10.4 
Solution 5 91.00 24.67 44.00 10.4 
Solution 6 56.61 76.01 29.93 10.0 
Solution 7 181.28 110.26 223.66 9.9 
Solution 8 161.40 68.16 170.09 9.8 
Solution 9 336.50 23.12 206.00 9.8 
Solution 10 280.56 100.93 342.83 9.7 
Table 5.5 The rotation solutions from AMoRe for the binary wild type D-HicDH complex 
using the NAD+-binding domain monomer of L. casei D-HicDH as the search model. 
The top 20 rotation solutions were then put into the translation function. 
Again, the translation function results were consistent with a random array of 




Rotation of Eulerian angles Translation 








Solution 1 227.94 91.48 90.15 0.1711 0.9923 0.3765 41.3 57.6 
Solution 2 18.91 113.74 358.11 0.1970 0.0000 0.4164 35.8 56.8 
Solution 3 70.18 65.23 37.95 0.0917 0.0705 0.3645 40.6 57.5 
Solution 4 198.70 88.13 12.00 0.1970 0.0000 0.4164 35.8 56.8 
Solution 5 91.00 24.67 44.00 0.1010 0.9141 0.4574 40.6 57.6 
Solution 6 56.61 76.01 29.93 0.1970 0.0000 0.4164 35.8 56.8 
Solution 7 181.28 110.26 223.66 0.7587 0.5083 0.6657 40.0 57.7 
Solution 8 161.40 68.16 170.09 0.1970 0.0000 0.4164 35.8 56.8 
Solution 9 336-50 23.12 206.00 0.8295 0.4926 0.6238 41.1 57.6 
Solution 10 280-56 100.93 342.83 0.1970 0.0000 0.4164 35.8 56.8___. 
Table 5.6 The translation solutions from AMoRe for the binary wild type D-HicDH complex 
using the NAD+-binding domain monomer of L. casei D-HicDH as the search model. 
The inability to solve the wild type binary complex using MR may have 
been due to the incompleteness of the observed data (84.1% complete). 
There is considerable evidence to suggest that data incompleteness can have 
a negative effect on the solution of a structure by molecular replacement 
(Dodson et al., 1992; Dodson, 1995). 
(iii) Using the H205Q D-HicDH binary complex diffraction data obtained 
from crystals grown using condition 3a LP211 
The data was 91.6% complete at 3. OA. VM = 9.4 
Ä3/Da =4 
molecules/a. s. u. 
Small rotation peaks above the noise were found using e. g. a -240 amino 
acid residue poly-alanine trace of the NAD+-binding 
domain monomer of 
L. bulgaricus D-LDH (Vinals et al., 1995) (a knowledge-based modelled 
structure). 
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Search model: Poly-alanine trace of the NAD+-binding domain monomer of 
L. Bulgaricus D-LDH. 
Radius of integration: 25A. Cell model: 100A x 100A x 100A. Resolution 










Solution 1 258.55 , 79.22 209.77 11.9 
Solution 2 353.50 52.23 93.03 10.7 
Solution 3 335.73 69.70 212.38 10.6 
Solution 4 121.50 35.79 91.53 10.4 
Solution 5 242.38 90.00 258.22 10.3 
Solution 6 297.77 90.00 77.56 10.3 
Solution 7 328.40 76.28 211.45 10.3 
Solution 8 126.25 77.47 209.20 10.2 
Solution 9 209.50 90.00 111.09 10.0 
Solution 10 329.26 90.00 291.40 10.0 
Table 5.7 The rotation solutions from AMoRe for the binary H205Q D-HicDH complex 
using the poly-alanine trace of the NAD'-binding domain monomer of LbulgaricuS D-LDH 
as the search model. 
Solution Rotation of Eulerian angles Translation Correlation R- 
Number (0) (fractions of the unit cell) coefficient factor 
cc p x y z (%) (%) 
Solution 1 258.55 79.22 209.77 0.1000 0.0000 0.4762 10.4 57.6 
Solution 2 353.50 52.23 93.03 0.2250 0.0000 0.2619 10.2 58.2 
Solution 3 335.73 69.70 212.38 0.2000 0.0000 0.0595 8.9 58.4 
Solution 4 121.50 35.79 91.53 0.2250 0.0000 0.1310 12.8 57.2 
Solution 5 242.38 90.00 258.22 0.1125 0.0000 0.4167 11.5 57.3 
Solution 6 297.77 90.00 77.56 0.0250 0.0000 0.0238 11.5 57.4 
Solution 7 328.40 76.28 211.45 0.2000 0.0000 0.0595 8.8 58.1 
Solution 8 126.25 77.47 209.20 0.0125 0.0000 0.1310 9.4 57.9 
Solution 9 209.50 90.00 111.09 0.2625 0.0000 0.0595 11.1 57.2 
Solution 10 329.26 90.00 291.40 0.2375 0.0000 0.4405 11.2 5L2 
Table 5.8 The translation solutions from AMoRe for the binary H205Q D-HicDH complex 
using the poly-alanine trace of the NAD'-binding domain monomer of 
LbulgaricUS D-LDH 
as the search model. 
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(iv) Using the H205Q D-HicDH binary complex diffraction data obtained 
from crystals grown using condition 3b (C2) 
The data was 95.2% complete at 2.8A. Vm = 9.6 A3/Da =* 4 molecules/a. s. u. 
Rotation peaks were observed, usually with search model dimers (Table 
5.7), but again there were no convincing translation solutions (Table5.8). 
Search model: Dimer of L. Helveticus D-LDH (Dunn and Holbrook, 1996) at 
2.7A. 
Radius of integration: 34A. Cell model: 125Ax 125Ax 125A. Resolution 
cutoff. - 15.0-3.5A. 
Solution Rotation of Eulerian angles Correlation 
Number coefficient 
..... ........ ......... ...... . 
(%) 
Solution 1 0.37 78.01 122.46 11.3 
Solution 2 241.00 44.83 178.82 8.3 
Solution 3 86.44 45.87 160.47 8.3 
Solution 4 267.87 13.57 38.43 8.0 
Solution 5 356.77 85.01 340.07 7.8 
Solution 6 335.02 49.21 27.66 7.5 
Solution 7 349.78 41.95 258.47 7.5 
Solution 8 41.00 12.42 84.00 7.3 
Solution 9 121.18 72.80 278.16 7.3 
Solution 10 330.31 54.79 133.26 7.3 
Table 5.9 The rotation solutions from AMoRe for the binary H205Q D-HicDH complex 
using the dimer of L. helvetiCUS D-LDH as the search model. 
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Solution Rotation of Eulerian angles Translation Correlation R- 
Number (0) (fractions of the unit cell) coefficient factor 
cc p I x y z (%) (%) Solution 1 0.37 78.01 122.46 0.2708 000 0.2115 39.2 55.9' 
Solution 2 241.00 44.83 178.82 0.3542 0.0000 0.3462 36.4 57.1 
Solution 3 86.44 45.87 160.47 0.1042 0.0000 0.2500 33.2 56.8 
Solution 4 267.87 13.57 38.43 0.2083 0.0000 0.4423 31.4 57.2 
Solution 5 356.77 85.01 340.07 0.3958 0.0000 0.4808 42.4 56.5 
Solution 6 335.02 49.21 27.66 0.3333 0.0000 0.0000 42.8 55.3 
Solution 7 349.78 41.95 258.47 0.1667 0.0000 0.0000 39.0 56.3 
Solution 8 41.00 12.42 84.00 0.2708 0.0000 0.3077 38.4 55.7 
Solution 9 121.18 72.80 278.16 0.2917 0.0000 0.0385 40.1 57.1 
Solution 10 330.31 54.79 133.26 0.3750 0.0000 0.0192 40.4 55.9 
Table 5.10 The translation solutions from AMoRe for the binary H205Q D-HicDH complex 
using the dimer of L. helvetiCUS D-LDH as the search model. 
The inability to find a solution may have again been to due to the 
incompleteness of the observed data. Similar problems were encountered 
when trying to solve the structure from the remaining D-HicDH incomplete 
low resolution data sets. 
5.1.4 Attempts at Solving the D-HicDH Structure using AMoRe. 
with Normalised Structure Factor Amplitudes 
5.1.4.1 Normalised Structure Factor A litudes 
Normalised structure factor amplitudes (E's) are structure factor 
amplitudes calculated from diffraction data that has been divided up 
into 
resolution shells of constant volume and then scaled so that the mean 
intensity does not decrease with resolution. The scaling usually 
involves 
applying an exponential 'temperature' factor to the structure 
factors (Dodson 
et al., 1992). The contrast of the Patterson map and the peaks should 
be 
better resolved if the data has been normalised 
(Dodson et al., 1992; Tickle, 
1998). 
The calculation of rotation and translation 
functions in AMoRe using E's 
required the use of several 
CCP4 programs. 
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5.1.4.2 Calculatin E values, Sortiniz and Tablin, and the Rotation. 
Fimr. tinn 
After removing the header information from the search model's PDB file, 
structure factor amplitudes for the model in a P1 cell were calculated using 
SFALL. The observed and calculated (search model) structure factor 
amplitudes were then normalised using the ECALC program. 
The sorting, tabling and cross-rotation functions were then carried out in 
AMoRe as usual. 
5.1.4.3 The Translation Function using E Values 
PDBSET was used to apply the rotation matrix to the search molecule (a 
rotation matrix for each molecule in the asymmetric unit should have been 
applied. However, only one rotation peak above the noise was ever found). 
Structure factor amplitudes and phases were then calculated using SFALL. 
CAD was used then used to combine the observed and calculated data into 
a single file. Fourier coefficients were calculated for the translation function 
using TFFC and then FFT (Fast Fourier Transform) used to obtain an intra- 
molecular vector translation function map. The signal to noise ratios (S 
/ 
of the subsequent peaks were then studied. 
5.1.4.4 AtteMpts at Phasing the D-HicDH Datasets using E's 
Unfortunately no improvement in the solutions was obtained with 
AMoRe 
when using normalised structure factor amplitudes. For example: 
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UsinR the H2050 D-HicDH binaKy complex diffraction data ght2ine. 1ri from 
cKystals grown using condition 3a fE21) 
*3 The data was 94.6% complete at 3. OA. Vm = 9.4 A /Da => 4 
molecules/a. s. u. 
Search model: Poly-alanine dimer of H. Methylovorum D-GDH at 2.4 
Radius of integration: 36A. Resolution cutoff. - 10.0-4.5A. 
Solution 
Number 
Rotation of Eulerian angles Correlation 
coefficient 
Solution 1 298.52 65.94 83.57 8.8 
Solution 2 129.00 56.38 101.00 8.2 
Solution 3 24.17 69.16 39.10 8.1 
Solution 4 28.50 20.28 139.00 7.9 
Solution 5 291.00 46.19 106.50 7.2 
Solution 6 135.32 65.51 71.99 6.8 
Solution 7 271.09 77.33 141.71 6.6 
Solution 8 40.66 71.15 261.31 6.6 
Solution 9 327.14 72.55 225.92 6.3 
Solution 10 223.91 47.06 176.81 6.1 
Table 5.11 The rotation solutions from AMoRe using normalised structure factor amplitudes 
for the binary H205Q D-HicDH complex, with the poly-alanine dimer of H. methylovorum 
D-GDH as the search model. 
Solution Translation Y AY 
Number (fractions of the unit cell) U '0 or 
tx ty tz 
Solution 1 0.277 0.002 0.271 6.02 0.61 
Solution 2 0.316 0.000 0.319 5.41 - 
Table 5.12 The translation function map peaks using normalised structure factor amplitudes 
from TFFC for the binary H205Q D-HicDH complex, with the poly-alanine dimer of 
H. methylovoruM D-GDH as the search model. 
A AS / cy ratio greater than I usually indicates a correct solution (Tickle, 
1998). Therefore the solution above is unlikely to be correct. 
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5.1.5 Attempts at Solving the D-HicDH Structureqýýý 
EPMR is a molecular replacement program that utilises an evolutionary 
search algorithm (Kissinger et al., 1999). It is a highly automated program 
that requires three input files, the search model PDB file; a file containing 
the crystal's space group and unit cell dimensions; and finally a file 
containing just the hkl indices and the corresponding observed structure 
factor amplitudes. 
The six-dimensional search carried out by the program first involves 
generating an initial set of random orientations and positions for the search 
model. A Patterson correlation coefficient is then calculated for each 
orientation, and the highest scoring orientations are retained and used to 
generate a new set of trial orientations. This is achieved by applying random 
alterations to the orientation angles and translations for each 'parent' 
orientation. This procedure is then repeated for a specified number of cycles. 
At the end of the evolutionary optimisation rigid-body refinement is then 
carried out on the search model. 
As well as allowing a specified number of runs of the evolutionary 
optimisation process, EPMR also allowed the search for multiple molecules 
in the asymmetric unit. The first solution was kept as a partial structure and 
the PDB file written out, whilst the program kept looking for the remaining 
solutions. 
Before starting the program, variables such as the resolution cutoffs, 
number of molecules to be located, number of optimisation cycles, number 
of runs, etc. were entered. Unfortunately, even when executing 
'50 runs' 
(about 4 days of computing time), EPMR still failed to find any sort of 
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molecular replacement solution. Moreover, the subsequent correlation 
coefficients and R-factors were consistent with a random array of atoms. 
Three examples Using the H205Q D-HicDH binary complex diffraction 
data obtained from crystals grown using condition 3a (P2, )are shown 
below: - 
(The data was 94.6% complete at 3. OA with an estimated 4 molecules in the 
a. s. u). 
(a) Search model: Monomer of L. Bulgaricus D-LDH. 
Number of Solutions: 4. Number of cycles: 50. Number of Runs: 50. 
Resolution cutoffs: 15.0 - 4. OA. 
(b) Search model: NAD+-binding domain monomer of L. casei D-HicDH. 
Number of Solutions: 1. Number of cycles: 50. Number of Runs: 20. 
Resolution cutoffs: 15.0 - 4. OA. 
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(c) Search model: Poly-alanine dimer of H. Methylovorum D-GDH. 
Number of Solutions: 4. Number of cycles: 50. Number of Runs: 20. 
Resolution cutoffs: 15.0 - 4. OA. 
Rotation of Eulerian Translation Correlation R- 
angles (fractions of the unit cell) coefficient factor 
cc xyz M) (%) 
Final 312.07 75.01 40.35 0.3822 0.5277 0.3149 42.2 57.6 
Solution 
Table 5.13 The rotation and translation solutions from EPMR for the binary H205Q D- 
HicDH complex using a variety of search models. 
5.1.6 Conclusions 
The XPLOR program (BrUnger, 1992a) was also used to try and solve the 
best D-HicDH data sets. However, even though this program applied 
Patterson correlation refinement (i. e. rigid-body refinement in Patterson 
space) to the computed cross-rotation functions, no rotation peaks above the 
noise were ever observed. 
The inability to solve the D-HicDH structure with some of the data sets 
using molecular replacement may have been down to the general poor 
quailty and incompleteness of the data. 
Curiously, attempts to solve the better diffraction data sets with the 
structurally conserved NAD'-binding domain as the search model also 
failed. One possible explanation for this is that there may be substantial 
structural differences in the cofactor-binding domains of the target and 
search molecules: Chothia and Lesk, (1986) showed that the same general 
fold differs in structure by amounts that increase as the amino acid sequence 
diverge. After comparing the structures of a number of proteins Chothia and 
Lesk concluded that the divergence in structure of two homologous cores 
could be measured as a simple function of the 
fractional identity of the cores: 
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0=0.40e 1.87 H 
where 
A the root mean square deviation (r. m. s. d. ) in the main chain atoms. 
H the fraction of mutated residues in the homologous region. 
Therefore if the sequence identity is > 50% the protein structure should 
provide a close general model for the unknown protein structure. However, if 
the amino acid sequence identity between the two proteins is about 20% 
there will probably be large structural differences. 
It was shown that differences in the common cores consist mainly of 
changes in the relative position and orientation of packed secondary 
structures. Moreover, in the case of P-sheets (found in e. g. the cofactor- 
binding domains) local changes in structure were also observed. 
5.2 Multiple IsomoEphous Replacement 
As attempts at solving the D-HicDH structures using molecular 
replacement were not successful, the multiple isomorphous replacement 
method was attempted. 
5.2.1 Heavy Atom Soakina Procedures 
The methods employed in the soaking of crystals prior to cryogenic data 
collection involved gradually soaking the protein crystals in mother 
liquor 
containing increasing concentrations of the heavy atom salt and glycerol 
(often with a slightly increased precipitant concentration). 
Preliminary investgations were carried out to determine the maximum 
duration for a particular heavy atom soak and the optimum concentrations of 
the salt needed. This was achieved by observing soaked crystals at regular 
time intervals and noting when cracks started to appear, morphology started 
to change, and / or the protein crystals started 
to lose their birefrigence. 
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5.2.2 The Heavv Atom Salts Utilised 
Many different heavy atoms salts were employed in the search for useful 
derivative crystals for MIR phasing. However, the majority of the salts 
utilised caused a severe deterioration in the quailty of the crystals resulting in 
very poor diffraction and / or the inability to collect complete derivative data 
sets. This problem was compounded by the fact that the corresponding native 
crystals were themselves weakly diffracting. 
It was found that the H205Q D-HicDH binary complex crystals grown 
using condition (3a) in Chapter 4 (i. e. 35-40mg/ml protein, ImM NADH; 20- 
25% PEG MME 5000,0.2M ammonium sulphate, OAM MES pH 6.5), were 
the most suitable for heavy atom soaking studies. 
Derivative Crystal soaking Observed 
number conditions maximum 
resolution 
(A) 
1 24 hours in 1mM uranyl acetate -5.5 
2 6 days in 1mM uranyl acetate (very 3.5 
large crystal) 
3 19 hours in ImM platinum potassium 3.2 
nitrate 
4 5 hours in lmM p- 5.8 
chloromercuribenzene sulphonic acid 
5 5 hours in 0.5mM p- 5.6 
chloromercuribenzene sulphonic acid 
6 12 hours in 2mM mercuric acetate 5.2 
7 48 hours in 2mM mercuric cyanide 4.9 
8 48 hours in 2mM platinum potassium 2.9 
nitrate 
9 24 hours in 2mM cadmium lactate 5.8 










11 24 hours in 8mM uranyl nitrate 3.3 
12 48 hours in 4mM uranyl nitrate -5.5 
13 20 hours in 2mM platinum potassium 
chloride 
-6.0 
14 15 hours in 0.5mM platinum potassium 
chloride 
4.9 
15 1 hour in 0.5mM potassium uranyl 
iodate 
-5.5 
16 3 hours in 4mM samarium chloride 3.2 
17 24 hours in 1mM samarium chloride 5.2 
18 24 hours in 3mM iridium chloride 5.1 
19 12 hours in 4mM cadmium acetate -5.5 
20 16 hours in 3mM erbium chloride -5.0 
Table 5.14 A selection of X-ray diffraction tests on various heavy atom soaked crystals. 
The X-ray diffraction was found to be even worse when using the other 
crystals forms of H205Q D-HicDH in heavy atom soaking experiments. 
5.2.3 Diffraction Data Collection of Potential Derivatives 
Only a handful of the numerous soaked crystals diffracted to a sufficiently 
high resolution for attempts to be made at collecting a complete data set. 
However, most of those chosen had a high mosaicity. The Strategy computer 




Derivative 2 3 8 10 11 17 
number 
(uranyl (platinum (platinum (thallous (uranyl (samarium 
acetate) potassium potassium acetate) nitrate) chloride) 
nitrate) nitrate) 
Number of 1 2 1 3 2 1 
crystals 
Total number of 
observations 36,283 17,986 25,616 12,085 10,499 42,577 
Redundancy 2.9 1.6 2.5 2.6 2.2 2.8 
Resolution in the 
outer shell 4.0-3.6 4.3-4.0 4.1-4.0 5.0-4.8 4.7-4.4 3.8-3.2 
(A) 
Mosaicity 1.17' 0.86' 1.29' 0.86' 1.68' 1.60' 
Mean I/ c7 (1) in 
the outer 2.96 4.14 3.66 2.56 3.14 3.93 
resolution shell 
Completeness in 
the outer 88.7 89.4 82.1 69.4 51.8 93.4 
resolution shell 
M 
Overall R., rge 22.6 23.0 38.1 
32.2 21.4 22.0 
MI II I I I 
Table 5.15 Diffraction data collection statistics of heavy atom soaked crystals. 
5.2.4 Location and Refinement of possible Heavy Atom Sites 
Once a putative derivative data set had been collected and reduced, a series 
of CCP4 programs were used in order to locate and refine the position(s) of 
any possible heavy atom binding sites. 
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5.2.4.1 Scaling the Derivative and Native Datasets 
Initially, the computer program CAD was used to combine and sort the 
truncated native and putative derivative reflection data into one file. 
The X-ray diffraction experiment does not take into account variations in 
the incident beam intensity, wavelength, crystal size and all other factors. 
Therefore, an absolute scale-factor has to be calculated to put the and native 
and derivative structure factor amplitudes on the same scale. 
The derivative-to native structure factor amplitude scale factor was 
calculated with SCALEIT (using the Wilson option); this program applied 
Wilson's method to determine the absolute scale factor k (Wilson, 1942; 
Blundell and Johnson, 1976; Wolf et al., 1991): 




Finally, instead of applying Wilson"s method, the SCALEIT program 
determined an overall temperature factor B using a least-squares 
minimisation procedure. 
5.2.4.2 Locatin the Heavv atom Sites 
The FFT program was used to calculate a difference Patterson map from 
the reflection data. 
PEAKMAX was then used to look for possible heavy atom sites in the map: 
All positive peaks with a height above a given threshold were 
listed in grid 
and fractional coordinates. 
The difference Patterson map was then plotted using NPO. After 
conversion to postscript format using the 
PLTDEV program, the Harker 
section(s) were then checked for peaks corresponding 
to those found in 
PEAKMAX. 
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5.2.4.3 Refinement of Heavy Atom Parameters 
If any heavy sites were found, MLPHARE was used to refine the heavy 
atom parameters and error estimates, and then use these refined parameters 
to generate phase information. 
MLPHARE refinement utilises the maximum likelihood principle. A basic 
treatment of this principle is that a joint probability density function is 
constructed which measures the likelihood that the particular set of 
measurements that were actually obtained, would have been obtained given 
any specified set of values for the unknown parameters. The optimal set of 
parameters is then those which maximise the likelihood of having made the 
actual set of measurements. With this method of refinement all possible 
values of the phase are considered, each value being weighted according to 
its probability of being correct. The weighted values are then minimised 
between the observed and calculated values of FPHgenerated with this phase, 
with respect to the heavy atom parameters. The parameters are then up-dated 
and another cycle of refinement is carried out. 
5.2.4.4 Locating and Refining possible Heavy Atom Sites in the 
H205Q D-HicDH 'Derivatives' 
Only four of the data sets collected were considered to be complete enough 
o 
-85%) and to a sufficiently high resolution (> -4.5A) 
for attempts to be 
made at locating and refining possible heavy atom sites. 
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Derivative 2 3 8 17 
number 
(uranyl (platinum (platinum (samarium 
acetate) potassium potassium chloride) 
nitrate) nitrate) 
Mean Ri,. 21.3 11.5 23.2 29.1 
(%) (with native (with native (with native (with native data to 3.6A) data to 4. OA) data to 4. OA) data to 3.6A) 
First site 
x 0.099 No No 0.098 
y 0.50 peaks peaks 0.50 
z 0.213 visible visible 0.167 
Relative 0.273 - - 0.905 
occupancy 
Rc,, iii, 
centric 0.93 - - 0.83 
acentric 0.97 - - 0.92 
Phasing power 
centric 0.34 - - 0.56 
acentric 0.45 0.89 
Table 5.16 Attempts at the location and refinement of possible heavy atom sites in the 
H205Q D-HicDH soaked crystals. 
Peaks in the Harker sections, and PEAKMAX, were not found in the 
H205Q D-HicDH crystals soaked in platinum potassium nitrate. 
The crystals soaked in uranyl acetate had too high an Rc. iiis for centric 
reflections and a relatively low a phasing power for them to be considered 
useful in phasing. 
The crystal which had been soaked samarium chloride appeared to have 
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Harker section v= 1/2 
Figure 5.1 Harker section (v = 1/2 ) of the scaled native and samarium chloride structure 
factor amplitude difference Patterson map. 
However, the Ri,. was rather high (29.1 %) suggesting that the 
nonisornophorphism was too great (Native P2, crystal; a=77.41, b=112.21, 
c=81.14, cc=90', P=96.81', y=90'. SMC13 soaked P2, crystal; a=76.73, 
b=1 13.89, c=81.14, (x=90', 0=97.55', y--90'): Therefore the accurate location 
of any bound heavy atom would be very difficult. The problems were 
compounded by the fact that the data had a high Rculli, for centric reflections 
and far too low a phasing power, and thus the crystal could not be used as a 
derivative. 
5.2.5 Conclusions 
SOLVE, an automated structure solution program, was also employed in 
searching for potential heavy atom derivatives; this program was also unable 
to find any suitable candidates. 
Numerous attempts at preparing a heavy atom derivative had all been 
unsuccessful. This was due to the poor diffraction by the soaked crystals, 
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high mosaicity, nonisomorphism and / or low occupancy of the heavy atoms 
within the crystals. 
5.3 Multiwavelength Anomalous Dispersion 
5.3.1 Introduction 
Selenomethionine derivatives can be used in the MAD phasing of a protein 
(as discussed in Chapter 2). L. bulgaricus D-HicDH contains 10 methionine 
residues (Figure 1.14) out of a total of 333 amino acid residues. After, 
comparing the sequence to known D-2-Hydroxyacid dehydrogenase 
structures it was estimated that nine methionine residues were probably 
ordered and would thus give a usable anomalous signal if substituted by 
selenomethionines; the remaining methionine residue is on the N-terminus of 
the polypeptide and therefore is probably disorded. Bearing in mind that 
some of the D-HicDH crystal forms contained multiple molecules in the 
asymmetric unit, the number of anomalous signals could be greater. 
5.3.2 Preparation of selenomethionyl D-HicDH protein for phase 
determination 
In order to prepare selenomethionyl (Se-Met) protein the cells expressing 
the protein of interest should be auxotrophic for methionine. One method of 
creating an auxotrophic strain is to inhibit the biosynthetic pathway for 
methionine. Alternatively, another approach is to tranform a pre-existing 
methionine autotrophic strain with the plasmid carrying the gene of interest 
(Doublie, 1997). 
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5.3.2.1 Methionine Bio,; vn hetic Pathwav Inhibition 
5.3.2.1.1 Inhibiting Aspartokinases 
High concentrations of isoleucine, lysine and threonine are known to block 
methionine biosynthesis in E. coli by inhibiting aspartokinases. Furthermore, 
phenylalanine and leucine act in synergy with lysine (Doublie, 1997; Voet 
and Voet, 1995; Van Duyne et al., 1993). Selenomethionyl protein can thus 
be expressed by a nonauxotrophic prokaryotic strain if it is grown in a 
medium without methinone but with selenomethionine and large amounts of 
the amino acids known to inhibit methionine biosynthesis. This recently 
developed technique does not require the making of new met- expression 
vectors and so neither transformation nor transduction of the plasmid is 
needed. This procedure has been successfully employed in the determination 
of several structures (e. g. Doublie et al., 1996; Benson et al., 1995; Van 
Duyne et al., 1993). 
5.3.2.1.2 Bacterial Growth in Selenomethionine Containiniz Media 
It was found that bacterial growth in selenomethionine could be 
unpredictable unless certain precautions were taken. One problem was that 
cells that were permitted to reach stationary phase often died, and could not 
then be used to innoculate larger cultures. A possible explanation for this is 
that selenomethionine is incorporated almost entirely into the protein while 
the cells are in the exponential growth phase (Huber et al., 1967).. However, 
during stationary phase, selenium in toxic forms may be released on the 
breakdown of selenomethionine. 
Another problem is that cells grow more slowly in minimal media 
containing selenomethionine, reaching stationary phase at a lower cell 
density, and having a longer lag time (Huber et al., 1967; Cowie and Cohen, 
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1957). Slow growth can also lead to the potential problem of oxidation of the 
selenomethionine (Doublie et al., 1996); oxidation can lead to a loss of 
birefrigence and diffraction of the selenomethionyl protein crystals 
(Hendrickson et al., 1990). 
It has been suggested that cells growing in selenomethionine need a small 
amount of rich medium, for example Luria broth, to get out of stationary 
phase (Yang et al., 1990). In order to drastically reduce the concentration of 
the methionine from the starter culture, the cells are then used to innoculate a 
larger volume of selenomethionine containing, methionine-free, minimal 
media, which in turn is used to innoculate a much larger volume of minimal 
media supplemented with selenomethionine. The final dilution of the 
methionine in the starter culture has to be as great as possible because the 
cells preferentially incorporate methionine rather than selenomethionine 
(Huber et al., 1967). 
5.3.2.1.3 PreliminaKy Investigations into AR58p[GINI 13/6]Bacterial Growth 
on Selenomethionyl Rich Media 
(i) In order to determine the best conditions for initial cell growth, a glycerol 
stock of the clone harbouring the H205Q mutant D-HicDH was streaked onto 
two agar plates: One of these was a rich 1.6% LB agar plate and the other a 
minimal media agar plate supplemented with seleno-L-methionine (Sigma; 
S3132): - 
Preparing Rich Luria Bertani Agar (100ml) 
(From Dept. of Microbiology and Pathology, University of Bristol) 
Agar 1.65 g 
Bacto-tryptone Ig 
Bacto-yeast extract 0.5 g 
Ampicillin 0.1 mg 
(pH to 7.2-7.5 and autoclave for 15mins) 
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(1.28g Na2HP04»7H20,0. g KH2P04,10()Mg 
NH4C1,50mg NaC1) 
Ampicillin 0.1 mg 
seleno-L-methionine 6 mg 
(pH to 7.0-7.2 and autoclave for 15mins) 
The plates were incubated at 37'C. Overnight many single bacterial 
colonies had grown on the LB agar plate. However, even after 3 days, there 
were still no visible colonies on the minimal agar plate. 
(ii) Single colonies from the rich LB agar plate were used to innoculate 10ml 
of rich Luria broth and 10ml M9 minimal media supplemented with seleno- 
L-methionine (Sambrook et al., 1989). The same procedure was repeated 
using colonies from the minimal agar plate (as there were no visible 
colonies, samples were transferred from regions of the tray where 
indentations had been made whilst streaking the glycerol stock). 
Preparing Rich Luria Media (100ml) 
(From Dept. of Microbiology and Pathology, University of Bristol) 
Bacto-tryptone Ig 
Bacto-yeast extract 0.5 g 
Ampicillin 0.1 mg 
(pH to 7.2-7.5 and autoclave for 15mins) 
Preparing M9 Minimal Media (100ml) 
Glucose 0.2 g 
Ix M9minimal salts (1.28g Na2HPO4,7H20, O. g 
KH2PO49 I OOM9 
NH4CI, 50mg NaCI) 
Ampicillin 0.1 mg 
seleno-L-methionine 
6 mg 
(pH to 7.0-7.2 and autoclave for 15mins) 
. )bt in a shaking incu All four samples were placed overnig 
bator set at 37'C. 
The cell density of each sample was then measured: - 
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Sample OD600nm 
RM (Colony from rich agar innoculating 10ml M9 minimal media) 0.11 
MM (Colony from minimal agar innoculating 10ml M9 minimal media) 0.001 
MR (Colony from minimal agar innoculating 10ml M9 rich L media) 0.01 
RR (Colony from rich agar innoculating 10ml rich L media) 1.81 
Table 5.17 AR58p[GIN1 13/61 cell densities in various 'start' media 
These results show that the AR58p[GIN113/6] bacterial strain expressing D- 
HicDH is unable to grow on M9 minimal media agar containing Se-Met. 
(iii) The 10ml cultures that grew, namely samples RM and RR, were then 
used to innoculate 500ml M9 minimal media supplemented with Se-Met: The 
samples were called RMM and RRM, respectively. The cell density of both 
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The results seem to suggest that the cells, growing in selenomethionine, do 
indeed require a small amount of rich medium to get out of lag phase (as 
proposed by Yang et al., 1990). 
(iv) The whole procedure was repeated a further two times in order to obtain 
4average') cell growth curves. 
It was concluded that, in order to obtain the optimum Se-Met protein 
expression, colonies grown on LB agar should be used to innoculate 10ml L 
broth; which in turn should be to innoculate 500ml M9 minimal media 
supplemented with Se-Met. Protein expression should then be induced after 
the cell had reached an OD600nrn = 0.3-0.35; this was calculated to be the 
stage at which the cells were in the mid-log phase of growth. The cells 
should then be harvested at an OD600nm = 0.4-0.45 Oust before the onset of 
stationary phase). 
5.3.2.1.4 Se-Met D-HicDH Purification Protocol using the 
AR58p[GIN113/61 Expression System 
Using aseptic techniques, a glycerol stock of AR58p[GIN1 13/6] was 
streaked out onto a 1.6% LB agar plate and grown overnight at 370C. A 
single bacterial colony was toothpicked from the plate and used to inoculate 
10ml L Broth, this was again grown at 370C in a shaking incubator 
overnight. All of the culture was then transferred to a sterile 21 flask 
containing 500ml M9 minimal media, which was then grown at at 37 0C until 
the cells had reached an OD600nm of 0.33. 
When the culture had reached the mid-log phase of growth, an amino acid 
'cocktail' consisting of lysine, phenylalanine and threonine at 100 mg/litre; 
isoleucine, leucine and valine at 50 mg/litre, was added to the culture to 
inhibit methionine biosynthesis: Also, seleno-L-methionine at 60 mg/litre 
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was added (Van Duyne et al., 1993). 15 minutes after the addition of amino 
acids, protein expression was induced (by heat shocking the culture at 420C 
for 3 hours and thus derepressing the lambda repressor). The cells were 
allowed to grow until an OD600nm of 0.42 had been reached. 
The cells were then harvested and the D-HicDH protein purified in a very 
similar way to that for the native enzyme. However, to avoid oxidation of the 
seleneomethionine residues, all the buffers used were degased, and fresh 
5mM dithiothreitol (DTT) and 0.2mM ethylenediaminetetra- acetic acid 
(EDTA) added to them. EDTA is a chelator that forms a complex with any 
metal ions in solution that might aid in oxidation (Stoll and Blanchard, 
1990). 
Protein samples were taken at various stages during the purification 
procedure. After protein concentration, the subsequent SDS-PAGE 
expression gels were very similar to that of the native (Figure 4.3), however, 
the protein yield had been dramatically reduced. Only about 1mg of purified 
D-HicDH was obtained from a2 litre culture (Table 5.18), whereas during a 
2 litre native D-HicDH protein preparation 100-150mg of enzyme was 
obtained. 
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Stage Volume Total Total Specific Yield Purification 
(MI) protein activity activity factor 
....... ............ .......... ............ ...... 
Lnjg (U) -fold (Ulm ) 
Crude cell extract 31 59.3 298 .......... 5.0 100 1.0 
After acid dialysis 26 33.4 291 8.7 97.7 1.74 
After cationic 58 24.3 221 9.1 74.2 1.8 
exchange 
(S - column) 
After anionic 64 1.2 24.6 20.5 8.3 4.1 
exchange 
(Q - column) 
Table 5.18 D-HicDH selenomethionyl protein purification statistics from a2 litre 
AR58p[GIN113/6] culture. 
Compared with the native protein preparation, there was an enormous 
reduction in the total amount of protein isolated from the crude cell extract 
during selenomethionyl D-HicDH purification. This could be partly 
attributed to the differences in the cells densities reached by the cultures of 
the two preparations. However, there was also a substantial drop in the yield 
of D-HicDH obtained during the penultimate step of the purification process 
: About 20% of the protein was lost after S-sepharose cationic exchange, 
whereas, during native protein purification only about 10% of the enzyme 
had been lost after the sample had passed through the S-sepharose column. 
Furthermore, 65% of the protein was lost after the Q-sepharose step in the 
procedure, whereas during the native purification preparation only 10% of D- 
HicDH was lost after anionic exchange. Therefore, there was insufficient 
protein for crystallisation trials and mass spectrometric analysis, and more 
enzyme had to be purified. 
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5.3.2.1.5 Using JM105D[KK1831 Cells and Catabolite Repression 
Pre-Induc6on D-HicDH Expr -, ssion 
Smith (1991) suggested that in order to obtain a satisfactory anomalous 
signal at least 98% of the methionine residues must be substituted for 
selenomethionine in the derivative crystal. It was soon realised that the final 
dilution of the initial methionine from the rich medium (-1: 50) was probably 
not great enough to obtain suitable crystals for MAD phasing. Furthermore, 
it was also known that the pGIN plasmid (whose inserted gene promoter is 
controlled by a lambda repressor) expressed low levels of D-HicDH protein 
even when the cells were uninduced. As methionine is preferentially 
incorporated into proteins and seleno-L-methionine is added to the culture 
only a few minutes before induction, this low level of pre-induction protein 
expression would inevitably lead to the translation of some native enzyme. 
In order to carry out mutagenic studies on the H205Q D-HicDH protein, 
the gene encoding the enzyme had previously been subcloned into a pKK 
expression vector (pKK 183) and then transformed into an E. coli JM105 host 
strain (K. Moreton, unpublished results). As well as conferring ampillicin 
resistance, the pKK plasmid also contains a tac promotor for over-expression 
of recombinant proteins. The tac promotor is very similar to the lac promotor 
and is inducible with isopropyl-P-D-galactopyranoside (IPTG), an analogue 
of lactose (Tumer et. al., 1997). 
The JM105 bacterial strain lacks the lad gene (i. e. it is a lac Iq strain) that 
encodes the lac repressor which is a potent inhibitor of trancription (Watson 
et al., 1992). In the absence of IPTG, the lac repressor would bind to the tac 
operator, just upstream of the promoter, and repress transcription 
from the 
tac promoter. Upon induction, an IPTG-repressor complex, which 
is unable 
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bind to the operator site, is formed allowing expression of the H205Q D- 
HicDH gene product at a very low level. 
Previous protein expression experiments had shown that very little D- 
HicDH was produced prior to induction in JM105p[KKI83] cells (Figure 
5.3; K. Moreton, unpublished results)-- 







Figure 5.3 SDS- PAGE analysis of D-HicDH expression. This 12.5% acrylamide gel shows 
protein expression 3 hours after induction. The AR58p[GIN113/6] and JM105p[KKI83] 
expression systems were either induced with ImM IPTG, or heat-shocked at 42'C for 3 
hours, or the cells remained uninduced. 
The JM105p[KKI83] expression system seemed ideal for selenomethionyl 
protein production. It showed both a lower level of pre-induction protein 
expression when compared with AR58p[GINI 13/6], and the tac promoter 
could be regulated by catabolite repression. 
Transcription from the Pt,, promoter is not only dependent on the presence 
of IPTG / lactose but also on the concentration of glucose 
in the culture 
(Makman and Sutherland, 1965; Watson et al., 1992, Turner et al., 
1997). 
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pKK pGIN pKK pGIN pKK pGIN Mwt 
induced induced induced induced not not Std 
by by by by induced induced 
IPTG IPTG temp temp 
The decreased rate of transcription from operons in the presence of glucose, 
termed catabolite repression, is mediated by an allosteric protein that binds 
to cyclic adenosine 3', 5'-monophosphate (CAMP) and is thus called CAMP 
receptor protein (CRP). In the absence of glucose the cAMP concentration in 
Exo1i cells rise (Voet and Voet, 1995). CRP binds to cAMP to form a 
cAMP: CRP complex which is able to bind to a specific sequence near the tac 
promoter which is just upstream from the site for T7 RNA polymerase. The 
protein complex binding induces a 90' bend in the DNA, which is thought to 
enhance RNA polymerase binding to the promoter and thus enhance 
transcrip ion. 
The cAMP levels in E. coli cells growing in in the presence of glucose is 
low, and CRP exists in an inactive form unable to bind DNA. Therefore 
transciption is initiated inefficiently in the presence of glucose. 
Protein expression levels in JM105p[KKI83] in the presence of excess 
glucose, namely 1% glucose (Makman and Sutherland, 1965), were analysed 
and compared with expression of E. coli cells grow in cultures containing 
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Figure 5.4 SDS- PAGE analysis of D-HicDH expression in JM105p[KKI83] in the presence 
0.2% or I% glucose. Samples were either taken just prior to induction or 4 hours after. 
In the presence of excess glucose there was very little pre-induction D-HicDH 
expression. It was also observed that there was still a substantial amount of 
expression of protein after induction with IPTG even when the culture 
contained 1% glucose. 
5.3.2.1.6 Se-Met D-HicDH Purification Protocol using the JM I 05p[KK 1831 
Expression System 
Initially, preliminary experiments were carried out to determine the typical 
growth curve for the JM105p[KKI83] cells in M9 minimal media containing 
seleno-L-methionine and I% glucose. 
After the cell growth conditions had been established, a procedure was 
devised that would this time include a much larger dilution of the initial 
methionine in the starter media. 
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A single JM105p[KKI83] bacterial colony grown on a 1.6% LB agar plate 
was used to innoculate 5ml L broth containing a further 1% glucose, this was 
grown overnight at 37C. 250ýtl of this culture was then used to innoculate 
5ml M9 media. This minimal media, along with all the subsequent media in 
this protocol, contained 60mg/l seleno-L-methionine and 1% glucose. 
After the culture had reached the desired cell turbidity ( OD600nmof 0.3- 
0.35) 2.5ml was used to innoculate 10ml M9. All of this culture was later 
used to innoculate 25ml M9. And in turn, when the correct cell density had 
been reached, this culture was poured into a2 litre flask containing 100ml 
minimal media. This was then used to innoculate 500ml M9 minimal media. 
Each step in this process could take up to two days, and so therefore the 
ampillicin in the media was replenished every 24 hours. The final dilution of 
the initial methionine was about 1: 10,000. 
The 625ml M9 minimal culture was allowed to grow until an OD600nm Of 
0.3-0.35, then the amino acids that inhibit methionine biosynthesis were 
added (at the previous concentrations mentioned above). 15 minutes later, 
protein expression was induced with the addition of lmM IPTG. The cells 
were grown until they had reached an OD600nm of 0.42-0.46, and then 
harvested. D-HicDH was then purified as before. Typically, 12-17mg of 
purified D-HicDH was obtained from a2 litre culture. 
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Stage Volume Total Total Specific Yield Purification 
(ml) protein activity activity factor 
...... . ........ -- --------- -_. - .............. .... ... . .................. . ... 
-fold 
Crude cell extract 42 96 556 5.8 100 
After acid dialysis 58 54 491 9.1 88.3 1.6 
After cationic 62 42 372 8.9 66.9 1.5 
exchange 
(S - column) 
After anionic 98 16.4 348 21.2 62.6 3.7 
exchange 
(Q - column) 
Table 5.19 Typical D-HicDH selenomethionyl protein purification statistics from a2 litre, 
JM105p[KK183] culture. 
During the purification preparations using JM105p[KK183] cells there was 
only about a 5% loss in yield after the protein had been eluted from the 
sepharose column. However, there was still a substantial loss in protein after 
cationic exchange. 
After sonication, there was a greater amount of total protein and D-HicDH 
activity obtained from the crude cell extract in these preparations when 
compared with the selenomethionyl protein purification from 
AR58p[GIN113/6] cells. However, when induced, the AR58p[GIN113/6] 
cells tended to have a greater level of protein expression than the 
JM105p[KKI83] cells in 1% glucose (cf. Figures 5.3 and 5.4). These two 
observations seem to suggest that the Exo1i cells prefer a gradual drop in the 
methionine concentration rather than a sudden change to seleno-L- 
methionine. 
The biochemical company 'Novagen' had stated that the use of a protein 
extraction reagent, such as 'BugBuster', would liberate up to 8 times as 
much soluble protein from E. coli cells compared with conventional 
sonication. The detergent mixture works by disrupting the cell walls without 
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denaturing soluble protein. However, when BugBuster was employed there 
was slightly less protein in the soluble crude cell extract. 
5.3.3 Mass Svectrometry 
In order to ascertain the degree of selenomethionyl incorportation, the 
protein samples were analysed using mass spectrometry (MS). Two distinct 
types of MS were employed. 
5.3.3.1 Electrospray Ionization Mass Spectrometry 
In the electrospray process intact protein molecules in ionized form are 
produced from a dilute solution of the protein sample by creating a spray of 
highly charged droplets in the presence of a strong magnetic field. The 
protein solution is usually in a water-organic solvent with a trace of 
trifluoroacetic acid added to promote ionization. 
During electrospray ionisation mass spectrometric (ESI-MS) analysis, the 
protein solution is sprayed from a region of strong electric field. The ionized 
droplets are then attracted to an inlet pipe which is held at an OPPOSILU 
potential. During their journey through a vacuum system, solvent contained 
in the droplets is caused to evaporate by applying a directed flow of dry gas. 
The ionized protein molecules then undergo collisions with neutral gas 
molecules in the entrance of the vacuum system. The resulting protein 
molecules carry an excess positive charge related to their charge state in 
solution (Fenn et al., 1989). The molecules are then directed into a quarupole 
filter (Chait and Kent, 1992) for mass / charge (mlz) ratio analysis. An 
algorithm is then used to convert the ion peaks into a single peak 
corresponding to the neutral molecule. 
Only picomole amounts of protein are consumed using ESI-MS, so the 
sample should be at a concentration of 1-300 pmole/microliter. 
Mass 
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accuracies of ±I Dalton in 1,000 Daltons are commonly observed (Chait and 
Kent, 1992). 
5.3.3.2 Matrix-Assisted Laser DesoMfion Ionization Mass 
Spectrometry 
The protein sample is prepared for matrix-assisted laser desorption mass 
spectrometric (MALDI-MS) analysis by adding the solution to an aqueous 
solution containing a large excess of concentrated matrix-forming material 
such as 3,5-dimethyoxy-4-hydroxycinnamic acid (Chait and Kent, 1992). A 
small volume of this mixture is dried on a probe which is then inserted into 
the mass spectrometer. 
The sample now consists of a layer of matrix microcrystals containing 
isolated protein molecules. This is bombarded with short pulses of ultra- 
violet radiation produced by a laser. The laser pulse causes a fraction of the 
matrix and trapped protein molecules to go into a gas phase and also ionizes 
the protein. A static field is then imposed on the ions. This is generated by 
application of a high potential with respect to a closely spaced electrode. The 
ions are accelerated through a hole in the electrode into a electric field free 
flight tube (about 0.5 to 2 metres long). 
Because the ions are accelerated through a fixed potential difference, the 
velocity of the ions is simply proportional to (mlz)- 
1/2 
, and thus simple time of 
flight (TOF) analysis can be used to calculate the masses of the protein ions. 
MALDI-MS requires only femtomole amounts of the protein and usually a 
sample concentration of 250 fmole - 500 pmole is used. 
MALDI-MS is a very sensitive and the TOF analyser has to be calibrated 
with a protein of known mass with a similar molecular weight to 
that of the 
protein sample. Assuming the mass spectrometer 
is properly calibrated, 
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MALDI has a mass accuracy of ±I Dalton in 10,000 Daltons (Chait and 
Kent, 1992). 
5.3.3.3 Mass Spectrometric Analysis of Selenometh D-HicDH 
Protein Produced by Inhibitin, (z Methionine Biosvnthesis 
Before protein samples can be analysed using mass spectrometry involatile 
salts and solvents found in the sample buffers must be removed. Therefore 
0.5ml samples of the native and putative selenomethionyl H205Q D-HicDH 
protein were dialysed against 5 litres of milli Q water overnight. However, it 
was clear from the subsequent electrospray ionization mass spectrometric 
analyses performed by John Crosby (Department of Chemistry, Bristol 
University) that there was still a substantial amount of salt still left in the 
samples (Figure 5.5). 
Other methods for removing salt include reversed-phase HPLC and size- 
exclusion chromatography. However, these methods are not suitable for 
desalting small quantities of protein (1-100 pmol). Firstly, these procedures 
(along with dialysis) dilute the protein samples which then have to be 
concentrated before MS analysis. And secondly, these desalting methods 
require multiple handling steps. 
The protein samples were concentrated and desalted using the approach 
devised by Winston and Fitzgerald (1998): Approximately 1-5mg of 
reversed-phased C4 chromatographic media (which binds protein) was 
suspended in 100gl of methanol. This mixture was added to the dialysed 
protein solution, and the sample vortexed for 5 minutes. The samples were 
then spun for 3 minutes at 14,000rpm in order to pellet the 
C4 media. 10ýtl of 
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Figure 5.5 ESI mass spectrum of a protein sample just dialysed against water. 
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Figure 5.6 ESI mass spectrum of a protein sample stored in TFA overnight. It appears 
plasticiser has leached into the sample from the containing Eppendorf tube. 
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The supernant was then removed and the remaining pellet washed twice with 
Iml of 0.1% aqueous trifluoroacetic acid (TFA), vortexed for I minute, and 
spun again. The samples were then stored in a 0.5ml Eppendorf tube at 4'C, 
ready for MS analysis the following day. 
Initially, only protein sample spectra similar to that in Figure 5.6 were 
observed. It is suspected that the TFA solvent caused plasticiser to leach out 
of the Eppendorf tubes containing the protein samples. Therefore it was 
decided to concentrate and desalt the D-HicDH samples just prior to 
analyses. 
During ESI-MS it is not uncommon for some of the termini amino acid 
residues to get knocked off whilst the protein molecules undergo collisions 
with residual neutral gas molecules in the entrance region of the vacuum 
system (Chait and Kent, 1992). 
When the native H205Q D-HicDH protein sample was analysed (Figure 
5.7) it appeared that 'species A' had the N-terminal methionine and 
threonine residues removed. In 'species B' only the methionine residue 
appeared to be missing. The average molecular mass of the native H205Q 
protein was calculated to be around 36,938 Daltons. This corresponded 
extremely well to the theoretical mass for H205Q D-HicDH of 36,939-34 
Daltons (SWISS-PROT protein sequence database; Bairoch and Apweiler, 
2000). 
On analysing the putative selenomethionyl H205Q protein sample the 
spectrum again had a species with a mass consistent with the removal of 
the 
N-terminal methionine and threonine residues from the native protein 
molecule (Figure 5.8). However, there was also a peak 
in the spectrum that 
appeared to correspond to H205Q again 
having only its N-terminal 
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methionine removed but this time with the remaining 9 methionine residues 
all 
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Figure 5.7 ESI mass spectrum of the native H205Q D-HicDH protein sample 
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Figure 5.8 ESI mass spectrum of the putative selenomethionyl H205Q D-HicDH protein 
sample produced by inhibiting methionine biosynthesis. 
being substituted for selenomethionine residues. The mass spectrum seems to 
suggest that there was an all-or-nothing substitution of methionine residues 
for seleno-L-methionine. 
During expression of the 'selenomethionyl' protein, the inintial methionine 
in the cultures was diluted by about 1: 10,000. Therefore, it appears that the 
methionine biosynthetic pathway was not completely inhibited by the excess 
concentrations of specific amino acids. 
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5.3.4 Selenomethionyl Protein Expression usin,! ý a Methionine 
Auxo 
Attempts at fully incorporating selenomethionine into D-HicDH by 
inhibiting methionine biosynthesis proved to be only partially successful. in 
order to ensure 100% Se-Met incorporation into the protein, the pKK 183 
plasmid needed to be transformed into a preexisting E. coli methionine 
auxotrophic strain. 
5.3.4.1 The DL41 and DL41(DE3) Methionine Auxotrophic E. coli cell 
strains 
DL41 and DL41(DE3) are Exo1i methionine auxotrophic cells strains. 
Glycerol stocks of both strains were a gift from Mark Banfield (School of 
Biological Sciences, Auckland University, N. Z. ). 
The DL41 and DL4 I (DE3) strains are derived from E. coli K 12, and were 
constructed by LeMaster by introducing a lesion into the metA gene coding 
for homoserine 0-succinylase (Hendrickson et al., 1990). There is therefore a 
block in the biosynthetic pathway for methionine between homoserine and 
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Figure 5.9 Lesion in the metA gene corresponding to a block in the methionine pathway in 
DL41 and DL41(DE3) cells. 
162 
The designation (DE3) indicates that the DL41(DE3) is a lysogen of XDE3, 
and therefore carries a chromosomal copy of the T7 RNA polymerase gene 
under the control of the lacUV5 promoter. Therefore expression of this gene 
can also be induced by IPTG, thus making transcription of the H205Q gene 
even more efficient. Thus it was decided to transform the pKK 183 into the 
DL41(DE3) strain. 
5.3.4.2 KK 183 Plasmid DNA Extraction 
A single JM105p[KKI83] bacterial colony grown on a 1.6% LB agar plate 
was used to innoculate 5ml 2xYT medium (Sambrook et al., 1989) 
containing 1ýtg/ml ampillicin and this was grown overnight at 37C. 
Preparing 2xYT Medium (100ml) 
(From Dept. of Microbiology and Pathology, University of Bristol) 
Bacto-tryptone 1.6 g 
Bacto-yeast extract 1.0 g 
NaCl 0.5 g 
(pH to 7.2-7.5 and autoclave for 15mins) 
Plasmid DNA was then extracted from the cells using the QIAGEN Plasmid 
Miniprep Kit QIAGEN Ltd., Dorking, Surrey, U. K. ). The kit uses a 
combination of alkline lysis and SDS protein denaturation to release the 
DNA from the bacteria. The DNA is then precipitated with isopropanol. The 
plasmid DNA is then separated from the genomic DNA using an anion 
exchange resin and differential salt washes. 
The plasmid DNA extracted was then quantified on an 0.8% agrose gel, 
stained with ethhidium. bromide, by comparison of band intensities with 
XHindIII markers (Turner et al., 1997). It was found that the plasmid 
DNA 
had a concentration of about 50ng/ýtl and this was subsequently stored at - 
20'C. 
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5.3.4.3 Preparation of Competent DL41(DE3) Cells 
(1) In order to make the cells competent a glycerol stock of DL41(DE3) was 
streaked onto a minimal agar plate supplemented with 8OMg/l L-methionine. 
The plate was then incubated for 24 hours at 370C; the colonies that grew 
were very small. 
(2) A single colony was then used to innoculate 5mI 2XYT medium. (No 
antibiotics were added to the 2xYT as the DL41(DE3) cell strain does not 
carry an antibiotic resistance gene. ) 
(3) 0.5ml of the overnight culture was added to 50m]. 2xYT (in a sterile 
250ml flask). This was then grown at 37'C until the cells had reached an 
O. D-550nmof about 0.3. 
(4) The culture was then poured into pre-cooled sterile oakridge tubes, and 
the cells harvested by centrifugation at 4'C for 5 minutes at 4,000rpm. 
(5) The cell pellets were each gently resuspended in pre-cooled 25ml CaC12 
solution. 




(pH to 7.6 and autoclave for 15mins) 
From here onwards, the cell solutions were always kept cold. 
(6) The cell suspension was then incubated on ice for 30 minutes, 
occassionally gently mixing the solution. 
(7) The cells were spun down at 4'C for 5 minutes at 
4,000rpm. And the 
resulting cell pellets each resuspended in pre-cooled 
lml CaC12 solution. 
(8) The cells were then left on ice for 2 hours; during this 
time the 
competence of the cells increased. 
164 
5.3.4.5 Transformation of the pKK 183 plasmid into the Competent 
DL41(DE3) Cell Strain 
(1) 200[tl of the cell suspension was mixed with 100ng of the thawed 
plasmid DNA solution (i. e. 2ýtl). This was then incubated on ice for 30 
minutes. 
(2) The cells were then heat shocked by putting them in a water bath set at 
42'C for 90 seconds. 
(3) 250ýd of pre-warmed 2xYT medium (at 42'Q was then added to the cells 
and incubated at 37'C for 1 hour. 
(4) 350gl of the transformed cells were onto 1.6% LB agar plate (containing 
ampillicin) and grown overnight at 37C. 
5.3.4.6 Preparation of DL41(DE3)p[KK1831 Glycerol Stocks 
(1) A single DL41(DE3)p[KKI83] colony was picked into 5ml 2xYT and 
grown overnight at 37C. 
(2) 700ýtl of the 5ml 2xYT culture was then added to 300ýtl sterile 50% 
glycerol in an Eppendorf tube, and then vortexed. 
(3) The mixture was then snap frozen in liquid nitrogen. The resulting 
glycerol stock was then stored at -70'C. 
5.3.4.7 Assessina the Transformation 
(1) In order to determine whether the DL41 (DE3) cells had been 
















Figure 5.10 Plasn-ýd DNA extraction from the DL41(DE3)p[KKI83] expression system. 
The extracted plasmid DNA was deten-nined to be about 5Kbp. This 
corresponds well with the fact that the 4Kbp pKK 183 plasmid has a IKbp 
inserted gene. 
(2) The ability of the transformed and untransformed cell strains to grow 
(overnight at 37'C) on minimal media agar plates containing various 
supplements was tested (Table 5.20). 
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DL41(DE3) L-Methionine x ++++ 
DL41(DE3) Seleno-L-methionine x + 
DL41(DE3) L-Methionine v/ 
DL41(DE3) Seleno-L-methionine V/ 
DL41(DE3) x x 
DL41(DE3) x V/ 
DL41(DE3)P[KKI831 L-Methionine x ++++ 
DL41(DE3)p[KK1831 Seleno-L-methionine x ++ 
DL41(DE3)p[KK183] L-Methionine ++++ 
DL41(DE3)p[KKI83] Seleno-L-methionine ++ 
DL41(DE3)p[KK183] x x 
DL41(DE3)p[KK1831 x V/ 
Table 5.20 The supplements required for transformed and untransformed cell growth. 
The table shows that both the transformed and untransformed cell strains 
require methionine or its selenium derivative to grow. This suggests that 
both strains are methionine auxotrophs. Furthermore, both E. coli strains 
prefer L-methionine over seleno-L-methionine. 
The results also show that, unlike the untransformed cell line, 
DL41(DE3)p[KKI83] cells are able to grow on media containing ampicillin. 
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This proves that the DL41(DE3) strain has indeed been transformed with the 
pKK 183 plasmid carrying the ampicillin resistance gene. 
(3) Single colonies of the various strains were picked into 10ml M9 minimial 
media containing various supplements. These were then incubated at 37'C 
and grown for 2 hours. Protein expression in the cells was then induced with 
lmM IPTG, and 3 hours later the cells were harvested. D-HicDH activity 
was then assayed for in the crude cell extracts (Table 5.21). 





O. D-6oo,, m Activity 
(U) 
DL41(DE3) L-Methionine x 0.72 0.01 
DL41(DE3) Seleno-L-methionine x 0.17 0.0 
DIL41(DE3)p[KKI83] L-Methionine 0.65 46.2 
DL41(DE3)p[KKI83] Seleno-L-methionine 0.21 14.3 
Table 5.21 D-HicDH activities of the transformed and untransformed cell cells in various 
growth media. 
The results show that there only D-HicDH activity was found in the 
transformed cells. Moreover, the enzyme activity in the 
DL41(DE3)p[KKI83] cells supplemented with Se-Met was lower than those 
with the natural methionine substrate. However, it should be noted that the 
E. coli cells growing in seleno-L-methionine also had a lower cell density 
after 6 hours than the cells grown in methionine. 
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5.3.4.8 Se-Met D-HicDH Purification Protocol using the 
DL41(DE3)i)[KK1831 Methionine Auxotroj)h tem 
After the DL41(DE3)p[KKI83] cell growth conditions had been firmly 
established, a similar purification protocol to the one discussed above 
(5.3.2.1.6) was followed. This time, however, the 'cocktail' of excess amino 
acids used to inhibit the methionine biosynthetic pathway was not added. 
Also, considering that the transformed cells could not synthesise there own 
methionine, only 0.4% glucose was added to all media (as opposed to 1%). 
The methionine in the initial starter media would again be more than 
sufficiently diluted out. 
Stage Volume Total Total Specific Yield Purification 
(MI) protein activity activity M factor 
(mg) (U) (U/mg) -fold 
Crude cell extract 34 84 463 5.5 100 1.0 
After acid dialysis 43 49 403 8.2 87.0 1.5 
After cationic 51 34 298 8.8 64.4 1.6 
exchange 
(S - column) 
After anionic 73 9.7 214 22.1 46.2 4.0 
exchange 
(Q - column) 
Table 5.22 Typical D-HicDH selenomethionyl protein purification statistics from a2 litre 
methionine auxotrophic DL41(DE3)p[KK183] culture. 
Typically, about 6- 1 Omg of pure protein was obtained from a methionine 
auxotrophic purification preparation. Thus, numerous purification 
preparations were carried out to obtain sufficient amounts of pure 
H205Q 
HicDH for crystallisation trials and mass spectrometric analysis. 
During the purification procedures their was again still substantial 
loses in 
D-HicDH yield when the protein was put down the 
ionic exchange columns. 
The purification statistics above show that the purified 
D-HicDH had about 
the same specific activity as that of the pure native enzyme 
( 22.7 U/mg). 
169 
This strongly suggests that the incorporation of Se-Met into the protein has 
very little or no effect on the function of the enzyme. 
5.3.4.9 Mass Spectrometric Analysis of Selenomethioyl D-HicDH 
Protein Produced by using a Methionine Auxotroph 
Using ESI-MS, problems were encountered in obtaining a sufficiently 
concentrated Se-Met protein sample. Therefore, MALDI-MS was employed 
instead, as this technique does not require a relatively high protein sample 
concentration. MALDI, however, does need to be calbritrated with a protein 
of known molecular weight (similar to that of the sample to be measured). 
Again, problems were encountered in trying to get a decent spectrum from 
the known native H205Q D-HicDH protein sample. Numerous attempts to 
desalt and concentrate the native sample failed. Thus, the commercially 
available aldolase enzyme from E. coli, which has a mass of 37979.3Da was 
used to calibrate the MALDI machine. After further desalting with a C18 
chromatographic media loaded pippette tip (Waters), the mass of theSe-Met 
H205Q D-HicDH protein sample was measured (Figure 5.11). 
The spectrum suggests that aldolase was not sufficiently similar in mass to 
the D-HicDH protein to produce an accurate, clear-cut, single mass peak. 
However, the spectrum does suggest that there is probably only one protein 
ion species in solution with a mass of about 37,123 Daltons; this peak mass 
corresponds to the H205Q D-HicDH ion having its N-terminal methionine 
removed with the remaining 9 methionine residues all being substituted for 
Se-Met residues (cf. Figures 5.8 and 5.11). This is supported by the 
fact that 
the overwhelming concentration of substrate in the growth media was 
in the 
form of Se-Met (about 99.9999%), and coupled with the 
fact that the host 
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strain was unable to synthesise methionine, this strongly suggests that Se- 
Met was fully incorporated into H205Q D-HicDH. 
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Figure 5.11 MALDI mass spectrum of a selenomethionyl H205Q D-HicDH protein sample 
produced by a methionine auxotroph. 
5.3.4.10 Crystallising the Selenomethionyl H205Q D-HicDH Protein 
Produced using a Methionine Auxotroph 
The crystallisation conditions for selenomethionyl proteins are very similar 
to those for the natural proteins (Drenth, 1995). Se-Met protein crystals are 
usually grown in the presence of DTT and EDTA to avoid oxidation. 
The crystals that form tend to be smaller and usually diffract to a lower 
resolution compared with their native counterparts (Doublie, 1997). 
Many binary Se-Met H205Q crystals of type (3) (i. e. 35-40mg/ml protein, 
ImM NADH; 20-25% PEG MME 5000,0.2M ammonium sulphate, 0. IM 
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MES pH 6.5) were grown in the presence of 0.2mM EDTA and 5mM DTT, 
as these reproducible crystals gave the best diffraction. 
Although they shared the same morphology, the Se-Met crystals that grew 
were slightly smaller than the corresponding native crystals. These crystals 
were then cryo-cooled and stored in liquid nitrogen as soon as possible again 
to avoid oxidation (Hendrickson et al., 1990) 
5.3.5 Attempts at MAD phasing 
5.3.5.1 X-ray Fluorescence: Choosing Wavelengths for MAD Data_ 
Collection 
Before starting the MAD phasing experiment at the Daresbury SRS 
laboratory (PX9.5), a X-ray fluoresence experiment was performed using a 
selenomethionyl D-HicDH protein crystal. The program CHOOCH ( Evans 
and Pettifer, 2001) was then used to calculate the anomalous scattering 
factors from the subsequent X-ray fluoresence spectrum (Figure 5.12). 
E(inf 1) = 
r mlii = 
uo 
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Figure 5.12 Plot showing experimental values for and 
f as a function of X-ray energy. 
(NB. lKeV = 12.398 /X in A). 
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The plot above clearly indicates that the Se-Met D-HicDH crystals should 
be suitable for MAD phasing experiments. 
5.3.5.2 Attempts at Data Collection at the Absorption Edge 
In all 17 binary Se-Met H205Q crystals of type (3) (P21 and C2) were 
mounted. Each crystal diffracted very poorly (5-6 AO) and had a large mosaic 
spread (-1.5'). These crystals were not adequate for MAD as this technique 
requires crystals to diffract to at least 3.5A and have a small Rmerge (to 
determine the background noise in measuring Bijvot differences) in order for 
useful phase information to be extracted. 
5.3.6 Conclusions 
Other crystal forms of the Se-Met protein were grown such as the wild 
type D-HicDH apoenzyme type (1) crystals and the H205Q mutant binary 
enzyme type (2) crystals (see Chapter 4). 
When taken up to Daresbury (PX 9.5). The alternative crystal complexes 
and forms were also found to diffract poorly and thus could not be used in 
MAD phasing. 
It seems as though the poor diffraction of the original native crystals was 
made even worse by the incorporation of selenomethionine into the protein. 
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Chapter 6 
Subunit Interface Mutants of L-Lactate 




Malaria is an infectious disease which is estimated to kill between 1.5-2.7 
million people annually (WHO, 1996), the majority of these being children 
under the age of five (Knell, 1991). Another 300 to 500 million people have 
the disease. 
A third of the world's population, -1.78 billion, live in zones where they 
are at risk of catching malaria. Countries in tropical Africa account for more 
than 90 percent of the cases and more than 6 percent occur in India, Brazil, 
Sri Lanka, Afghanistan, Vietnam and Colombia (WHO, 1987). 
6.1.2 The Causes of Malaria 
Malaria is transmitted by the parasitic protozoa of the genus Plasmodium. 
The female mosquitoes of the genus Anopheles are the sole hosts of human 
malarial parasites (Knell, 1991). Whilst feeding on blood, the mosquitoes 
transmit the Plasmodia to humans through saliva. On entering a human, the 
parasite invades a liver cell where it rapidly multiplies. Eventually, the liver 
cell ruptures and releases the parasites into the bloodstream where they infect 
red blood cells. Most parasites again reproduce, killing the red blood cells 
and then invading more blood cells. Other parasites, while in the red blood 
cells, develop into male and female form. When these cells are 
ingested by a 
feeding mosquito, the cells burst, freeing the sexual forms of the parasite. 
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The two forms merge creating an oocyst; after maturing in the stomach wall 
of the mosquito, the oocyst ruptures to release thousands of parasites. These 
then migrate to the mosquito's salivary glands. When the insect feeds on 
another human, saliva containing the parasite is injected into the blood and 
therefore the infective cycle can start again. 
There are four species of Plasmodia that infect humans: Plasmodium vivax, 
Plasmodium ovale, Plasmodium malariae and Plasmodiumfalciparum. 
The first three may cause severe illness but are rarely fatal. However, the 
fourth type of human parasite, Plasmodiumfalciparum, is much more serious 
and often leads to coma and death within a few days. 
6.1.3 Combating Malaria 
The life cycles of the Plasmodium parasite and humans are linked by the 
Anopheles vector. Initial attempts at eradicating malaria aimed to break this 
link, thus causing Plasmodium to perish. 
In 1942, the insecticide dichlorodiphenyl-trichloroethane (DDT) was 
discovered. DDT controlled the population of mosquitoes and thus reduced 
the outbreak of the malarial disease. However, despite its initial success, 
DDT failed to eradicate the disease. This failure was, in part, due to vector 
and parasite drug resistance (WHO, 1987). 
Recent malarial drug design strategies have focused on attacking the 
parasite; The main drugs in general use during the last century can be 
divided into two categories. 
The first class of anti-malarial drugs are the antifolates. These interrupt the 
synthesis of DNA in the parasite and are represented by the dihydrofolate 
reductase (DHFR) inhibitors, such as pyrimethamine and proguinal, and the 
sulfa drugs. 
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Unfortunately, antifolate resistance in both Rfalciparum and P. vivax 
developed rapidly following the introduction of pyrimethamine in many 
parts of the tropics (Knell, 1991). 
The mode(s) of action of the second class of anti-malarials is not fully 
understood. It is believed that the compounds form complexes with 
haematin, inducing aggregrate formation in the parasitic cell (Carroll and 
Behrens, 1998). This class of drugs includes the compounds quinine, 















Figure 6.1 The chemical structures of quinine, chloroquine and mefloquine. 
Chloroquine is the most widely used anti-malarial drug. Aside from 
adverse side effects related to the use of chloroquine, resistance to the 
compound (and other quinoline containing drugs) is also increasing at an 
alarming rate in all regions where malaria is endemic (Knell, 
1991). 
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The resistance of the malarial parasite, especially P-falciparum, to existing 
anti-malarial drugs is a serious and increasing problem in many parts of the 
world and the need for novel antimalarial drugs is great. The majority of 
drugs in use today act by inhibiting parasitic metabolic processes which are 
different from those of the host. Therefore in the search for new drugs, 
metabolic pathways or processes which are specific or sufficiently different 
from that of the host, are often the targets for structure-based drug design. 
6.2 Plasmodium Lalciparum L-Lactate Dehydroggenase 
Design of an effective antimalarial requires specific targeting of the 
metabolic pathways vital to the parasites' survival. The enzymes of the 
glycolytic pathway have been observed in Plasmodium, and identified both 
as potential antimalarial drug targets and indicators of blood parasitaemia 
levels in diagnosis (Makler and Hinrichs, 1993; Gomez et al., 1997; Olliaro 
and Yuthavong, 1999). 
The L-LDH enzyme from Plasmodium falciparum (PJLDH) has been 
shown to be electrophoretically, kinetically and structurally distinct from 
mammalian forms of the enzyme, including human (Vander Jagt et al., 
198 1; Dunn et al., 1996). 
Malarial parasites depend on anaerobic glycolYsis to satisfy much of their 
ATP demands (Vander Jagt et al., 198 1). They require a high level of energy 
production to maintain rapid multiplication rates 
during the asexual, 
intraerythrocytic cycle in the human host. Royer et A (1986) 
demonstrated 
that molecules which inhibit PfLDH are lethal to the parasite. 
Therefore, this 
enzyme is considered suitable as a potential antimalarial 
drug target 
(Sessions et al., 1997). 
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The crystal structure of the ternary complex of the PjLDH (enzyme + 
NADH + oxamate) revealed a number of differences compared with other 
known L-LDH structures (Dunn et al., 1996). 
Firstly, the cofactor is significantly displaced in PJLDH: The shift is more 
prominent at the nicotinamide end of NADH (closest to the active site), with 
the equivalent positions of the atoms in the nicotinamide ring differing by an 
average of 1.2A between the mammalian and malarial structures. This 
displacement of the NADH may explain why PftDH, unlike other known L- 
LDHs, is not inhibited by high levels of substrate (presumably as an adaption 
to the pyruvate-rich conditions of the red blood cell): The altered position of 
the coenzyme may cause the NAD' off-rate to increase, thus reducing the 
formation of the NAD'-pyruvate inhibitory adduct. 
Secondly, PftDH differs from other known L-LDHs in that it contains a5 
amino acid insert in the substrate specificity loop, linking (x-D/E to P-E, 
(Figure 1.4; cf. PJLDH and L. confusus L-HicDH). A distinctive cleft is 
formed alongside this extended loop, this contrasts sharply with the shallow 
groove found in the equilvalent postion in mammalian L-LDHs. It has been 
known for sometime that L-LDHs are inhibited by derivatives of gossypol 
(Royer et al., 1986), and that these compounds bind close to the 
pyruvate/nicotinamide-ribose site (Sessions et al., 1997). However, the 
gossypol derivative gossylic nitrile diacetate (GNDA) selectively inhibits 
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Figure 6.2 The chemical structures of gossypol and GNDA. 
This difference in binding may be attributed to the ability of the malarial 
enzyme to accomodate the acetyl groups of GNDA in its deep cleft. Thus, 
there is potential to use this cleft to provide selectivity in the rational 
structure-based drug design of antimalarial. 
Also, recently a crystal structure complex of PfLDH and chloroquine has 
been reported (Read et al., 1999). Chloroquine binds in a similar postion to 
that of the adenyl ring of the cofactor and acts a modest competitive 
inhibitor. Even though the mechanism by which chloroquine exerts its 
effects on Pfialciparum remains unclear. ) the 
ligand can be used to act as a 
template for new chemical compounds that specifically and efficiently 
inhibit PftDH. 
6.3 Mutations at the Subunit Interface of MLDH 
A substational amount of the PjLDH protein is required for malarial drug 
design / selectivity studies. So, in order to obtain a reproducible purification 
protocol for the enzyme a non-cleavable 6 Histidine tag had been attached at 
the C-terminus of the protein; furthermore it was shown that the 
'His-tag' 
has very little effect on the kinetic behaviour of PJLDH 
(Shoemark, 2000). 
However, it was also shown that, unless a 
high percentage of P- 
mercaptoetanol was added, the His-tagged enzyme would appear 
to run as a 
dimer at high concentrations on denaturating 
SDS PAGE. Furthermore, 
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kinetic experiments have also demonstrated that there is a loss in activity if 
the His-tagged enzyme was oxidised; and this activity could be recovered by 
the addition of dithiothreitol. 
It was thought that these unusual effects may have been the result of the 
formation of inappropriate disulphide bonds between two cysteine residues at 
the subunit interface. Indeed, the crystal structure revealed that residues C183 
and C76 came into apposition at the dimer subunit interface of the wild type 
Pft, DH (Figure 7.17). 
Of the two residues, C183 appeared to have the fewer space constraints 
exerted by the surrounding polypeptide. Therefore the cysteine 183 residue 
was substitued by valine, alanine and serine, and the atmospheric stability of 
the resulting mutants evaluated by Shoemark (2000): - 
1.2 
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Figure 6.3 Atmospheric Stability of the C183 mutants compared with the wild type 11is- 
tagged PJLDH enzyme. The samples were incubated at 25'C in a buffer containing 
50MM 
Tris and 50mM KCI at pH 7.5. A loosely applied lid was screwed onto the sample tubes. 
The results show that all the C183 mutants had enzymatic rates slightly 






Surprisingly however, the C183A and C183S mutants were not more stable 
against oxidation than the wild type PJLDH; in fact the rate of loss of 
activity for the two mutants was very similar to that for the wild type 
enzyme. 
Only the C183V mutant appeared to be slightly more stable against 
oxidation when compared with the wild type enzyme. However, this was at 
the cost of a reduction in kcat of about 40%. 
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Chapter 7 
Determination and Analysis of the Molecular 
Structures of the C183 PJLDH Subunit Interface 
Mutants 
7.1 Aims 
Frozen purified protein samples (stored in 10% glycerol at -70T) were 
obtained from Deborah Shoemark in order to determine if there were any 
structural pertubations at the subunit interfaces of the mutant enzymes, and 
whether they were the cause of the modified atmospheric stabilites in the 
C183 PJLDH mutants. 
7.2 Crystallisation of the Subunit Interface Mutant_ 
PA. 
., 
DH Ternary Complexes 
Any bound cofactor was removed from the protein by dialysing each of the 
thawed samples against 0.5glI activated charcoal until the A280nn)A260nm 
"bove 1.9. The samples were then concentrated and buffer measured anu 
exchanged against milli Q water using 30kD MWCO Centricon filters. The 
extinction coefficient at 280nm, for a 1% solution of PJLDH was taken to be 
0.47 (Dunn et al., 1996). 
Crystals of all 3 PftDH mutants of the ternary complex form were 
obtained using a method similar to one previously devised by Jonathon Read 
(unpublished results) for the wild type His-tagged enzyme. 
Crystals grew at 17'C using the hanging drop vapour diffusion method 
against a well containing 24-30% PEG 1,500. The mother liqour contained 
24-32 mg/ml protein, 200mM imidazole, 50mM Hepes pH 7.5, ImM 
NADH 
and ImM sodium oxamate. 
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Oxamate is an iso-steric and iso-electronic inactive substrate analogue of 
pyruvate which forms a stable abortive ternary complex with NADH in 







Figure 7.1 The chemical structures of pyruvate and oxamate. 
The ternary complex of the C183 mutants was found to crystallise as 
clusters of long rectangular rods. For data collection purposes, the clusters 
were separated into single crystals by micro-manipulation (Figure 7.2). 
Figure 7.2 Typical ternary complex crystals of the P)LDH C 183 mutants. 
7.3 Data Collection 
Diffraction data for the C 183 V mutant P)LDH were collected from a single 
crystal at the Daresbury-SRS laboratory (PX 7.2, ý. =1.488A) at a temperature 
of I OOK. The data statistics are surnmarised in Table 7.1. 
The in-house rotating anode X-ray source (X=1.5418A) was used to collect 
diffraction data, at 100 K, for both the C183A and C183S mutants from 
single crystals. The diffraction data statistics for the C183A and 
C183S 
proteins are summarised in Tables 7.2 and 7.3, respectively. 
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Data collected using the Daresbury SRS laboratory (PX7.2, X=1.488 AO). 
Cryoprotectant solution 32% PEG 1,500,200mM Imidazole, 
50mM Hepes pH 7.5, ImM NADH, 
ImM oxamate, 10% glycerol. 
Unit cell a=80.38, b=86.16, c=90.19, 
()C=P=Y--90' 
Space group 1222 
Total number of unique reflections 18,239 
Mean Redundancy 4.71 
Resolution 2.1A 
Mosaicity 1.36* 
Completeness - Overall (30.00-2. IA) 
Outer shell (2.07-2.1A) 
97.4% 
96.3% 









Table 7.1 Diffraction data collection statistics of the ternary C183V PfLDH mutant crystal. 




using the in-house rotating-anode X-ray source (X = 
Cryoprotectant solution 30% PEG 1,500,200mM Imidazole 
, 50mM Hepes pH 7.5, lmM NADH, 
ImM oxamate, 10% glycerol. 
Unit cell a=80.42, b=86.76, c=90.62 , 
()C=P=Y--90' 
Space group 1222 
Total number of unique reflections 35,072 
Mean Redundancy 3.84 
Resolution 1.7A 
Mosaicity 0.45* 
Completeness - Overall (22.00-1.7A) 99.7% 
Outer shell (1.76-1.7A) 99.9% 
1/ cy (1) - Overall 10.58 
Outer shell 3.19 
Rmerge 
-Overall 10.8% 
Outer shell 34.8% 
Table 7.2 Diffraction data collection statistics of the ternary CI 83A PfLDH mutant crystal. 
'3 Vm = 2.3 A /Da =* 1 molecule/a. s. u. 
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Data collected using 
1.5418A). 
the in-house rotating-anode X-ray source (X = 
Cryoprotectant solution 30% PEG 1,500,2OOmM Imidazole, 
50mM Hepes pH 7.5, ImM NADH, 
ImM oxamate, 10% glycerol. 
Unit cell a=80.49, b=86.79, c=90.80, 
OC=P=Y=900 
Space group 1222 
Total number of unique reflections 25,159 
Mean Redundancy 4.30 
Resolution 1.9A 
Mosaicity 0.76' 
Completeness - Overall (22.00-1.9A) 
Outer shell (1.97-1.9A) 
98.4% 
94.5% 









Table 7.3 Diffraction data collection statistics of the ternary C183S PftDH mutant crystal. 
(The Rmerge is particularly high in the outer resolution shell). 
'3 Vm = 2.3 A /Da => 1 molecule/a. s. u. 
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Analytical ultra-centrifugation had previously been used to show that 
PJLDH was in a tetrameric state in solution (Shoemark, 2000). And it was 
found that all three PfLDH mutants crystallised in space group 1222, with 
one monomer in the asymmetric unit. Therefore the three molecular two-fold 
axis, P, Q and R (described by Rossmann et al., 1971) must be coincident 
with the crystallographic axes. 
7.4 Solving the C183 Mutant PfLDH Structures 
7.4.1 Introduction 
After each of the data sets had been processed and reduced, the structures 
were solved using molecular replacement. A monomer of the original, 'non- 
His-tagged', wild type Pft-, DH: NADH: oxamate ternary complex was used as 
a search model in all three cases (Dunn et al., 1996, structure at 1.74A 
resolution, PDB I. D.: ILDG). 
The PDB header information, solvent molecules, and the NADH and 
oxamate ligands were removed from the model's coordinates file before 
running AMoRe. 
In each case, the top 20 rotation solutions were put into the translation 
function. Subsequently, the clear translation peak underwent rigid body 
refinement in the 'fiting' function in order to improve the solution. 
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7.4.2 SolvimF, the C183V Mutant 
Radius of integration: 25A. Cell model: 125A x 125A x 125A. 
Resolution cutoff. - 10.0-4. OA. 
Solution Rotation of Eulerian angles Correlation 
Number coefficient 
cc y (%) 
Solution 1 98.73 56.71 230.73 26.7 
Solution 2 2.24 88.57 206.31 10.2 
Solution 3 110.74 85.11 192.67 10.1 
Solution 4 177.81 90.00 28.65 10.0 
Solution 5 172.84 59.30 126.13 10.0 
Solution 6 94.00 29.56 223.50 9.9 
Solution 7 66.72 39.98 28-01 9.8 
Solution 8 44.61 30.31 59.95 9.7 
Solution 9 171.71 72.37 325.70 9.6 
Solution 10 162.22 75.53 319.00 9.6 
Table 7.4 The rotation solutions from AMoRe for the ternary C183V PfLDH mutant 
complex using the monomer of the wild type PfLDH as the search model. 
Solution 
Number 










Solution 1 98.73 56.71 230.73 0.3210 0.3105 0.0989 70.7 33.2 
Solution 2 2.24 88.57 206.31 0.0486 0.4577 0.4178 13.5 54.2 
Solution 3 110.74 85.11 192.67 0.1988 0.4385 0.0546 14.4 53.5 
Solution 4 177.81 90.00 28.65 0.2469 0.3867 0.3312 14.9 53.4 
Solution 5 172.84 59.30 126.13 0.0199 0.2468 0.2811 15.1 53.6 
Solution 6 94.00 29.56 223.50 0.0069 0.0103 0.4256 15.8 53.8 
Solution 7 66.72 39.98 28.01 0.3812 0.1618 0.2071 12.9 54.2 
Solution 8 44.61 30.31 59.95 0.1183 0.0511 0.0808 13.9 53.2 
Solution 9 171.71 72.37 325.70 0.2665 0.3098 0.0213 12.7 54.5 
Solution 10 162.22 75.53 319.00 
. ...... -. --0.2859 
0.0731 0.1220 13.8 53.9 
Table 7.5 The translation solutions from AMoRe for the ternary C183V PJLDH mutant 
complex using the monomer of the wild type PfLDH as the search model. 
Solution Rotation of Eulerian angles Translation 
Correlation R- 
Number (0) (fractions of the unit cell) coefficient 
factor 
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7.4.3 Solvin2 the C183A Mutant 
Radius of integration: 25A. Cell model: 125A x 125A x 125A. 
Resolution cutoff. - 10.0-4. OA. 
Solution 
Number 
Rotation of Eulerian angles Correlation 
coefflicient 
Solution 1 99.28 56.69 230.53 27.6 
Solution 2 107.26 14.68 20.18 10.5 
Solution 3 47.54 80.19 291.50 10.3 
Solution 4 2.75 87.06 205.50 9.9 
Solution 5 171.14 59.16 126.50 9.8 
Solution 6 162.27 60.77 239.00 9.2 
Solution 7 51.50 27.07 136.00 9.2 
Solution 8 20.60 62.55 186.97 9.1 
Solution 9 3.52 57.93 111.33 9.0 
Solution 10 36.46 58.92 229.70 8.9 
Table 7.7 The rotation solutions from AMoRe for the ternary C183A PfLDH mutant 
complex using the monomer of the wild type PJLDH as the search model. 
Solution Rotation of Eulerian angles Translation Correlation R- 
Number (0) (fractions of the unit cell) coefficient factor 
. ....... ... ... 
x y z (%) 
Solution 1 99.28 56.69 230.53 0.3210 0.3108 0.0981 72.8 31.2 
Solution 2 107.26 14.68 20.18 0.3650 0.1208 0.3437 14.5 52.6 
Solution 3 47.54 80.19 291.50 0.4276 0.4261 0.3466 12.2 53.0 
Solution 4 2.75 87.06 205.50 0.4273 0.4313 0.1965 14.2 52.0 
Solution 5 171.14 59.16 126.50 0.0393 0.0444 0.4659 15.2 52.8 
Solution 6 162.27 60.77 239.00 0.0079 0.4593 0.4086 13.1 52.9 
Solution 7 51.50 27.07 136.00 0.2835 0.0906 0.4495 13.1 52.9 
Solution 8 20.60 62.55 186.97 0.3934 0.0948 0.4583 13.0 52.1 
Solution 9 3.52 57.93 111.33 0.0007 0.2939 0.4616 13.1 52.8 
Solution 10 36.46 58.92 229.70 0.0403 0.2608 0.1371 12.7 22.2 j 
Table 7.8 The translation solutions from AMoRe for the ternary C183A PfLDH mutant 
complex using the monomer of the wild type PfLDH as the search model. 
Solution Rotation of Eulerian angles T ranslation Correlation 
R- 
Number (0) (fractions of the unit cell) coefficient factor 
(X PI-Xz (%) (%) 
Solution 1 99.89 56.63 230.25 0.3221 0.3108 0.0983 77.9 
27.5 
Table 7.9 The final solution after 'fiting' from AMoRe for the ternary 
C183A PfLDH 
mutant complex using the monomer of the wild type 
PfLDH as the search model. 
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7.4.4 SolvinLy the C193S Mutant 
Radius of integration: 25A. Cell model: 125A x 125A x 125A. 











Solution 1 99.05 56.71 230.64 29.4 
Solution 2 2.64 87.42 206.16 11.3 
Solution 3 107.17 14.70 20.18 11.3 
Solution 4 177.85 90.00 29.00 10.7 
Solution 5 172.22 58.95 127.09 9.6 
Solution 6 4.42 57.72 110.71 9.2 
Solution 7 14.15 82.45 88.21 9.1 
Solution 8 48.4 79.72 291.41 9.0 
Solution 9 94.63 29.98 224.00 8.8 
Solution 10 4.55 38.78 327.44 8.8 
Table 7.10 The rotation solutions from AMoRe for the ternary C183S PftDH mutant 
complex using the monomer of the wild type PJLDH as the search model. 
Solution Rotation of Eulerian angles Translation Correlation R- 
Number (0) (fractions of the unit cell) coefficient factor 
cc I x y z (%) (%) Solution 1 99.05 56.71 230.64 0.3210 0.3110 0.0980 74.2 30.9 
Solution 2 2.64 87.42 206.16 0.2690 0.4951 0.0549 14.1 53.3 
Solution 3 107.17 14.70 20.18 0.3651 0.1204 0.3429 14.3 53.7 
Solution 4 177.85 90.00 29.00 0.2404 0.3880 0.3375 14.6 52.8 
Solution 5 172.22 58.95 127.09 0.1879 0.4208 0.2021 15.0 52.8 
Solution 6 4.42 57.72 110.71 0.2355 0.1041 0.0354 12.7 53.8 
Solution 7 14.15 82.45 88.21 0.3181 0.1954 0.4639 14.3 53.5 
Solution 8 48.4 79.72 291.41 0.4159 0.4618 0.0088 11.5 54.2 
Solution 9 94.63 29.98 224.00 0.4371 0.3792 0.2472 15.2 52.6 
Solution 10 4.55 38.78 327.44 0.2174 0.1690 OA-99-1 
--------- 
12.8 53.5 
Table 7.11 The translation solutions from AMoRe for the ternary C183S PftDH mutant 
complex using the monomer of the wild type PXDH as the search model. 
Solution Translation Rotation of Eulerian angles Correlation R- 
Number (fractions of the unit cell) (0) coefficient factor 
(X 
-EIXYz 
(%) M [Solution 
1 99.79 56.72 230.33 0.3221 0.3109 0.0983 78.8 27.5 
Table 7.12 The final solution after 'fiting' from AMoRe for the ternary 
C183S PJLDH 
mutant complex using the monomer of the wild type PfLDH as the search model. 
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The final solutions for all three mutants have very high correlation 
coefficients and low R-factor values. 
For each C183 PJLDH mutant, the coordinates of the wild-type PfLDH 
search model were rotated and translated to the position in the unit cell 
determined by molecular replacement using the CCP4 lsqkab program. 
7.5 Crystallographic Refinement and Model Building of 
the C183 Mutant PýLDH Structures 
Prior to refinement, an Rfree test set was generated for each of the three 
mutants using the CCP4 program unique. The data sets contained 5% of the 
unique reflections (greater than 500 reflections), as required for statistical 
validity of the figure (BAinger, 1992b). 
All three structures were refined using similar methods (using all the 
available data). 
The structures were all initally subjected to twenty cycles of refinement 
using the Refinac CCP4 program (Murshudov et al., 1999), using the 
maximum-likelihood option with overall B-factor refinement. 
After converting the mtz reflection files into the appropriate cns format 
using mtz2various (CCP4), refinement of the structures was then continued 
using the CNS suite of programs (Crystallography and NMR System) 
(Briinger et al., 1998). 
After initially resetting each B-factor to 15. OA 
2, a round of simulated 
annealing (starting temperature 2500K) was run. In CNS the simulated 
annealing refinement task includes conjugate-gradient energy minimisation 
of the coordinates both before and after the simulated annealing; 
200 cycles 
of minimisation were run in both instances. This was 
followed by individual 
B-factor refinement. 
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A second round of simulated annealing (at a starting temperature of 
2500K) and conjugate-gradient minimisation (200 cycles each) were then 
run. This was followed by searching for solvent sites in jFobsj-jFcaIcj difference 
maps at positive sites with a sigma level cutoff greater than 3.0, with 
temperature factors less than 50A2 and within hydrogen bonding distance 
(3.5A) (using the waterLpick program in CNS). These sites were modelled as 
water molecules. The waterý-pick task includes 20 cycles of minimisation of 
the coordinates followed by 20 cycles of minimisation of the B-factors. 
jFobsj-jFcalcj and 21Fobsl-lFc,, Icl difference maps were then generated and 
converted to the omap format (using cns2omap) and the subsequent electron 
density maps, along with the coordinate files, viewed using the graphics 
program 0 (Jones et al., 199 1). Any water molecules that appeared 
positionally unstable (i. e. in poor electron density, near hydrophobic side 
chains, etc) were removed. 
All three C183 PJLDH mutant maps had positive densities indicating the 
presence of a NADH molecule and an oxamate molecule, these were then 
subsequently built into the maps (Figure 7.3). Moreover, positive density 
corresponding to a glycerol molecule was found in exactly the same position 
in all three mutant maps, this molecule was also built in to the structures 
(Figure 7.19). 
100 cycles of energy minimisation were then run, followed by individual 
B-factor refinement. At this stage further water molecule sites were 
identified in IF. bsi-IF,,, I, l and difference maps at positive sites > 
Ry and a B- 
factor less than 50A2. 
jFobsj-jFcaIc 1,21Fobs I-jFcaj, j and 3jFobsj-2jFcajcj electron density maps were then 
generated and the structures rebuilt (and 
ligands checked) with 0. The rsr- 
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rotamer and lego-side-chain commands in 0 were used to identify the amino 
acid sidechain conformations that fitted the electron density the best. Also, a 
macro was read into 0 that enabled the water molecules in the structures to 
be located and thus checked to see if they were in density. The occupancy of 
disordered parts of sidechains was set to zero. 
In all three mutant structures it was clearly evident that cysteine 183 (a169 
in the PDB files) had been mutated. Furthermore it was obvious that the 
positive and negative regions of electron density around this amino acid 
corresponded precisely with the proposed mutations, the appropriate amino 
acids were then substituted into the structure (Figures 7.4-7.6). The 
mutagenesis was later confirmed by sequencing the DNA of the C183V, 
C183A and C183S PftDHs (Shoemark, 2000). 
100 cycles of conjugate-gradient minimisation were then followed by 
individual B-factor refinement, which in turn was followed by a search for 
more water molecules (with > 3a and a B-factor less than 50A 
2). 
0 was then used to check the water molecules and rebuild the structure. In 
all three stuctures the alanine residue on the C-termini could not be 
positioned into density and were therefore removed from the PDBs. Density 
for the N-terminus alanine in the C183S PftDH mutant could not be 
observed and so was also removed. 
Whilst rebuilding the 3 mutant structures, it was noticed that some of the 
residues comprising the active site loop did not properly fit into electron 
density. 
The refinement procedure of minimisation followed by individual B-factor 
refinement followed by a water molecule search (with a cy value cutoff of 2.5 
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for the last round) and manual adjustment of the model in 0 was repeated a 
further two times. 
A summary of the C183V, C183A, and C183S refinement processes, along 
with the R,, rystý Rf,,,, rmsd bond lengths and angles values at each stage, are 
shown in Tables 7.13,7.14 and 7.15, respectively. 
It was evident from the Rcrsyst and Rf,,, values that the C183A mutant 
PfLDH structural data had been 'overfitted' during the final water search and 
manual rebuild, therefore the PDB coordinates after the preceding individual 
B-factor refinement were taken as the final model. The C183V model after 
the penultimate the rebuild so this was taken as the final model. The 
structure after the penultimate individual B-factor refinement step was taken 
as the model for the C183S PftDH mutant. 
The final refinement statistics for each of the three mutant structures are 
shown in Tables 7.16 - 7.18. 
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Figure 7.3 SIGAMA (CCP4) weighted 21F(, b, I-IF,,,, Il map (contoured at 1.5(y) with phases fi7om 
the final C183A P)LDH model. Electron density for NADH and oxamate can clearly be seen 




Figure 7.4 (a) SIGIMA weighted 2jF,, b, j-jFc,, jj (purple), IFobsklFcald positive difference (green), 
and jFobsj-jFc,, jj negative difference (brown) maps aH contoured at Ry with phases from the 
final C183V P)LDH model. The positive and negative difference density maps suggest that a 
valine residue is situated at this locus. (b) Sequencing of the PJLDH gene confirmed that 
there is a valine at this position. images produced using the Xfit program from the 




Figure 7.5 (a) SIGAMA weighted 21F, bI-IF, aj, l (purple) and jFobsj-jF, aj, j negative difference 
(brown) maps both contoured at Ry with phases from the final C183A P)LDH model. The 
negative difference density map suggests that a alanine residue is situated at this locus. 
(b) Sequencing of the P)LDH gene confirmed that there is a alanine at this position. 




Figure 7.6 (a) SIGAMA weighted 2jF,, b,, j-jFajcj (purple) and jFobsj-jF,,, jj negative difference 
(brown) maps both contoured at Ry with phases from the final C183S PJLDH model. The 
negative difference density map suggests that a serine residue is situated at this locus. 
(b) Sequencing of the P)LDH gene confin-ned that there is a serine at this position. 
Images produced using the Xjit program. 
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Step No. Refinement Final Rcry, t Final Rfree Geometry Procedure (%) (%) bond lengths/ 
bond angles 
AMoRe- rigid body fiting 29.1 - 
2 Refinac 26.0 29.8 0.013A/ 
1.54' 
3a Simulated annealing- 2500K 27.0 30.3 - 
3b Individual B-factor refinement 25.3 28.9 0.007A/ 
1.27' 
4a Simulated annealing- 2500K 25.1 28.9 - 
4b waterý_pick 23.7 27.5 0-006A/ 
1.21' 
5a Rebuild followed by minimisation 22.3 25.6 - 
5b Individual B-factor refinement 21.9 25.3 
5c waterý-pick 21.4 24.8 0.006A/ 
1.20' 
6a Rebuild followed by minimisation 21.5 25.0 - 
6b Individual B-factor refinement 21.3 24.9 
6c waterLpick 20.1 23.6 0.006A/ 
1.17' 
7a Rebuild followed by minimisation 17.7 21.1 - 
7b Individual B-factor refinement 17.5 20.9 
7c waterý-pick 17.1 20.8 0.005A/ 
1.14' 
8a Rebuild followed by minimisation 17.0 20.8 - 
8b Individual B-factor refinement 16.9 20.8 
8c waterý_pick 16.9 20.6 0.005A/ 
1.13' 
9a Rebuild followed by minimisation 16.9 20.7 - 
9b Individual B-factor refinement 17.0 20.6 - 
9C waterLpick 17.0 20.6 
0.005A/ 
1.13' 
10 Rebuild followed by minimisation 17.1 20.8 0.005A/ 
1.14' 
Table 7.13 Summary of crystallographic refinement and rebuilding of the CI 83V mutant. 
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step NO. Ketinement 
Procedure 
Final Rcry, t Final Rfree Geometry 
bond lengths/ 
bond angles 
1 AMoRe- rigid body fiting 27.5 
- - 
2 Refinac 26.9 29.8 0.01 IA/ 
1.49' 
3a Simulated annealing- 2500K 28.5 31.2 
- 
3b Individual B-factor refinement 26.4 29.3 0.006AO 
1.24' 
4a Simulated annealing- 2500K 26.3 29.4 - 
4b waterLpick 26.1 29.3 0.005A/ 
1.20' 
5a Rebuild followed by minimisation 26.1 29.3 - 
5b Individual B-factor refinement 26.1 29.4 
5c waterý_pick 24.3 27.7 0.005A/ 
L? 8' 
6a Rebuild followed by minimisation 23.3 26.5 
6b Individual B-factor refinement 23.2 26.4 
6c water-pick 21.3 24.0 0.005A/ 
1.18' 
7a Rebuild followed by minimisation 21.2 23.7 - 
7b Individual B-factor refinement 21.0 23.5 
7c waterýpick 20.1 22.4 0.005A/ 
1.16' 
8a Rebuild followed by minimisation 18.6 21.2 - 
8b Individual B-factor refinement 18.4 21.0 
8C waterLpick 18.0 20.7 0.005A/ 
1.18' 
9a Rebuild followed by minimisation 17.8 20.7 - 
9b Individual B-factor refinement 17.7 20.5 
9C water-pick 17.7 20.4 
0.005A/ 
1.16' 
10 Rebuild followed by minimisation 17.7 20.4 
0.005A/ 
1.15' 
Table 7.14 Summary of crystallographic refinement and rebuilding of the C183A mutant. 
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Step No. Refinement 
Procedure 




AMoRe- rigid body fiting 27.5 - - 
2 Refinac 25.3 31.8 0.010 AO/ 
1.47' 
3a Simulated annealing- 2500K 27.0 32.6 - 
3b Individual B-factor refinement 25.4 30.7 0-007k 
1.21' 
4a Simulated annealing- 2500K 25.1 30.6 - 
4b waterý-pick 23.9 29.3 0.006A/ 0 
1.20' 
5a Rebuild followed by minimisation 21.4 26.0 - 
5b Individual B-factor refinement 21.0 25.7 
5c waterý-pick 19.2 24.2 0.006A/ 
1.18' 
6a Rebuild followed by minimisation 18.9 24.0 - 
6b Individual B-factor refinement 18.7 24.0 
6c waterýpick 18.0 23.2 0.006A/ 
1.14' 
7a Rebuild followed by minimisation 17.8 22.8 - 
7b Individual B-factor refinement 17.7 22.9 
7c water-pick 17.5 22.8 
0 0.005A/ 
1.12' 
8a Rebuild followed by minimisation 17.5 22.7 - 
8b Individual B-factor refinement 17.5 22.7 
8c waterýpick 17.5 22.7 
0 0.005A/ 
1.13' 
9a Rebuild followed by minimisation 17.5 22.6 - 
9b Individual B-factor refinement 17.5 22.6 - 
9C waterLpick 17.6 22.7 
0.005A/ 
1.12' 
10 Rebuild followed by minimisation 17.6 22.7 
0.005A/ 
1.12' 






rmsd bond lengths 
rmsd bond angles 
Total number of non-H protein atoms 
Total number of NADH atoms 
Total number of oxamate atoms 
Total number of glycerol atoms 
Identified number of water molecules 
Average main-chain/side-chain B-factor 
Average NADH B-factor 
Average oxamate B-factor 
Average glycerol B-factor 

















Table 7.16 Final refinement statistics for the C183V PftDH mutant. 





rmsd bond lengths 0.005A 
rmsd bond angles 1.16' 
Total number of non-H protein atoms 2379 
Total number of NADH atoms 44 
Total number of oxamate atoms 6 
Total number of glycerol atoms 6 
Identified number of water molecules 324 
Average main-chain/side-chain B-factor 
22 6.87A / 8.96A 
Average NADH B -factor 8.23A2 
Average oxamate B-factor 9.01A2 
Average glycerol B-factor 2 13.69A 
Average B-factor for water molecules 16.94A2 
Table 7.17 Final refinement statistics for the C183A PfLDH mutant. 
Resolution range 22.0 - 1.9 AS 
F-cryst 17.5% 
Rfree 22.7% 
rmsd bond lengths 0.005A 
rmsd bond angles 1.13' 
Total number of non-H protein atoms 2385 
Total number of NADH atoms 44 
Total number of oxamate atoms 6 
Total number of glycerol atoms 6 
Identified number of water molecules 273 
Average main-chain/side-chain B-factor 5.84A 
2/7.14A 2 
Average NADH B-factor 
'2 11.51A 
Average oxamate B-factor 14.25A 
2 
Average glycerol B-factor 6.49A 
2 
Average B-factor for water molecules 16.71A 
2 
Table 7.18 Final refinement statistics tor tfie ui zs-iýi I-JLvri mutant. 
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7.6 Validation of the C183 Mutant NLDH Models 
The quality of the final C183 mutant PJLDH models were assessed using 
the CCP4 suite of programs PROCHECK (Laskowski et al., 1993) (Figures 
7.7 - 7.15). PROCHECK was also used during refinement to evaluate the 
current model. 
The Ramachandran plot (Ramachandran and Sasisekharen, 1968) shows 
that in all three models 90% of all the non-proline residues are in the 
favoured regions and the overwhelming majority of the remaining regions 
are in the allowed regions. The Chi l-Chi2 plots indicate that the models 
conform well to standard geometric criteria for their particular resolution 
ranges. Additionally, statistics for the main chain and side chain parameters 






Residues in most favculadragoms [ABý-] 2,52 91.6% 
Residues in additional allowed regiom [abjp] 21 7.6% 
Residues in gwmously allowed regions [-a, -b, -l, -pl 1 04% 
Residues in disallowed regions 1 04% 
NumtL-r ct nort-glydre and rim-proline residue: s 275 100.0% 
Nuinter ct end-residues (excl. Uly and Pm) 4 
Numter ct glycine lesidues (shown as triangles) 26 
Numbtr ct prolire residues 12 
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Figure 7.7 Ramachandran plots for the final model of the C183V P)LDH mutant, as 
produced by PROCHECK. (a) Ramachandran plot for non proline residues, (glycines shown 
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Figure 7.8 Chi I versus Chi2 plots for the residues in the final model of the CI 83V P)LDH 
mutant, produced with PROCHECK. 
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Figure 7.9 (a) Main chain and (b) side chain statistics for the final model of the C183V 
PJLDH mutant, produced with PROCHECK. 
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Plot statistics 
Residues in most favairedragons (ABl-j 251 91.9% 
Res idues in additional allmed regioms [a, t)ý, p] 21 7.7% 
Residues in gemously allowed regions C-a, -b, -I, -p] 0 0.0% Residues in disallowed regions 1 0.4% 
Numter ct non-glydre and mn-prohm residms 273 100.0% 
Number c( erd-residues (excl. Gly and Pio) 6 
Numter ct glycine residues (shown as triangles) 26 
Nuinter ct prolire residues 12 
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Figure 7.10 Ramachandran plots for the final model of the C183A PJLDH mutant, as 
produced by PROCHECK. (a) Ramachandran plot for non proline residues, (glycines shown 
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Figure 7.11 Chil versus Chi2 plots for the residues in the final model of the C183A PJLDH 
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Figure 7.12 (a) Main chain and (b) side chain statistics for the final model of the C183A 
PJLDH mutant, produced with PROCHECK. 
209 














1.0 1.5 2.0 2.5 10 3W5 4.0 
Resolution (Aftam=) 








10 LS 20 25 3'0 3'5 4.0 
Res&ýtmn (AnsM-) * 
a. Uu- 1 pQmcl mana4m wýuý 
30 35 4,0 
sumdw) 
d 183 a- Chain 
iso 
-135--b 




Residues in most favoumdragom CABL] 248 90.2% 
Residues in additional allowed regLons [abjp] 25 9.1% 
Residues in genmusly allowed regioms 1 04% 
Residues in disallowed regions 1 04% 
Numtxýr of non-glycire and ron-proline, residues 275 100.014 
Numter of ard-residues (exd. Oly and Pro) 4 
Murnter of glycine, residues (shown as triangles) 26 
Number of PMUM residues 12 






















Figure 7.13 Ramachandran plots for the final model of the C183S PJLDH mutant, as 
produced by PROCHECK. (a) Ramachandran plot for non proline residues, (glycines shown 
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Figure 7.14 Chil versus Chi2 plots for the residues in the final model of the C183S PJLDH 
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Figure 7.15 (a) Main chain and (b) side chain st atistics for the final model of the C183S 
PJLDH mutant, produced with PROCHECK. 
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7.7 Analysi s of the C 18 3 Mutant P/LDH Molecular 
Structures 
7.7.1 Reduced Enzvmatic Rates of the C 183 P/LDH Mutants 
As expected, The overall rms deviations between the WT PJLDH and three 
C 183 mutant structures were found to be small (Table 7.19). 
PILDH Structure RMS Deviation (A) 
1234 
1. WT 0.00 
2. C183V 0.99 0.00 
3. C183A 1.14 0.55 0.00 
4. C183S 1.13 0.51 0.40 0.00 
Table 7.19 Overall rms deviations between the wild type and C183 mutant PJLDH structures. 
Individual residue rms deviations amongst the 4 crystal structures where 
then calculated using the Uppsala suite Isqman program. Small but significant 
deviations in the positions of the residues involved in catalysis and substrate 
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Figure 7.16 Differences in the active sites of the C183 PJLDH mutants. (pyruvate shown 
in 
active site instead of the actual oxamate). 
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Mutation of the cysteine 183 residue causes a decrease in the enzymatic 
activity of Pft. DH: The C183S mutant has the greatest initial activity, 
followed by the C183A and C183V mutant Pft., DH enzymes, respectively 
(Figure 6.3). 
It is unclear how a mutation which is remote in both primary and tertiary 
structure from the active site can have such as an affect on kinetics. 
It seems as though the enzymatic rate of PfLDH is dependent on the degree 
to which the dimer subunit has been perturbed. The serine mutant has the 
greatest enzyme activity of the three C183 mutants presumably because it 
effects the subunit interface architecture the least (the serine residue has an 
-OH group instead of an -SH group of the cysteine residue). Indeed, two 
water molecules found closely associated with the C183 residue in the wild 
type enzyme were found in exactly the same position next to the serine 
residue in the C183S mutant. In the the C183A mutant the alanine residue is 
small and so would not alter the structure of the subunit interface. 
Furthermore, an additional water molecule in the C183A crystal structure 
was found. The C183V enzyme is the least active of the mutants presumably 
because V183 causes the greatest change at the dimer subunit interface: A 
tyrosine residue (73A) in the adjacent subunit has altered position. 
The least active mutant, C183V, has the greatest distance between the C4 
hydride of NADH and the -NH2 group of oxamate (or the methyl group of 
pyruvate). Also, the His-Asp catalytic pair are further apart in the valine 
mutant than in C183A or C183S. These slight increases in distance within 
the C183V PJLDH active site are enough to cause a 40% drop in k,,, t when 
compared to the wild type enzyme. 
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The initial activities of the C183A and C183S enzymes are approximately 
the same. This is probably due to the enzymes having very similar distances 
between their active site residues and the substrate and cofactor molecules. 
7.7.2 Oxidative Stability of the C183 MLDH Mutants 
The rationale for mutating the cysteine 183 residue in PftDH was three- 
fold (Richard Sessions, personal communication). Firstly, of the four 
cysteines in the enzyme only C76 and C183 where at the dimer subunit 
interface, therefore these residues were the most likely to form an 
inappropriate inter-subunit disulphide bond. However, the C183 and C76 
residues are too far apart (about 9.5A) in order to form a direct disulphide 
bond (Figures 7.17 and 7.18). ( The C183 residues are about 20A apart). It 
was presumed that the P-sheet on which C76 sits could undergo a minor 
conformational bringing the residue into apposition with C183. Finally, it is 
known that the association of two PXDH monomers to form a dimer is 
strong whereas the association of two dimers to form a tetramer is weak 
(Shoemark, 2000). Thus an alternative way an inter-subunit disulphide bond 
could form would be if the PJLDH structure disassociated at the tetrameric 
interface (Figure 7.17) and the two dimers re-associate by forming a 
disulphide bond between two solvent exposed C183 residues. 
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Figure 7.18 Enlarged view of a section of the tetrameric structure of His-tagged WT P)LDH. 
Image produced with Quanta. 
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Figure 7.17 Tetrameric structure of His-tagged WT P)LDH formed by the 1222 symmetry in the crystal. Produced with Mo1script (Kraulis, 199 1). 
Surprisingly, of the three C183 mutations only the valine substitution 
appeared to very slightly increase the stability of PfLDH against oxidation 
(Figure 6.3). 
The CCP4 program CONTACT was then used in order to ascertain whether 
there were any inter-subunit contacts/steric clashes in the various oligermic 
states of the protein that might help to explain the slight oxidative stability of 
the C183V PjLDH mutant. However, no such contacts were found. 
It is possible that C183 and C76 do not form a disulphide bond. On closer 
inspection of the PfLDH structures a cysteine residue (13 1) was found to be 
at the solvent exposed surface of the subunit. At high enough protein 
concentrations, this residue may be involved in the formation of inter-subunit 
disulphide bonds, and could lead to the affects described in Chapter 6. 
As mentioned earlier, a glycerol molecule was found to be present in all 
three C183 mutant PftDH structures (it is also present in the wild type 
enzyme). The ordered glycerol has either soaked into the crystal from the 
cryoprotectant solution or has come from the original protein storage buffer. 
The molecule binds at the subunit interfaces of the tetrameric structure 
(Figures 7.17 and 7.19). 
The glycerol molecule's location helps to explain the stabilising influence 
of 10% glycerol on dimer subunit association reported by Shoemark (2000). 
Adams et al. (1973) found an exchangeable anion binding site at the tetramer 
subunit boundary of dogfishM4 L-LDH that could bind citrate, sulphate, 
oxamate or pyruvate. Moreover, Hall et al. (1995) found that sucrose had a 
stabilising effect On the folding of rabbit muscle LDH and on 
its dimeric 
association. Therefore it is presumed that sucrose may stabilise rabbit muscle 
LDH in a similar manner that glycerol stabilises PJLDH. 
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7.8 Conclusions 
Although the C 183 mutations were far from the active site of the P)LDH 
enzyme, the mutations still lead to a substantial decrease in activity. It is 
unclear as to how a mutation at the subunit interface would affect the active 
site architecture. However, it is probable that the decrease in enzymatic rate is 
the result of a structural change at the dimer subunit interface which leads an 
increase in the distances between the amino acid residues involved in 
catalysis and substrate binding and the substrate and cofactor molecules. 
It difficult to determine whether the residues C 183 and C76 form a 
disulphide bond between subunits. However, a solvent exposed cysteine 
residue was found. This residue, C 13 1, could lead to the formation of 
inappropriate disulphide bonds and may help to explain the atmospheric 
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Figure 7.19 SIGAMA weighted 21F,, b, l-lFc,, I, l map (contoured at 1.5(; ) from the final C183A 
PJLDH model. Electron density corresponding to a glycerol molecule was seen in the same 
position in all three PJLDH mutant models (the asterisks' denotes water molecules). 
Image produced using 0. 
instability of the enzyme. Thus, mutagenesis of C131 may lead to a more 
stable form of the PfLDH enzyme. 
A glycerol molecule is present at the subunit interface of the C183 mutant 
(and wild type) PftDH structures. This may help to explain the stabilising 
influence of 10% glycerol on subunit association in PfLDH. It may be 
possible to further enhance the stabilisation of the oligorneric state of the 
enzyme by using other small solutes such as sucrose and glucose. 
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Chapter 8 
Crystallisation and Preliminary Characterisation of 
the Structure of a Recombinant Triple Mutant Pig 
M4L-LDH 
8.1 Introduction 
1.1 Mammalian LDH Isoenzymes 
Vertebrate LDH's consist of four catalytically independent, tetrahedrally 
arranged subunits. Each subunit is approximately 36kD. Three forms of 
subunit are expressed in mammals, termed H, M and X. The X form appears 
to be restricted to postpubertal testes. The distribution of the H and M 
isoenzymes in aerobic and anaerobic forms reflects their different affinites 
for lactate and pyruvate (Holbrook et al., 1975). The isoenzymes have 
evolved with common catalytic mechanisms but different susceptibilities to 
inhibition by NAD+-pyruvate to suit their different metabolic roles. H4 
(consisting of four H subunits) predominates in the heart. The H4 LDH 
catalyses the 'reverse' reaction (pyruvate to lactate) so that lactate from the 
tissues can fuel the heart. M4 is the major LDH isoenzyme in anaerobic 
skeletal muscle. 
The different subunits can combine to form mixed or hybrid tetramers (H4, 
MH3, M2H2, MA andM4), so it seems likely that the energy of inter-subunit 
contact is independent of isoenzyme type. An amino acid sequence 
comparison of the 12 known vertebrate reveals that the same isoenzymes 
from different species are more homologous than different isoenzymes from 
the same species. This suggests that the vertebrate isoenzymes are ancient 
and have remained distinct since the evolution of vertebrates. 
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8.1.2 A Recombinant Triple Mutant PigM4LDH 
Attempts to target LDH for specific drug design (e. g. PftDH for 
antimalarials) required a good model for the human LDH structures. The pig 
LDH isoenzymes were used as models, as the isoforms share considerable 
sequence identity. The pig and human LDH enzymes have a sequence 
identity of 97% and 92% between H and M isoforms respectively (Figure 
1.4). Furthermore, in the pigM4LDH structure all 23 differing residues are 
all on the surface of the protein away from the active site (El Hawarani et al., 
1996). Therefore, the Pig M4 LDH serves as an excellent model for human 
M4LDH. (Very recently the structures of the human M and H forms of LDH 
have been solved (Read et al., submitted for publication) and it was shown 
that the human and pig M subunits have an r. m. s. d of just 0.56A. ) 
In order to carry out antimalarial selectivity trials a large amount Of pig M4 
LDH was required. This was achieved by overproduction of the enzyme in 
E. coli: The pig lactate dehydrogenase A cDNA was ligated into pKK223-3 
and the plasmid was subsequently transformed into Exo1i TG2 cells (Otto 
Manhertz, unpublished results). However, during the synthesis of the 
recombinant three sets of non-silent mutations were introduced into the gene. 
This lead to the production of a recombinant pig muscle LDH with three 
amino acid mutations; S202N, V204I and F332L (Figure 
8.5). The genetic 
mutations were eventually repaired, allowing the overproduction of 
recombinant 'wild type' LDH- 
The enzymatic activties of the various forms of the pig muscle 
LDH were 
compared (Otto Manhertz, unpublished results) 
(Table 8.1): - 
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Protein kat Km Ki 
(S-1) pyruvate (mm) 
- 
(mM) 
Wild type (non-recombinant) 402 0.365 1.271 
'Wild type' (recombinant) 369 0.423 0.571 
Mutant 262 0.329 0.918 
Table 8.1 Kinetic constants of the various forms of pig muscle LDH. 
The enzymatic rate of the recombinant triple mutant pigM4LDH is about 
60% that of the wild type non-recombinant protein. How could three 
mutations remote from the active site have such an effect on the kinetics of 
the enzyme? This question was addressed by obtaining the structure of the 
triple mutant LDH enzyme. 
8.2 Protein Purification and Crystallisation 
8.2.1 Protein Expression 
The E. coli cells, carrying the pKK223-3 plasmid harbouring the pig A L- 
LDH gene, were selected by growing the cells in rich media containing 
lgg/n-d ampicillin. 
A glycerol stock of the E. coli cells was streaked out onto 1.6% LB agar 
and grown overnight at 37C. A single bacterial colony was used to 
innoculate 5ml L Broth. This was then grown at 37'C for 6 hours in a 
shaking incubator. The 5ml culture was then used to innoculate 500ml L 
Broth. When the culture had reached an 
A600nm of 0.5 (mid-log phase of 
growth), protein expession was induced by the addition of lmM IPTG. 
The 
cells were then allowed to grow for a further 2 hours. 
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8.2.2 Protein Purification 
The cells were harvested by centrifugation at 4,000rpm for 20 minutes at 
4'C. A suspension of the cells was prepared using a minimal volume of 
50mM TEA pH 6.0 prior to sonication on ice, using 3 repeats of 15 second 
medium-power bursts. The subsequent cell debris was then pelleted by 
centrifugation at 4'C for 20 minutes at 18,000rpm. The supernatant was then 
dialysed against 50mM TEA pH 6.0 overnight. 
The protein was then purified using a procedure similar to that described 
by Wilks et al. (1992). The dialysate was spun at 18,000rpm for 20 minutes 
at 4'C in order remove any sediment. After dialysis, NADH was added to the 
protein at a final concentration of 200gM. 
The dialysate was then loaded onto an affinity column packed with 100ml 
oxamate-Sepharose (Sigma) which had been pre-equilibrated with dialysis 
buffer, containing 100ýM NADH. After unbound protein had been eluted 
with column buffer, the triple mutant pig muscle L-LDH was eluted with 
50mM TEA pH 9.0,0.25M NaCl. LDH activity was determined by 
monitoring the drop in NADH absorbance at 340nm when the LDH sample 
was added to an assay mixture at 25'C (Figure 8.1). The assay mixture 
consisted of 0.2mM NADH, lmM sodium pyruvate buffered with 50mM 
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Figure 8.1 Plot of bound fraction eluting from the oxamate-Sepharose column using 0.25M 
NaCl. The elution profile was followed by measuring the drop in NADH absorbance at 340nm when the LDH sample was added to an assay mixture at 25T. 
The eluate was centrifuged at 18,000rpm for 20 minutes at 4'C in order 
remove any insoluble material. Then the supernatant was dialysed against 
50mM TEA pH 7.5. The protein was then loaded onto a 150ml Q-Sepharose 
column which had been pre-equilibrated with 2 column volumes of 50mM 
TEA pH 7.5. The protein was then eluted with a 500ml 0-0.5M NaCl 
gradient. The LDH protein eluted at around 0.2M NaCl. Again LDH activity 
was by measured by monitoring the drop in NADH absorbance at 340nm on 
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Figure 8.2 Plot of bound fraction eluting from the Q-Sepharose column using a 0-0.5M 
NaCl gradient. The LDH protein eluted at around 0.25M NaCl. The elution profile was 
followed by measuring the drop in NADH absorbance at 340nm when the LDH sample was 
added to an assay mixture at 25'C. 
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SDS-PAGE analysis showed that the protein had been purified to 
homogeneity (gel not shown). The protein was then filter sterilised using a 
0.22ýtm syringe driven filter, and then stored at 4'C in 40% (w/v) ammonium 
sulphate. 
8.2.3 Crvstallisation 
After purification, the protein concentration of the sample was measured 
by recording the absorbance spectrum of the sample. The extinction 
coefficient at 280nm, of a 1% solution of pig muscle L-LDH was taken to be 
1.39 (Jecsai, 1962). If the A280, m/A260nmmeasured above 1.9, the purified 
protein sample was dialysed against 0.5gll activated charcoal in order to 
remove any bound cofactor. The samples were then concentrated and buffer 
exchanged against milli Q water using 30kD MWCO Centricon filters. 
Crystals of the Pig M4 L-LDH/NADH/oxamate temary complex were 
obtained by using a modified method to that proposed by Stinson and 
Gutfreund (described in Hackert et al., 1973). Diamond-shaped prism like 
ternary crystals grew at 4'C using the hanging drop vapour diffusion method 
against a well containing 1.73-1.78M 
(NH4)2SO4. The mother liqour 
contained 3.5-4.5 mg/ml protein, 20mM TEA pH 7.9-8.1,240ýM NADH 
and 24mM sodium oxamate. 
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Figure 8.3 Ternary complex crystals of the S202NN2041/F332L pig muscle L-LDH. 
8.3 Data Collection 
The in-house rotating anode X-ray source (?, =1.5418A) was used to collect 
diffraction data at I OOK from a single pig muscle L-LDH crystal. The data 
statistics are surnmarised in Table 8.2. 
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Cryoprotectant solution 1.8M (NH4)2SO4,2OmM TEA pH 
8.0,24OgM NADH, 24mM 
oxamate, 30% glycerol. 
Unit cell a=59.13, b=135.35, c=84.79, 
()C=D=Y--900 
Space group P2,212 
Total number of unique reflections 14,695 
Mean Redundancy 2.64 
Resolution 2.9A 
Mosaicity 1.62' 
Completeness - Overall (20.00-2.9A) 
Outer shell (3.12-2.9 A) 
92.9% 
85.3% 









Table 8.2 Diffraction data collection statistics of the pig M4 LDH mutant triple mutant 
ternary complex crystal. 
03 Vm = 4.7 A /Da =* 2 molecule/a. s. u. 
The data were found not to be complete. However, the completeness of the 
diffraction data could not be improved upon as other pigM4 LDH triple 
0 
mutant crystals did not diffract to a high enough resolution (-3. A). 
The pig muscle L-LDH triple mutant crystallises in the P21212 space group, 
with two molecules in the asymmetric unit. This implies that one of the 
tetramer 2-fold rotation axes is parallel to the crystallographic 2-fold axis 
(Hahn, 1995; Hackert et al., 1973). 
The diffraction data were then processed and reduced. 
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8.4 Solving the PigM4LDH Triple Mutant Structure 
The structure was solved by molecular replacement using the AMoRe 
program. The monomeric structure of a ternary complex of wild type pigM4 
LDH (Dunn et al., 1991) (with the NADH and oxamate removed) was used 
as a search model. 
The top 10 rotation peaks obtained (Table 8.3) were used in the translation 
function (Table 8.4), to identify the first translation solution. This was then 
fixed and used to find the translation solution for the second molecule in the 
asymmetric unit (Table 8.5). The two solutions obtained clearly stand out 
from the background. Rigid body refinement was preformed via 'fiting' in 
AMoRe, to maximise the correlation between the calculated and observed 
structure factor amplitudes, giving the final positions of the solutions (Table 
8.6). 
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Radius o integration: 25A. Cell model: 125A x 125A x 125A. !f 
Resolution cutoff. - 10.0-4. OA. 
Solution Rotation of Eulerian angles Correlation 
Number coefficient 
y (%) 
Solution 1 45.57 74.94 344.48 17.9 
Solution 2 72.70 73.97 343.60 16.2 
Solution 3 70.11 52.81 29.65 10.9 
Solution 4 73.50 48.97 20.61 10.8 
Solution 5 137.45 90.00 190.52 9.3 
Solution 6 42.55 90.00 9.63 9.3 
Solution 7 55.51 89.00 313.75 8.9 
Solution 8 123.50 90.00 134.68 8.9 
Solution 9 177.06 52.16 147.40 8.9 
Solution 10 172.33 82.43 179.23 8.6 
Table 8.3 The rotation solutions from AMoRe for the pigM4LDH mutant triple mutant 
ternary complex using the monomer of the wild type Pig M4 LDH as the search model. 
Solution 
Number 
Rotation of Eulerian angles 
(0) 
UP 
- -- -- y 
Translation 






Solution 1 45.57 
- 74.94 344.48 0.1092 0.3749 0.2331 30.6 48.0 
Solution 2 72.70 73.97 343.60 0.2269 0.4081 0.0688 30.3 47.3 
Solution 3 70.11 52.81 29.65 0.3221 0.0337 0.4701 9.1 54.2 
Solution 4 73.50 48.97 20.61 0.4577 0.3482 0.0220 8.6 53.9 
Solution 5 137.45 90.00 190.52 0.3817 0.4289 0.0415 9.9 53.6 
Solution 6 42.55 90.00 9.63 0.1213 0.4298 0.4614 9.6 53.8 
Solution 7 55.51 89.00 313.75 0.0988 0.0336 0.0574 9.8 53.6 
Solution 8 123.50 90.00 134.68 0.9909 0.0789 0.1070 10.1 53.6 
Solution 9 177.06 52.16 147.40 0.3545 0.3152 0.4310 7.5 53.9 
Solution 10 172.33 82.43 179.23 0.3346 
-- ............. -. - 
0.2731 0.2036 8.8 54.0 
Table 8.4 The initial translation solutions from AMoRe for the Pig M4 LDH mutant triple 
mutant ternary complex using the monomer of the wild type Pig M4 LDH as the search 
model. 
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Solution Rotation of Eulerian angles Translation Correlation R- 
Number (0) (fractions of th e unit coefficient factor 
cell) 
. . ...... ... L y X y z Fixed 45.57 74.94 344.48 0.1092 0.3749 0.2331 30.6 48.0 
Solution 1 
Solution 2 72.70 73.97 343.60 0.7238 0.9082 0.0685 61.0 36.8 
Solution 3 70.11 52.81 29.65 0.8279 0.5088 0.9054 21.7 50.8 
Solution 4 73.50 48.97 20.61 0.7571 0.0974 0.6986 21.6 50.9 
Solution 5 137.45 90.00 190.52 0.2325 0.4284 0.3603 22.3 50.5 
Solution 6 42.55 90.00 9.63 0.2667 0.9287 0.6403 22.2 50.4 
Solution 7 55.51 89.00 313.75 0.5868 0.0179 0.8939 22.1 50.5 
Solution 8 123.50 90.00 134.68 0.4157 0.8737 0.6066 22.2 50.4 
Solution 9 177.06 52.16 147.40 0.0604 0.0514 0.7008 21.4 50.6 
Solution 10 172-33 82.43 179.23 0.4442 0.9820 0.2375 21.6 
Table 8.5 A search for the second translation solution for the Pig M4 LDH mutant triple 
mutant ternary complex from AMoRe after fixing the first solution and using the monomer 
of the wild type pig M4 LDH as the search model. 
Solution Rotation of Eulerian angles Translation Correlation R- 
Number (0) (fractions of the unit cell) coefficient factor 
cc YXYz 
Solution 1 45.78 75.22 344.94 0.1100 0.3741 0.2314 68.8 32.9 
Solution 2 72.51 74.88 344.68 0.7251 0.9091 0.0679 68.8 32.9 
Table 8.6 The final solutions after 'fiting' from AMoRe for the pig M4 LDH mutant triple 
mutant ternary complex using the monomer of the wild type Pig M4 LDH as the search 
model. 
The coordinates of the wild-type Pig M4 LDH search model were then 
rotated and translated to the position in the unit cell determined 
by molecular 
replacement. 
The dimer in the asymmetric unit was then constructed in the graphics 
program 0 using the monomer and symmetry equivalents. 
As with the wild 
type enzyme, the P21212 packing of the triple mutant pig muscle 
LDH 
produces a tetramer (Figures 8.4 and 8.5). 
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y 
Figure 8.4 The packing arrangement of the tetramer in the pig M4 LDH crystals. Viewed down the the Z axis, with the unit cell outlined. (The P, Q, R are described by Rossmann et 
al., 1971). 
Figure 8.5 Tetrameric structure of the wild type Pig M4 LDH formed by the P2,212 symmetry 
in the crystal. The residues shown were accidently mutated. Produced with MoIscript. 
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F332 -.., -3 nA 
8.5 Crystallo graphic Refinement and Model Biiiidin 
The low resolution and incompleteness of the data made refinement of the 
structure difficult owing to the low observation to parameter ratio. 
After generating an Rfree test set, the structure was subjected to a round of 
simulated annealing in CNS at a starting temperature of 2500K (with the B- 
factors reset to 30. OA2) . The 
Rcryst value decreased substantially. However, 
the Rf,,, value remained high (Table 8.7), this may suggest that the data were 
being over-fitted. 
The structure then underwent overall B factor refinement. This was 
followed by searching for solvent sites in jFobsj-jFc,, jcj difference maps at 
positive sites with a sigma level cutoff greater than 3.0, with temperature 
'2 factors less than 50A and within hydrogen bonding distance (3.5A). As 
expected, only a small number of such peaks were found (15 peaks). IFobsl- 
lFcalcl and 2jFobsj-jFcaIcj were then generated and the electron density maps, 
along with the coordinate files, viewed in 0. Only 4 of the solvent sites were 
modelled as water molecules. The electron density maps were very poor in 
places: There were many regions of the molecule where the electron density 
was discontinous (Figure 8.6). Attempts were made at rebuilding the 
structure. 
The three mutations in pigM4LDH were built into the structure (Figures 
8.7-8.9). However, the electron density for the S202N mutation was rather 
ambiguous. 
The R-factors still had not improved after re-building and conjugate 
minimisation of the model. 
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As there are two LDH subunits in the asymmetric unit, NCS (Non- 
Crystallographic Symmetry) constraints were applied during refinement. The 
rotation and translation matrix relating one molecule to the other was 
calculated using lsqkab. Maximum likelihood refinement was then carried 
out using Refinac version 5 (this has a bulk solvent correction alogarithm). 
Unfortunately, the R-factors and electron density maps did not improve. 
Without over-fitting the data it was not possible to refine the structure 
further. 
p No. Refinement 
Procedure 







1 AMoRe- rigid body fiting 32.9 - 
2 Simulated annealing- 2500K 24.8 34.5 
3 Overall B-factor refinement 23.6 33.21 0.009A/ 
1.54' 
4 water-pick 24.1 33.3 
5 Rebuild followed by minimisation 23.7 33.2 - 
6 Overall B-factor refinement 23.6 33.3 0.010k 
1.56' 
7 NCS averaging followed by Refinac 5 23.6 33.4 
Table 7.13 Summary of crystallographic refinement and rebuilding of the Pig M4 triple 
mutant LDH. 
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"d, -IF, I negative .1 
(purple, contoured at 2a), and IF, )bsl al Figure 8.6 SIGAM weighted 2117obsl-117c 
difference (brown, contoured at 3(; ) maps. Some regions of the map have large breaks in 




Figure 8.7 (a) SIGAMA weighted 2jF. bj-jF,, a, (purple, contoured at 10), and IFobsl-lFc . alcl 
positive difference (green, contoured at RF) maps. The S202N mutation is not clearly evident. 





Figure 8.8 (a) SIGAMA weighted 2117obsj-117,, ýI, j (purple, contoured at la), and jFbj-jF,, jj 
positive difference (green, contoured at 3(7) maps. There is some positive density, suggesting 
that there is a branched residue at this locus. (b) Substitution of the valine 204 residue by 




] (purple, contoured at I ), F C- Fc Figure 8.9 (a) 
SIGAUA weighted 2117obsj-117rý GI obsj I alcl POSitiVC 
difference (green, contoured at 3(; ), and Fobsi-117calcl negative difference (brown, contoured at 
3(; ) maps. The negative difference map suggests that phenylalanine shoud not be present at 
this position. Moreover, the 2jF&, j-jFca1cj maps shows that there is a branched residue at this 
locus. However, the electron density is discontinuous. (b) Substitution of the phenylalanine 
residue at position 332 by leucine. Images produced using the Xfit program. 
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8.6 Discussion 
Although the quality of the structure of the triple mutant pigM4LDH is 
rather poor, it is possible to speculate on how the triple mutation in LDH 
could have an effect on enzyme activity. 
The loss in activity of the mutant could be attributed to the destabilising 
change at residue 202. The serine at position 202 in the wild type Pig M4 
LDH forms two hydrogen bonds with glutamate 309 (Figure 8.10). However, 
the asparagine residue at position 202 in the triple mutant structure could 
occur in a position where it only forms one hydrogen bond with the 
glutamate (Figure 8.11). This destabilisation is likely to be compounded by 
the change of valine at position 204 to the larger isoleucine residue as the 
residue is in the vinicity of the asparagine residue at position 202. Finally, 
the mutation of the last amino acid in the triple mutant, F332L, has 
presumbably no effect on the activity of the enzyme as the phenylalanine and 
leucine residues are remote from the other amino acids. 
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Figure 8.11 In the triple mutant pig M4 LDH structure Asn 202 forms just one hydrogen 
bond with Glu 309. (Image taken from the current model of the triple mutant Pig M4 LDH) 
Producedin 0. 
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Figure 8.10 In the wild tYPe Pig M4 LDH structure Ser 202 forms two hydrogen bonds with 
Glu 309. Producedin 0. 
Summary 
The aim of the work presented in this thesis was to understand the kinetic 
and mechanistic properties of NAD+-dependent D- and L- 2-hydroxyacid 
dehydrogenases and their mutants from a structural point of view. 
L-bulgaricus D-2-hydroxyisocaproate dehydrogenase (D-HicDH) catalyses 
the NAD'-dependent stereospecific and reversible reduction of a broad 
spectrum of aliphatic and aromatic 2-ketoacids. Previous site-directed 
mutagenic studies had shown that substitution of histidine at position 205 
with glutamine leads to a dramatic increase in the catalytic efficiency of the 
enzyme. By elucidating the structure of the the wild type and mutant D- 
HicDH I had hoped to gain further insight into the molecular basis of the 
enzyme's mechanism, substrate specificity and stereospecificity. 
Numerous crystal forms of the wild type and H205Q mutant D-HicDH 
were found. However, attempts at phasing the subsequent diffraction data 
using several molecular replacement programs were unsuccessful. The 
inability to solve the D-HicDH structure using some of the data sets may 
have been due to incompleteness of the data. However, the inability to solve 
the structure may suggest that there are substantial structural differences 
between the target and search molecules. 
The multiple isomorphous replacement method was then used in an 
attempt to phase the D-HicDH data sets. Unfortunately, numerous attempts at 
preparing heavy atom derivatives had been unsuccessful. 
This was due to the 
poor diffraction by the soaked crystals, 
high mosaicity, nonisomorphism and 
/ or low occupancy of the heavy atoms within the crystals. 
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The multiwavelength anomalous dispersion phasing method was then 
employed to try to solve the D-HicDH structure. In order to obtain a usable 
anomalous signal, methionine residues in the protein had to be substituted 
for selenomethionine. 100% Selenomethionyl incorporation into the protein 
was eventually achieved by transforming the plasmid harbouring the D- 
HicDH gene into a methionine auxotrophic cell strain. However, the 
subsequent Se-Met D-HicDH were not of sufficient quality for MAD 
phasing experiments. 
The L-lactate dehydrogenase from Plasmodium falciparum is a target for 
antimalarial drug design. Previous kinetic experiments had shown the 
enzyme to be catalytically unstable against oxidation. This was thought to be 
the result of inappropriate inter-subunit disulphide bond formation. In order 
to stabilise the enzyme, one of the cysteine residues at the subunit interface 
was mutated to valine, alanine and serine. The mutations did not increase the 
oxidative stability of PJLDH and in fact reduced the catalytic activity of the 
enzymes by varying degrees. The structures of these three single mutant 
PJLDH have been solved. The models show that the loss in activity due to 
oxidation is probably not the result of disulphide bond formation at the 
subunit interface. 
On analysing the three mutant PftDH, it seems as though the initial 
enzymatic rate is dependent on the degree to which the dimer subunit has 
been perturbed. 
All three mutant PJLDH structures clearly show electron density for a 
glycerol molecule at the dimer interface of the tetramer. 
This is interesting 
because 10% glycerol is known to stabilise the tetramer. Thus, it may be 
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possible to further enhance the stabilisation of the oligomeric state of the 
enzyme by using other small solutes such as sucrose and glucose. 
Pig M4 L-LDH is used as a model for human M4 L-LDH in antimalarial 
selectivity studies. In order to overproduce the enzyme, the gene encoding 
the pig muscle LDH had previously been ligated into a pKK plasmid, this 
was then transforned into an E. coli strain. On sequencing of the gene 3 sets 
of non-silent mutations were discovered. This had the effect of mutating 3 
residues in the protein. Even though the mutations are at remote sites from 
the active site, the recombinant triple mutant pigM4LDH has a k,,, t drop of 
40% compared to the wild type. The crystal structure of the mutant has been 
solved. The model shows that the loss in activity of the mutant could 
probably be attributed to a destabilising change due to the S202N mutation. 
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